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Cell cycle regulation is essential for all organisms and has profound impacts on 
development, tissue regeneration, and when aberrant, results in cancer. Mitosis, the 
process of nuclear division, is highly regulated by posttranslational modifications 
including sumoylation. The SUMO family consists of three paralogs, SUMO-1, -2 and -3, 
which are covalently attached to the lysine residues of substrates and affects substrate 
localization, function, and/or protein-protein interactions. In this thesis, we hypothesized 
that dynamic SUMO modification and demodification is essential for mitotic progression 
and that deregulation of the sumoylation machinery can lead to mitotic defects resulting 
in cancer. We analyzed the function of sumoylation in mitosis by a two-pronged 
approach. First, we conducted a mass spectrometry study to identify the proteins 
sumoylated in mitosis, which will provide a foundation for future studies identifying the 
molecular mechanisms of mitotic SUMO functions. Secondly, we characterized two 
SUMO deconjugating enzymes, SENP1 and SENP2, to enhance our understanding for 
how sumoylation is regulated temporally and spatially in mitosis. We demonstrated that 
sumoylation is required for chromosome alignment through SENP2 overexpression 
studies. Furthermore, we demonstrated that desumoylation is required for a timely 
metaphase to anaphase transition through SENP1 siRNA knockdown analysis. Finally, 
we conducted a literature review to describe the functions of sumoylation in regulating 
chromatin structure, which may impact the mitotic functions of sumoylation in 
chromosome condensation and/or centromere structure. In its entirety, this thesis presents 
a foundation of mitotic SUMO substrates for further analysis and a mechanism of 
isopeptidase-mediated regulation of sumoylation in mitosis. 
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Mitosis is highly regulated by posttranslational modifications (PTMs), including 
phosphorylation, ubiquitination, and sumoylation. Further characterizing how mitosis is 
regulated is critical for enhancing our knowledge about mitotic aberrant events like 
cancer cell division. In this chapter, I will focus on sumoylation and explain how this 
PTM occurs and functions in the cell. Then, I will summarize the studies demonstrating 
that small ubiquitin-related modifiers (SUMOs) regulate mitosis at multiple stages and 
through a variety of mechanisms.  
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MAIN TEXT 
Post-translational modifications and cell cycle regulation 
Cell cycle regulation is essential for all organisms and has profound impacts on 
development, tissue regeneration, and when aberrant, results in cancer. Post-translational 
modifications (PTMs) are a hallmark of cell cycle regulation because of their highly 
dynamic nature and ability to alter protein function. Since the discovery of the cyclin 
proteins, ubiquitination and phosphorylation have been shown to be critical regulators of 
the cell cycle. In particular, mitosis, the phase that ensures high fidelity chromosome 
segregation between mother and daughter cells, is highly regulated by PTMs. 
Phosphorylation occurs early in mitosis to promote chromosome alignment. At the 
metaphase to anaphase transition, rapid dephosphoylation and ubiquitination occurs to 
initiate turnover of the mitosis specific proteins and reset the mitotic state. However, in 
recent years, the small ubiquitin-related modifier (SUMO) has also been demonstrated to 
play a key role in mitotic regulation, which will be the focus of this chapter.  
 
SUMO Family and the Function of the SUMO signal 
The small ubiquitin-related modifier (SUMO), like ubiquitin, is conjugated to 
other proteins through an isopeptide linkage between the carboxyl-terminus of SUMO 
and the lysine residue of a target protein. Both ubiquitin and SUMO are synthesized as 
precursor proteins that must be cleaved by isopeptidases to expose a C-terminal GG-
motif, which makes the proteins functional for conjugation (1). In vertebrates, four 
different SUMO paralogs have been identified in the genome: SUMO-1, SUMO-2, 
SUMO-3, and SUMO-4 (Figure 1A). However, SUMO-4 contains a non-conserved 
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proline residue that prevents precursor processing into the mature form and thus cannot 
function as a PTM (2). SUMO-2 and -3 share ~97% identity and cannot be distinguished 
with current tools and are thus often referred to collectively as SUMO-2/3. In contrast, 
SUMO-1 only shares ~50% identity with SUMO-2/3 and is functionally unique from the 
other two paralogs (3). For example, SUMO-1 but not SUMO-2 can complement a yeast 
strain deficient in yeast SUMO, known as smt3 (H. Newman, unpublished). Furthermore, 
the different SUMO paralogs have unique localizations and modify unique substrates in 
interphase and mitosis (Figure 1B) (4). Thus, SUMO-1 and SUMO-2/3 and their 
characterized functions in mitosis will be the focus on this chapter. 
SUMO generates unique signals through the unique paralogs, monosumoylation, 
polysumoylation, and a combination of sumoylation and other PTMs (Figure 1C). 
SUMO-1 and SUMO-2/3 are conjugated to distinct pools of protein substrates. For 
example, SUMO-1 is required for proper Ran GTPase-activating protein (RanGAP1) 
targeting to the nuclear pore complex (NPC) (5), while SUMO-2/3 is required for CENP-
E targeting to the kinetochore (4). Furthermore, SUMO can form polymeric chains that 
act as another unique signal, which is illustrated by preferential binding of RNF4 to 
polymeric SUMO-2 (6). Finally, there is now evidence that hybrid SUMO-ubiquitin 
chains are important in the recruitment of DNA repair factors to sites of DNA damage, 
further illustrating how combinations of PTMs can further diversify the SUMO signals 
(7). 
Once a protein has been modified by SUMO, it can interact with proteins 
containing a SUMO-interacting motif (SIM). The best dcharacterized SIM is a 
hydrophobic patch (V/I-X-V/I-V/I) with a flanking acidic patch (8). However, other non-
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consensus SIMs have been discovered, like the noncanonical SIM in CoREST1, so other 
novel SIMs are likely to be characterized in the future (9). Thus, once a protein is 
sumoylated it can be recognized by proteins containing SIMs, and more specifically by 
proteins containing tandem binding motifs that recognize SUMO and the target protein 
itself, like in the case of Srs2 recognition of sumoylated PCNA (10). Enhanced protein-
protein interactions by sumoylation can occur between two proteins, as in Srs2 and 
PCNA, or alternatively, can result in the formation of large multimeric protein 
complexes. The best-characterized example of large protein complex formation by 
SUMO occurs through the sumoylation of the promyelocytic leukemia protein (PML). 
The combination of SUMO modification and SUMO binding activity of PML allows for 
large structures of PML to form PML-nuclear bodies that act as hubs for organizing and 
recruiting proteins containing SIMs (11,12). 
Because sumoylation acts as a PTM, it affects the function of many key cellular 
processes including the stress response, chromatin structure, DNA repair and mitotic 
progression (13,14). The effects of sumoylation on each individual substrate protein can 
vary dramatically. Sumoylation can affect the enzymatic activity of a protein like 
thymine DNA glycosylase (TDG), where sumoylation promotes TDG enzymatic turnover 
(15). In addition, sumoylation can affect the stability of a target protein in two ways. 
Sumoylation can promote the degradation of proteins by recruiting SUMO-targeted 
ubiquitin ligases like RNF4, which ultimately targets that protein for degradation by the 
proteosome (6). In contrast, sumoylation of lysine residues can compete for 
ubiquitination of these resides to antagonize the degradation of a protein. Finally, the 
most common effect of sumoylation is the alteration of protein-protein interactions, 
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which can impact the localization, binding partners, and ultimately the function of the 
modified protein.  
 
SUMO Conjugation and Deconjugation 
Sumoylation occurs through a three enzyme cascade analogous to, but distinct 
from, the ubiquitination pathway (Figure 2). First, SUMO is processed into its mature 
form by SUMO-specific isopeptidases (16,17). After a C-terminal diglycine motif has 
been exposed, the heterodimeric SUMO-activating enzyme called Aos1/Uba2 activates 
SUMO (1). The E1 enzyme utilizes ATP to form a thiol-ester bond between SUMO and a 
cysteine residue on the E1 (1).  Then, the E1 can interact with E2, the SUMO-conjugating 
enzyme called Ubc9, and transfer SUMO to a high-energy thiolester bond on Ubc9 
(18,19). The SUMO is then transferred to the target protein, with or without the 
requirement of a SUMO E3 ligase.  
Ubc9 can interact directly with target proteins and transfer SUMO to the !-amino 
group of the substrate lysine. This can occur by Ubc9 recognizing the sumoylation 
consensus site, " -K-X-D/E, where " is a hydrophobic residue and X is any amino acid, 
and thus, and modify the K residue within this sequence. (20-23).  In addition, Ubc9 can 
recognize target proteins through their SIM domains. The SUMO-charged Ubc9 is 
recognized by a SIM in the target protein, which facilitates Ubc9 interaction with the 
target protein and ultimately, sumoylation of a lysine residue on that protein (24). 
Notably, this second mechanism of Ubc9 transfer also explains the paralog specificity of 
modification observed in proteins like BLM, where the BLM SIM preferentially 
recognizes SUMO-2, resulting in its preferential modification by SUMO-2 (24).  
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In addition to direct SUMO modification by Ubc9, sumoylation can also require 
the activity of a SUMO E3 ligase. In vitro, the requirement for E3 ligases in SUMO 
conjugation assays depends on the concentration of Ubc9 (25). Thus, in the context of a 
cell, SUMO E3 ligases are likely to be critical for sumoylation. To date, multiple SUMO 
E3 ligases have been identified. The best-characterized family includes Siz1, Siz2, and 
Mms21 in yeast and the protein inhibitor of STAT (PIAS) proteins in higher eukaryotes, 
which all contain a conserved SP-RING domain. These RING-domain containing SUMO 
E3 ligases function as a scaffold to bring SUMO-charged Ubc9 into close proximity with 
the substrate protein in an analogous fashion to the ubiquitin RING E3 ligases. However, 
other non-RING E3 ligases have also been described, such as RanBP2 and Pc2, whose 
mechanisms for enhancing sumoylation of substrates are still not fully understood (26-
29). Because there is only one SUMO E1 enzyme and one E2 enzyme, the E3 ligases are 
likely to be important for regulating substrate recognition and specificity of sumoylation 
in vivo.  
In addition to regulation at the conjugation level, sumoylation can be regulated by 
deconjugation as well. The first SUMO isopeptidases identified were Ulp1 and Ulp2 in 
yeast (16,30). Since this time, six related isopeptidases have been identified in vertebrates 
(SENP1, SENP2, SENP3, SENP5, SENP6, SENP7) (17). The SENPs belong to the CE 
class of cysteine proteases that contain a catalytic triad of aspartate, histidine and cysteine 
(31). These enzymes share a conserved C-terminal catalytic domain that confers unique 
paralog specificity for each isopeptidase (Figure 3A) (17). The SENPs also contain 
divergent N-terminal domains. The N-terminus of Ulp1 regulates localization and 
substrate specificity, and thus it has been suggested that the N-termini of the SENPs have 
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an analogous function (32). The vertebrate SENPs localize to unique cellular structures: 
SENP1 and SENP2 localize to NPCs, SENP3 and SENP5 to the nucleolus and SENP6 
and SENP7 to the nucleoplasm (Figure 3B) (33-37). Notably, the isopeptidases are not 
functionally redundant, as the SENP1 and SENP2 knockout mice are embryonic lethal 
(38,39). More recently, other non-classical SUMO isopeptidases have been identified, 
including Wss1 in yeast and DeSI-1 and Uspl-1 in mammals (40-42). However, the 
functional significance of these isopeptidases remains to be determined. 
Because sumoylation is reversible, it is the balance between SUMO conjugation 
and deconjugation that creates the steady state level of sumoylation in cells. This concept 
is demonstrated by the mechanism for SUMO-1 specific modification of RanGAP1. 
RanGAP1 is efficiently modified by SUMO-1 and SUMO-2/3 but only SUMO-1 
modified RanGAP1 can bind RanBP2, which protects this modification from cleavage by 
isopeptidases. Thus, knockdown of either RanBP2 or SENP1 and SENP2 results in an 
increased accumulation of SUMO-2 modified RanGAP1, demonstrating the delicate 
balance between sumoylation and desumoylation (43). Notably, the interplay of dynamic 
conjugation and deconjugation results in a very low percentage of a given substrate to be 
sumoylated at a time, which has been termed the “SUMO enigma” (44). Precisely how 
such a small pool of a sumoylated substrate can have a profound effect on the function of 
a protein remains an important question in the field today.  
 
SUMO is a regulator of mitosis 
Sumoylation was shown to be critical for mitotic progression before SUMO was 
even discovered when Seufert and colleagues demonstrated that ubc9 temperature 
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sensitive mutants arrest in G2/M (45). Shortly thereafter, the yeast form of SUMO, smt3, 
was identified as a high copy suppressor of mif2 mutants, the vertebrate CENP-C 
homolog, suggesting a role for SUMO in centromere structure (46). Since these initial 
studies, genetic manipulation of the SUMO E1, E2, and E3 enzymes exhibited mitotic 
arrest phenotypes in Drosophila melanogaster, Saccharomyces pombe, Danio rio, and 
mammalian cells, demonstrating a conserved requirement for SUMO in mitotic 
progression (4,47-50). Surprisingly, dynamic desumoylation is also required for proper 
mitotic progression because knockdown or genetic manipulation of the SUMO 
deconjugating enzymes also leads to G2/M arrests (16,51-53). Thus, sumoylation and 
desumoylation are both required for mitotic progression, suggesting a critical temporal 
regulation for sumoylation throughout mitosis. 
Microscopy studies have demonstrated that sumoylation is regulated spatially and 
temporally throughout the mitotic cycle. In Saccharomyces cerevisiae, smt3 localizes to 
mitotic chromosomes, but in mammalian cells, the different SUMO paralogs localize to 
distinct mitotic structures (54). SUMO-1 localizes to the mitotic spindle and moves to the 
spindle midzone in anaphase, while SUMO-2/3 colocalizes with centromeres in the early 
phases and associates with whole chromosomes after metaphase (4). Thus, the different 
SUMO paralogs are uniquely regulated spatially in mitosis and also exhibit temporal 
regulation at the metaphase to anaphase transition.   
The mechanisms regulating the dynamics of sumoylation in mitosis are still 
poorly understood. Recent data demonstrated that two SUMO E3 ligases, PIASy, and 
PIAS3, are centromere associated in mitosis, suggesting a role in promoting centromeric 
SUMO-2/3 modification (55-57). Furthermore, another SUMO E3 ligase called RanBP2 
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localizes to kinetochores and mitotic spindles, indicating a potential role in regulating 
SUMO-1 modification on the spindle (58,59). However, further studies are required to 
determine the functional impact of these E3 ligases on mitotic sumoylation. Notably, the 
yeast isopeptidase Ulp1 and the mammalian SENP5 also change localization in mitosis, 
indicating that these enzymes could also be regulating sumoylation dynamically in 
mitosis (51,60). Ulp1 is released from NPCs in mitosis to regulate septin sumoylation at 
the budneck and thus, is a genuine regulator of mitotic sumoylation (60). Thus, there is 
preliminary evidence that the SUMO E3 ligases and isopeptidases are regulating 
sumoylation temporally and spatially in mitosis.  
As reviewed below, a number of hallmark studies have provided evidence that 
sumoylation is required at nearly every regulated step in mitosis. In the remainder of this 
chapter, I will highlight the roles of sumoylation in many of the key regulatory steps of 
mitosis including DNA condensation and decatenation, sister chromatid cohesion, 
chromosome segregation, and finally cytokinesis.  
 
Chromosome Condensation 
Sumoylation has been implicated as a regulator of chromosome condensation. 
One of the non-core subunits of the condensin complex, Ycs4 (the homolog of vertebrate 
CAP-D2), is sumoylated, but the function of this sumoylation is still unknown (61). 
However, there is evidence that sumoylation promotes chromosome condensation in flies 
and mammals. Hypocondensation of mitotic DNA occurs in mouse embryonic fibroblasts 
(MEFs) hypomorphic for Ubc9 and in flies containing a mutant form of the E3 ligase 
Su(var)2-10. (62,63). Because defects in chromosome condensation can be caused by 
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defects in general chromatin structure, the condensin complex or in DNA decatenation 
(64), further studies are required to determine which process sumoylation is regulating to 
produce these hypocondensation phenotypes.  
 
DNA decatenation  
 Sumoylation also plays a pivotal role in the proper decatenation of DNA. For 
example, MEFs hypomorphic for Ubc9 have increased chromosome bridges and broken 
chromosomes, suggesting the DNA was catenated at the time of division (63). In 
Xenopus laevis extracts, topoisomerase II!, the major decatenase enzyme, is 
preferentially modified by SUMO-2/3 and this modification has been proposed to occur 
specifically during mitosis (65). Even though sumoylation has no direct effect on the 
decatenase activity of topoisomerase II! in vitro (65), evidence in multiple organisms 
suggests that SUMO regulates topoisomerase II! targeting to centromeres. In yeast, 
expression of a topoisomerase II!-SUMO fusion protein caused enrichment of 
topoisomerase II! at centromeres (66). Furthermore, MEFs hypomorphic for the SUMO 
E3 ligase RanBP2 have reduced topoisomerase II! recruitment to centromeres and 
exhibit high levels of chromosome bridges in anaphase, suggesting a defect in 
decatenation (67). A comparable phenotype is seen in HeLa cells with knockdown of 
another SUMO E3 ligase PIAS#, which has reduced recruitment of topoisomerase II! to 
centromeres and heavily catenated DNA that cannot segregate (49). Thus, sumoylation of 
topoisomerase II! at least partially regulates its activity through the proper targeting and 
recruitment to centromeres, which are sites of still heavily catenated DNA in mitosis.  
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However, why sumoylation acts as a signal for topoisomerase II! recruitment to 
centromeres is still not understood. Treatment of HeLa cells with ICRF-187, a 
topoisomerase inhibitor, increases the sumoylation of topoisomerase II! and results in the 
retention of SUMO-2/3 associated with mitotic chromosomes (68). Agostinho and 
colleagues interpreted this result to signify that sumoylation occurs on catalytically 
committed topoisomerase species, which were artificially stabilized by the inhibitor 
treatment (68). One prediction based on this model could be that sumoylation facilitates 
the recycling of topoisomerase II! from DNA after it has been catalytically active. 
Notably, in vitro analyses have demonstrated that SUMO-modified topoisomerase II! has 
a lower affinity for DNA than the unmodified forms, supporting a model for sumoylation 
facilitating the recycling and optimal activity of topoisomerase II! (65). However, this 
recycling model for SUMO regulation of topoisomerase II! does not explain why loss of 
sumoylation results in the failed recruitment of topoisomerase II! to centromeres. Thus, 
further biochemical studies are required to determine precisely how sumoylation 
regulates topoisomerase II function temporally and spatially in mitosis.  
 
Cohesion Maintenance 
 Sumoylation was first identified as a negative regulator of cohesion through 
genetic studies. In S. cerevisiae, either overexpression of the isopeptidase Ulp2, or 
knockdown of Ubc9 increased cohesion between sister chromatids, suggesting that 
sumoylation has a pro-separation function (69). This anti-cohesion activity of SUMO is 
at least partially explained by sumoylation of Pds5, a protein known to regulate sister 
chromatid cohesion. Pds5 mutants are defective in cohesion but their phenotypes are 
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suppressed by Ulp2 overexpression, suggesting that removal of SUMO from Pds5 
promotes the maintenance of cohesion (70). Furthermore, phosphorylation of Ulp2 by the 
kinase cdc25 inactivates the pro-cohesion activity of Ulp2, providing an explanation for 
the temporal regulation of this process (71). This mechanism has yet to be demonstrated 
in vertebrates. Furthermore, a recent study in DT40 chicken cells demonstrated that 
SENP1-/- cells, which are in a hyper-sumoylation state, have reduced cohesive capacity in 
the presence of microtubule destabilizing agents, supporting the hypothesis that 
sumoylation is a negative regulator of cohesion in vertebrates (72). 
In addition to Pds5, multiple components of the cohesion complex itself have 
been shown to be sumoylated, including Scc1 (73-75). One of the greatest challenges in 
studying the function of sumoylated complexes like cohesin is the production of SUMO-
deficient mutants for all complex subunits. For example, a lysine-less Scc1 mutant has 
normal sister chromatid cohesion in mitosis but it is unclear if sumoylation of other 
subunits compensates for SUMO-less Scc1 (74). Thus, to evaluate the functional role of a 
completely SUMO-deficient cohesin complex, Almedawar and colleagues created an 
Scc1 fused to the SUMO isopeptidase Ulp1 catalytic domain. S. cerevisiae cells 
expressing the Scc1-Ulp1 catalytic domain fusion were not functional for maintaining 
centromere cohesion in metaphase (75). Surprisingly, this result suggests that 
sumoylation is a positive regulator for cohesion, which opposes the function of SUMO in 
the Pds5 pathway. Notably, MEFs hypomorphic for Ubc9 also exhibited reduced 
cohesion, demonstrating that sumoylation can also be a pro-cohesion signal in vertebrates 
(63). Thus, cohesion is an example of one of the many cellular processes that is regulated 
by sumoylation in a dichotomous manner. Sumoylation of different proteins in the same 
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pathway, like Pds5 and Scc1, can have opposing effects, highlighting the importance of 
studying how sumoylation affects cellular functions at the level of the substrate protein.  
 
Chromosome segregation  
 Genetic studies have implicated sumoylation and desumoylation as critical 
regulators of chromosome segregation. For example, SUMO E3 ligase mutants in S. 
cerevisiae and S. pombe exhibit increased mini-chromosome loss (66,76). Furthermore, 
endogenous chromosome segregation defects have been observed in flies and mammalian 
cells with mutants in Su(var)2-10 and RanBP2, supporting a requirement for sumoylation 
in chromosome segregation (62,77). These defects in chromosome segregation observed 
in a hypo-sumoylation environment are at least partially due to faulty chromosome 
alignment because chromosome congression defects are observed with overexpression of 
SENP2 or knockdown of Ubc9 (4). Notably, desumoylation is also required for proper 
chromosome segregation, as siRNA knockdown of SENP6 also results in the 
misalignment of chromosomes (53). Because chromosome segregation depends on proper 
kinetochore-microtubule interactions and the mitotic spindle, the functions of SUMO in 
each of these processes will be discussed next.  
 
Centromere and kinetochore structure 
In mammalian cells, sumoylation is critical for regulating centromere structure by 
two mechanisms: maintaining the chromatin environment and regulating the stability of 
proteins in the constitutive centromere associated network (CCAN). The human 
centromere is composed of !-satellite DNA that extends up to 4 Mbp and is a 
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predominantly heterochromatin environment (78). Sumoylation of the heterochromatin 
protein, HP1!, is critical for its targeting to the centromere and thus, establishing the 
heterochromatin environment of the centromere. Notably, this sumoylation must be a 
transient event, as SENP7 desumoylates HP1! after recruitment to allow proper HP1! 
enrichment at the centromere (52,79). Thus, HP1! is a nice example of the “SUMO 
enigma,” where low levels of sumoylation are critical for function (44). In addition, 
SUMO regulates the stability of two of the proteins present in the CCAN called CENP-H 
and CENP-I. When sumoylated, CENP-H and CENP-1 are targeted for degradation by 
the proteosome via the SUMO-targeted ubiquitin E3 ligase called RNF4 (53). However, 
CENP-H/I protein levels are kept stable by the activity of the chain editing isopeptidase 
SENP6, suggesting a role for sumoylation in maintaining the proper complement of 
proteins required for the CCAN (53). Thus, sumoylation appears to be critical for the 
basic structure of the centromere, affecting the chromatin structure and CCAN proteins.  
Notably, sumoylation has also been implicated as a regulator of the outer 
kinetochore, which is layered on top of the CCAN and regulates kinetochore and 
microtubule attachments. Knockdown of the SUMO E3 ligase RanBP2 results in the 
failed recruitment of kinetochore proteins (CENP-E, dynein, and CENP-F) and spindle 
assembly checkpoint proteins (Mad1, Mad2, and Zw10), suggesting that sumoylation 
facilitates the formation of protein complexes at kinetochores (80). A role for SUMO in 
the formation of dynamic subcomplexes in the kinetochore was confirmed when CENP-E 
targeting to kinetochores was shown to be SIM-dependent (4). However, which 
kinetochore proteins are being sumoylated to promote this complex formation is still 
poorly understood. Besides protein complex formation, the function of sumoylated 
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kinetochore proteins is still largely unknown (Table 1). However, it is clear that two 
components of the RZZ complex, Rod and ZW10, are important for recruiting the SUMO 
E3 ligase PIASy to kinetochores, which is required for strong SUMO-2/3 association 
with kinetochores in X. laevis (55). PIAS3 and RanBP2 are also found on kinetochores, 
so it will be important determine how these E3 ligases regulate the sumoylation of 
kinetochore proteins and thus, the formation of dynamic SUMO-dependent protein 
complexes in the kinetochore (57-59).  
 
Mitotic spindle 
Sumoylation is important for proper spindle structure and positioning in the cell. 
In S. cerevisiae, a mutant allele of smt3 was identified to have short mitotic spindles, 
resulting in a reduced distance between sister chromatids after separation (54). 
Furthermore, smt3 and ubc9 mutants also have a spindle alignment defect that prevents 
proper asymmetrical division at the budneck, which was at least partially mediated by 
sumoylation of Kar9 (81). These phenotypes have yet to be characterized in vertebrates, 
but RanBP2 localization to mitotic spindles suggests a conserved role for sumoylation in 
spindle function (59). Notably, desumoylation also regulates spindle function. In 
mammalian cells, SENP6 knockdown results in an increased distance between spindle 
poles and between sister chromatid kinetochores, suggesting a defect in regulation of 
spindle tension (53). Thus, there is preliminary evidence in the literature that SUMO is 
regulating spindle dynamics but further investigation is required to understand the 
molecular mechanisms involved.  
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Cytokinesis and septin sumoylation 
Finally, a role for sumoylation in cytokinesis has been suggested by studies of 
sumoylated septins in yeast (23,60). Yeast strains lacking septin sumoylation can cycle 
normally, but accumulate old bud scars because sumoylation is required for the proper 
disassembly of septin rings after mitotic exit (23). Siz1 and Ulp1 temporally regulate 
septin sumoylation, providing another example for the requirement for dynamic 
sumoylation in regulating mitotic processes (60,82). Septin sumoylation has not been as 
well characterized in vertebrates, but there are examples of cytokinesis defects in 
mammalian cells upon manipulation of the SUMO pathway. For example, knockdown of 
RanBP2 or expression of a SUMO-less Aurora B results in an increase in multinucleated 
cells (80,83). Dynamic sumoylation also appears to be critical for cytokinesis in 
vertebrates, as knockdown of SUMO isopeptidases also results in an increase in 
multinucleated cells (84). Future studies are required determine precisely how 
sumoylation affects proper cytokinesis divisions.  
.  
SUMO is a master regulator of mitosis 
 In this thesis, I will investigate the functional role of sumoylation in mitosis 
through a two-pronged approach. Because sumoylation can affect mitotic processes in a 
dichotomous fashion, as was highlighted throughout this chapter, it is critical that more 
mitotic SUMO-modified proteins be identified. Thus, in Chapter 2, I utilized a 
combination of cell fractionation, immunopurification, and mass spectrometry to identify 
the SUMO-2/3 modified proteins associated with mitotic chromosomes. In addition, I 
conducted an analysis of two SUMO isopeptidases, SENP1 and SENP2, to better 
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understand the temporal and spatial regulation of sumoylation in mitosis, which is 
presented in Chapter 3. For this study, I utilized a combination of overexpression and 
knockdown studies to decipher the functional role of SENP1 and SENP2 in mitotic 
progression. In Chapter 4, I conducted a literature analysis of the role of sumoylation in 
chromatin structure because understanding how sumoylation impacts chromatin structure 
could have important implications on its mitotic functions in centromere structure and 
chromosome condensation. Finally, I conducted a more targeted study of SENP1 to 
further characterize the molecular mechanism involved in a metaphase to anaphase 
progression defect observed with SENP1 knockdown, which is presented in the 
Appendix. In its entirety, this thesis provides a foundation for further analysis of the roles 
of sumoylation in regulating progression through mitosis, and for understanding how 
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Figure 1-1.  The SUMO paralogs modify distinct proteins and act as unique signals. 
(A) Cartoon schematic showing the precursor forms of the four SUMO paralogs found in 
vertebrates. The diglycine motif (GG) that must be exposed by isopeptidase cleavage to 
form mature SUMO is shown. Percent identity between the SUMO paralogs is also 
depicted. (B) HeLa cells were fixed, permeabilized and stained with antibodies specific 
for SUMO-1 or SUMO-2/3. DNA was stained with DAPI. SUMO-1 localizes diffusely in 
the nucleoplasm, to the nuclear rim, and is observed in bright nuclear foci that represent 
PML nuclear bodies. SUMO-2/3 localizes diffusely in the nucleoplasm and is also 
observed in PML nuclear bodies but is excluded from nucleoli and the nuclear rim. Bar = 






Figure 1-2.  The SUMO modification pathway. SUMO is translated as a precursor 
protein that is cleaved to mature SUMO by a family of isopeptidases (SENPs). Mature 
SUMO is activated by the E1 enzyme, Uba2/Aos1, and transferred to the SUMO 
conjugating enzyme Ubc9. Ubc9 interacts with the SUMO E3 ligases to directly transfer 
SUMO to a substrate protein. Desumoylation of a substrate occurs through the activity of 




Figure 1-3.  The domain structure and localization of the SENPs, a family of SUMO 
isopeptidases. (A) Cartoon schematic showing the domain structure of the isopeptidases. 
The conserved catalytic domains are shown in blue (CD) and the divergent N-termini are 
shown in red. Known targeting signals within the N-terminus are highlighted in green. 
Differences in the isopeptidase activity inherent in the catalytic domains of the SENPs 
are summarized on the right (36). (B) Cartoon schematic showing the unique cellular 




Table 1-1. Sumoylated proteins in mitosis. This table lists the previously identified 
sumoylated proteins in mitosis. The E3 ligases and isopeptidases known to interact with 
these proteins are also listed. However, many of the studies did not conduct exhaustive 
analysis of the E3 ligases or isopeptidases, so other sumoylation enzymes may also 
interact with each substrate.  
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  SENP1  SENP2 Unknown (4,85) 



















































    Unknown (87) 
Nuf2 Kinetochore   SENP2 Unknown (4) 
PARP1 Unknown PIASy   Unknown (25) 








































































SUMO modification of proteins (sumoylation) is essential for mitotic progression 
from yeast to humans, but only a limited number of sumoylated proteins with functions in 
mitosis have been discovered. Vertebrates express three SUMO paralogs, SUMO-1, 
SUMO-2 and SUMO-3, which are uniquely associated with chromosomes in mitosis. In 
this study, we used chromosome spreads to more precisely define the localization of 
endogenous SUMO-2 and SUMO-3 to the centromere as well as the chromosome protein 
scaffold. Furthermore, we developed methodologies for the immunopurification of 
endogenous SUMO-2 and SUMO-3 modified proteins from cell extracts. Using nLC-
ESI-MS/MS, we identified proteins immunopurified from mitotic chromosome fractions 
and from G0 nuclei as a comparison. We identified a total of 244 putative sumoylated 
proteins (results have been deposited in the ProteomeXchange, identifier PXD000381), 
with 149 of these proteins being associated with the mitotic chromosome fraction. We 
identified proteins with known mitotic functions and that localize to centromeres, 
kinetochores and the chromosome protein scaffold, consistent with SUMO-2 and SUMO-
3 localization. Our results provide a foundation for characterizing the functions of 
sumoylation in regulating diverse aspects of mitotic function from chromosome 
segregation to cytokinesis. 
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INTRODUCTION 
 The small ubiquitin-related modifiers (SUMOs) are covalently conjugated to 
other proteins and regulate many essential cellular processes including transcription, 
DNA repair, and mitosis (1,2). Invertebrates express only one SUMO to regulate these 
diverse processes but vertebrates express three SUMO paralogs (SUMO-1, SUMO-2, and 
SUMO-3). While SUMO-2 and SUMO-3 share 97% identity and are referred to 
collectively as SUMO-2/3, SUMO-1 only shares ~50% identity with SUMO-2/3 (3). All 
three paralogs are conjugated to target proteins through an enzymatic cascade involving 
an E1 activating enzyme, an E2 conjugating enzyme and a family of SUMO E3 ligases. 
(3). Once sumoylated, the modified protein is often recognized by downstream factors 
containing SUMO-interacting motifs (SIMs), which can affect protein complex 
formation, localization, and/or stability (3). Paralog-selective SIMs may underlie the 
distinct effects of the different SUMO paralogs (4-6). In general, however, paralog-
specific functions are still poorly understood. SUMO-modified proteins are also 
recognized by a family of cysteine isopeptidases (SENPs) that deconjugate SUMO, 
reversing the sumoylation process (7). As a relatively small fraction of most sumoylated 
proteins is modified at steady state, dynamic sumoylation appears to underlie many of the 
diverse cellular functions of the SUMO pathway (8). 
 Like phosphorylation and ubiquitylation, sumoylation is increasingly being 
recognized as an important mitotic regulator. Early genetic studies in yeast discovered an 
important role for sumoylation in mitotic progression (9,10). Subsequent studies from 
yeast to humans further demonstrated that sumoylation and desumoylation are both 
critical for mitotic progression, chromosome condensation, and sister chromatid 
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segregation (11). In mammalian cells, sumoylation is globally down-regulated as cells 
enter mitosis, however SUMO-1 and SUMO-2/3 are uniquely regulated following mitotic 
entry. SUMO-1 modified proteins localize predominantly to the mitotic spindle and 
modification by SUMO-1 remains low as mitosis progresses. In contrast, SUMO-2/3 
modified proteins localize to mitotic chromosomes and modification by SUMO-2/3 
increases from metaphase to telophase. This increase in SUMO-2/3 modification 
correlates with immunofluorescence data showing SUMO-2/3 restricted to the 
centromere/kinetochore in early mitosis, but along the length of the chromosomes in the 
later stages (5). Understanding the functional significance of the temporal and spatial 
changes in SUMO-2/3 modification during mitotic progression requires the identification 
of relevant SUMO-modified proteins. However, a comprehensive analysis of proteins 
modified by SUMO specifically during mitosis has not been previously reported.  
 To date, the best-characterized functions for sumoylation in mitosis have come 
from targeted analyses of a limited number of SUMO-modified proteins. For example, 
sumoylation of topoisomerase II! has been shown to be critical for the proper 
decatenation of sister chromatids at the metaphase to anaphase transition (12-16). In 
addition, sumoylation of centromere and kinetochore proteins have been shown to be 
critical for kinetochore assembly and function (5,7,17-19). However, sumoylation outside 
of the kinetochores and centromeres is largely still unexplored.  
 To develop a more complete understanding of the roles of sumoylation in mitosis, 
we have analyzed SUMO-2/3 modification of proteins on mitotic chromosomes at a 
global level. We refined the localization of SUMO-2/3 modified proteins in 
prometaphase arrested cells, showing that SUMO-2/3 localizes to the centromere and the 
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chromosome protein scaffold. Furthermore, we developed a procedure for 
immunopurifying sumoylated proteins using an antibody recognizing endogenous 
SUMO-2/3.  Using this procedure in combination with mass spectrometry, we identified 
SUMO-2/3 modified proteins associated with purified mitotic chromosomes and, for 
comparison, G0 nuclei. We identified a total of 244 putative SUMO-2/3 modified 
proteins, with 149 of these proteins being identified in the mitotic chromosome fraction.  
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MATERIALS AND METHODS 
Cell culture and synchronization  
For immunofluorescence, HeLa cells were cultured on glass coverslips at 37°C 
and 5% CO2 in Dulbecco’s modified eagle medium (Gibco) supplemented with 10% fetal 
bovine serum, 1% penicillin-streptomycin and 10 mM HEPES (pH=7.2-7.5). For SUMO-
2/3 immunopurifications, HeLa cells were grown in suspension cultures at 37°C and 5% 
CO2 in minimum essential medium eagle (Sigma) supplemented with 5% fetal bovine 
serum, 1% penicillin-streptomycin, and 2 g/L sodium bicarbonate. HeLa cells were 
synchronized with an overnight treatment of 100 ng/ml nocodazole prior to harvest. This 
resulted in an approximately 50% mitotic population, defined by counting condensed 
propidium iodide-stained DNA by fluorescence microscopy.  
 
Antibodies 
The monoclonal antibody to SUMO-2/3 (8A2) (5) was purified from mouse ascites fluid 
by DEAE ion exchange chromatography (20) and immobilized onto Affigel-10 beads 
(BioRad) according to the manufacturer’s protocol. For each immunopurification 
experiment, 6.5 mg of 8A2 (experimental) or 6.5 mg of mouse control IgG (Protein Mods 
LLC, Wisconsin) were immobilized onto 2 ml of Affigel-10 beads. The other antibodies 
used in this study were obtained from the following sources: CREST human auto-
antibodies from Dr. Ted Salmon (University of North Carolina, NC); anti-TIF1b (ADI-
KAM-TF200) from Enzo Life Sciences; anti-topoisomerase IIa (sc-13058) from Santa 
Cruz Biotechnology; anti-SMC4 from Dr. Tatsuya Hirano (Riken, Japan); anti-phospho-
histone H3-Ser10 (06-570) from Upstate-Millipore); anti-histone 3 (39163) from Active 
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Motif; anti-Hsp90 (610418) from BD Transduction Laboratories; and anti-KIF4A from 
Genetex (GTX115579). 
 
Immunofluorescence microscopy  
To obtain chromosome spreads, HeLa cells were treated with 100 ng/ml 
nocodazole for 4 hours, permeabilized, fixed, and post-permeabilized as previously 
described (21). Permeabilization buffers were supplemented with 20 mM N-
ethylmaleimide (NEM) to inhibit SUMO-specific isopeptidases. Immunostaining was 
done as described previously (22). Images were collected using a Zeiss Observer.Z1 
fluorescence microscope with an Apotome VH optical sectioning grid and were 
processed using the AxioVision Software Release 4.8.2.  
 
Cell fractionation  
For mitotic samples, four liters of synchronized HeLa cells were harvested by 
centrifugation and a chromosome fractionation was conducted using a modification of 
described protocols (23). Notably, the lysis buffer was supplemented with 10 mM NEM. 
After dounce lysis, lysates were spun at 200 x g for 5 minutes to remove unlysed cells 
and intact nuclei. The lysate was layered onto 15% sucrose cushion and spun for 30 
minutes at 2,000 x g. The supernatant was removed and discarded. The pellet was 
resuspended in RIPA Buffer (20 mM Tris-HCl pH=7.5, 150 mM sodium chloride, 2mM 
EDTA, 1% sodium deoxycholate, 1% triton x-100) supplemented with 1% SDS, 10 mM 
NEM and protease inhibitors (5 mg/ml leupeptin, 5 mg/ml pepstatin A, and 1 mM PMSF) 
and used as the soluble chromosome fraction in subsequent steps. 
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For G0 samples, the initial lysis steps were identical to the chromosome 
fractionation protocol. After dounce lysis, lysates were spun at 200 x g for 5 minutes to 
pellet intact nuclei and the soluble fraction was removed. The nuclei pellets were 
resuspended in RIPA Buffer supplemented with 1% SDS, 10 mM NEM and protease 
inhibitors and used as the soluble nuclear fraction in subsequent steps.  
 
Immunopurification 
The chromosome fraction or nuclear fraction was sonicated (3 times for 15 sec) 
and diluted 1:10 in RIPA supplemented with 10 mM NEM and protease inhibitors to 
reduce the SDS concentration to 0.1%. The sample was spun for 2 hours at 50,000 x g. 
The supernatant was collected, passed through a 0.22 mm filter. The input was split 
equally between Affigel-10 beads containing immobilized SUMO-2/3 antibody or mouse 
IgG control antibody 4˚C (see antibody section for more information). Samples were 
washed 4X with RIPA buffer supplemented with 0.1% SDS and 4X with the elution 
buffer (20 mM Tris-HCl pH = 7.5, 500 mM sodium chloride, 2 mM EDTA, 0.1% sodium 
deoxycholate, 0.1% triton x-100 and 0.1% SDS). Samples were eluted in elution buffer 
supplemented with 0.5 mg/ml of an 8A2 epitope-specific peptide (IRFRFDGQPINE), 
TCA precipitated, and analyzed by mass spectrometry. For validation of the mass 
spectrometry results, immunopurification elutions were analyzed by SDS-PAGE and 





Mass spectrometric analysis 
Samples were resuspended in 30 ml XT sample buffer and separated via 4-12% 
Bis-Tris Criterion XT SDS-PAGE with XT-MES buffer (BioRad). Gels were stained 
with Coomassie brilliant blue, and each lane was cut out as a single section. Each gel 
section was sliced into 3 mm2 pieces, and subjected to three cycles of dehydration 
(acetonitrile 20 min) and rehydration (deionized water 20 min). Following a final 
dehydration step (20 min SpeedVac), gel pieces were rehydrated in 50 mM ammonium 
bicarbonate pH 8.3 containing 1.5 mg TPCK trypsin (Promega), and incubated at 37°C 
for 16 hr. Peptides were extracted from the gel pieces using three dehydration/rehydration 
steps (as above). Eluted peptides were pooled, lyophilized and resuspended in 5% (v/v) 
acetonitrile in 0.1% (v/v) formic acid for MS analysis. 
Analytical columns (75 "m inner diameter) and pre-columns (100 "m) for LC-
MS analysis were prepared in-house from silica capillary tubing (InnovaQuartz, Phoenix, 
AZ), and packed with 3 "m 100Å C18-coated silica particles (Michrom). Analytical 
columns were fitted with metal emitters (Thermo Proxeon) using zero dead volume 
connections. Peptides were subjected to nanoflow liquid chromatography - electrospray 
ionization - tandem mass spectrometry (nLC-ESI-MS/MS), using a 90 min reversed 
phase (10-40% acetonitrile, 0.1% formic acid) buffer gradient running at 250 nL/min on a 
Proxeon EASY-nLC pump in-line with a hybrid linear quadrupole ion trap (Velos LTQ) 
Orbitrap mass spectrometer (Thermo Fisher Scientific). A parent ion scan was performed 
in the Orbitrap, using a resolving power of 60,000. Simultaneously, up to the twenty most 
intense peaks were selected for MS/MS (minimum ion count of 1000 for activation) 
using standard CID fragmentation. Fragment ions were detected in the LTQ. Dynamic 
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exclusion was activated such that MS/MS of the same m/z (within a 10ppm window, 
exclusion list size 500) detected two times within 15 sec were excluded from analysis for 
30 sec. 
Thermo .raw files were uploaded to the ProHits (24) analytical suite and 
converted to .mzXML format using ReAdW software. Data were searched using 
X!Tandem (25) against human ORFs (RefSeq v45). Search parameters specified a parent 
MS tolerance of ±15ppm, and an MS/MS tolerance of 0.4 Da, with up to two missed 
cleavages for trypsin. Oxidation of methionine and tryptophan, ubiquitylation of lysine, 
and alkylation of cysteine (by NEM) were allowed as variable modifications. Statistical 
validation of the results was performed using Peptide Prophet and Protein Prophet 
(26,27) as part of the trans-proteomic pipeline. For each search, the Protein Prophet 
probability at a 1% false discovery rate and minimum of 2 unique peptides were used as 
cutoff values to generate SAINT-compatible input files. SAINT parameters were as 
follows: 5000 iterations, low mode Off (0), mincFold 1 and normalization off (0) (28). 
SAINT cutoff values 0.8 MAX SAINT, 0.6 Avg SAINT were used to generate a high-
confidence list of protein identifications.   The mass spectrometry proteomics data have 
been deposited to the ProteomieXchange Consortium 
(http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the 
dataset identifier PXD000381 (29).  
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RESULTS 
SUMO-2/3 localization on mitotic chromosomes 
We previously demonstrated that SUMO-2/3 localize to mitotic chromosomes 
throughout mitosis using fixed, intact mitotic cells (5). To more precisely investigate the 
localization of SUMO-2/3 on mitotic chromosomes, we analyzed HeLa cell chromosome 
spreads by immunofluorescence microscopy. One chromosome is depicted for clarity 
(Figure 2-1) but whole fields for each chromosome spread are also shown (Figure 2-2). 
Co-staining with human CREST auto-antibodies that recognize CENP-A, CENP-B, and 
CENP-C (30) (Figure 2-1A) shows that SUMO-2/3 localizes to the paired sister 
chromatid centromeres. These results are consistent with the co-localization of SUMO-
2/3 with CENP-B that has been previously demonstrated in intact mitotic cells (5).  
Intriguingly, SUMO-2/3 was also detected on the chromosome arms. To 
determine where SUMO-2/3 localizes more specifically, we conducted co-localization 
studies with antibodies to a histone marker, phospho-H3 (Figure 2-1B), and a 
chromosome scaffold marker, Smc4, a primary subunit of the condensin complex (Figure 
2-1C). The SUMO-2/3 signal does not co-localize with the peripheral phospho-H3, 
demonstrating that it is not globally present throughout mitotic chromosomes. However, 
SUMO-2/3 partially overlaps with Smc4, indicating that SUMO-2/3 is present in the 
chromosome protein scaffold. These results are similar to a previous report showing 
SUMO-2/3 on the chromosome protein scaffold in cells treated with a topoisomerase 
inhibitor (31). Collectively, these results demonstrate that endogenous SUMO-2/3 
localizes to both the centromere and the chromosome protein scaffold during mitosis.  
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Cell synchronization  
To identify proteins modified by SUMO-2/3 in mitosis, and to characterize the 
modification of these proteins in a separate phase of the cell cycle, we synchronized 
HeLa cells in both mitosis and G0. We isolated G0 cells through serum starvation and 
mitotic cells through nocodazole synchronization and release. We obtained distinct 
cellular populations with only 2.5% (+/- 0.5%) of cells in mitosis in G0 preparations and 
53.2% (+/- 5.1%) of cells in mitosis in mitotic preparations (Figure 2-3). Our method for 
mitotic synchronization resulted in a predominantly prometaphase population of cells, but 
other phases of mitosis were also present to varying degrees between the two biologically 
independent preparations (Figure 2-3B). Even though the mitotic synchronization did not 
reach 100%, further enrichment was achieved during cellular fractionation when mitotic 
chromosomes were separated from intact interphase nuclei (see experimental 
approaches).  
 
Cell fractionation isolation 
Mitotic chromosomes from nocodazole treated cells, or intact nuclei from G0 
cells, were isolated by differential centrifugation and analyzed by SDS-PAGE. 
Coomassie Blue staining of whole cell lysates, isolated G0 nuclei and mitotic 
chromosomes fractions revealed distinct protein profiles (Figure 2-4A). Furthermore, the 
fractionation successfully separated a well-characterized cytosolic protein, heat shock 
protein 90 (Hsp90), from  nuclear histone 3 (H3) as revealed by immunoblot analysis 
(Figure 2-4B). Significantly, immunoblot analysis also revealed that unconjugated 
SUMO-2/3 remained in the soluble protein fractions, while high-molecular weight 
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SUMO-modified proteins were found in both the soluble and pellet fractions (Figure 2-
4B). Thus, by performing cellular synchronization and fractionation prior to 
immunopurification, we enriched for high molecular weight SUMO-2/3 modified 
proteins associated with mitotic chromosomes or G0 nuclei and removed unconjugated 
SUMO-2/3.  
 
Immunopurification and identification of endogenous SUMO-2/3 modified proteins 
To identify sumoylated proteins associated with isolated mitotic chromosomes 
and G0 nuclei, we conducted SUMO-2/3 immunopurifications and analyzed the proteins 
by nanoflow liquid chromatography-electrospray ionization-tandem mass spectrometry 
(nLC-ESI-MS/MS) (Figure 2-5A). Chromosome or nuclear pellets were solubilized with 
SDS and proteins were immunopurified using the SUMO-2/3 specific monoclonal 
antibody, 8A2, conjugated to agarose beads. As a control, immunopurifications were also 
performed using mouse IgG similarly conjugated to agarose beads. Isolated proteins were 
eluted using an 8A2 epitope-specific peptide and analyzed by SDS-PAGE. 
Immunoblotting demonstrated that high molecular weight SUMO-2/3 modified proteins 
were specifically purified with the SUMO-2/3 antibody but not with the mouse IgG 
control (Figure 2-5B). Furthermore, silver stain analysis demonstrated that the SUMO-
2/3 immunopurification uniquely enriched for high molecular weight proteins, relative to 
the IgG control (Figure 2-5C).  
We conducted immunopurifications from two independently prepared fractions of 
purified mitotic chromosomes and G0 nuclei. Purified proteins were separated by SDS-
PAGE to remove the elution peptide and analyzed by nLC-ESI-MS/MS. The significance 
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analysis of interactome (SAINT) approach was used to identify proteins unique to the 
SUMO-2/3 immunopurifications (28). SAINT utilizes statistical analysis of the total 
number of spectra obtained for individual proteins in experimental and control 
immunopurifications to determine the probability that a protein is unique to the 
experimental sample. Using this method, we identified a total of 244 proteins specific to 
SUMO-2/3 immunopurifications from mitotic chromosomes and G0 nuclei (Table 2-1). 
Of these proteins, 149 were identified from fractions of purified mitotic chromosomes 
and 184 were identified from G0 nuclei.  89 of the identified proteins were common to 
both the mitotic chromosome fraction and G0 nuclei. These results indicate that at least 
half of the sumoylated proteins associated with mitotic chromosomes are also SUMO 
modified in G0. Proteins identified uniquely in mitosis or G0 may be sumoylated in a cell 
cycle dependent manner, although further studies are required to determine if this is the 
case. 
 
Bioinformatic analysis of identified proteins 
We first compared the proteins identified in our study to three recent proteomics 
studies, two by Hay and colleagues in which >750 sumoylated proteins were identified 
from asynchronous cells after heat shock (1,32), and a third by Melchior and colleagues 
in which proteins modified by endogenous SUMO-2/3 were identified from whole cell 
lysates of asynchronous cells (33) (Figure 2-6). Overall, 63% of the proteins identified in 
our study were identified previously. Notably, 83% of the proteins we identified as 
sumoylated in both G0 and mitosis were identified in the Hay and Melchior proteomic 
studies, suggesting that these proteins are likely high abundance SUMO substrates that 
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are detected under various cellular conditions. In contrast, only 51% and 55% of the 
proteins identified specifically in G0 and mitosis, respectively, were identified previously. 
Thus, the cell synchronization and fractionation techniques utilized in this study may 
promote the detection of lower abundance SUMO substrates that are omitted from large 
scale whole cell lysate analyses. 
We next compared the list of putative SUMO-2/3 substrates identified in our 
mitotic chromosome fraction to proteins identified in other mass spectrometry studies 
focused on chromosome composition. In particular, we compared our results to two 
proteomics studies by Earnshaw and colleagues that identified proteins on the non-
histone protein chromosome scaffold as well as on whole mitotic chromosomes (34,35). 
62% of the proteins that we identified as SUMO substrates in mitosis were also observed 
in these two studies, consistent with their association with mitotic chromosomes (Figure 
2-7A). Importantly, a number of proteins identified in our study correspond to known 
constituents of the chromosome protein scaffold, centromeres or kinetochores, which is 
consistent with our detection of SUMO-2/3 at these sites on mitotic chromosomes (Figure 
2-1 and Figure 2-7B).   
To gain further insight into the biological functions of sumoylation and its effects 
and regulation in mitosis, we next analyzed the associated interaction networks and 
functional pathways of the identified proteins (Figure 2-8). Each protein identified is 
represented as a colored circle (proteins identified specifically in mitosis are red, 
specifically in G0 are blue, and in both G0 and mitosis are green), while known protein-
protein interactions are shown as lines connecting the proteins (Figure 2-8). Consistent 
with other proteomic studies, SUMO substrates identified in our study function in a wide 
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range of cellular processes, including transcription, DNA repair, RNA processing and cell 
cycle regulation (1,32). Of note, mitochondrial proteins were enriched for in the mitotic 
chromosome fraction, but likely represent contaminants from co-purifying mitochondria.  
Of greater interest, 73% of the identified SUMO-2/3 substrates with cell cycle regulatory 
functions were identified in the mitotic chromosome fraction, compared to only 48% of 
proteins with functions in RNA processing, 55% with functions in DNA repair, and 59% 
of proteins with functions in transcription and chromatin remodeling.   
In addition to the protein-interaction analysis, we also conducted a literature 
search to identify previously characterized mitotic functions for the 149 sumoylated 
proteins identified in association with mitotic chromosomes. Notably, more than one-
third of the identified proteins (Table 2-2) regulate mitotic processes, including 
chromosome segregation, sister chromatin cohesion and the anaphase promoting 
complex. The proteins with characterized mitotic functions are represented schematically, 
color-coded to identify the characterized mitotic functions and connected by lines to 
show known protein-protein interactions (Figure 2-9). Collectively, our analysis has 
therefore identified >50 proteins that co-purify with mitotic chromosomes, have known 
mitotic functions, and are potentially regulated by SUMO-2/3 modification.  
 
Validation of identified proteins 
To provide validation that the proteins identified in our study are bona-fide 
SUMO-2/3 substrates, we used immunoblot analysis to investigate proteins from the 
same fractions used for the mass spectrometry identification. Antibodies specific for three 
proteins identified in the screen were used, including antibodies to topoisomerase II!, 
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Trim28 (KAP-1) and KIF4A. Topoisomerase II! was included as a positive control 
because it is known to be sumoylated in mitosis (12-16). Trim28, in contrast has only 
been shown to be sumoylated in asynchronous samples, while KIF4A has not previously 
been identified as a sumoylation substrate. All three proteins were detected at their 
predicted, unmodified, molecular weights in the starting cellular fractions. Consistent 
with sumoylation, all three proteins were also specifically detected in the SUMO-2/3 
immunopurification at higher than expected molecular weights, but absent in the mouse 
IgG control (Figure 2-10). In addition to being detected in the SUMO-2/3 
immunopurification from mitotic chromosomes, all three proteins were also detected in 
the immunopurification from G0 nuclei.  
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DISCUSSION 
 SUMO-2/3 is detected on mitotic chromosomes throughout mitosis and is 
required for mitotic progression. However, the precise localization of SUMO-2/3 on 
chromosomes, and the identity of chromosome-associated proteins modified by SUMO-
2/3, has not been fully characterized. We utilized prometaphase chromosome spreads to 
refine SUMO-2/3 localization to mitotic centromeres and the chromosome protein 
scaffold. In addition, we immunopurified endogenous SUMO-2/3 modified proteins from 
isolated mitotic chromosomes and G0 nuclei and identified 244 putative sumoylated 
proteins by mass spectrometry. Notably, 149 proteins were detected in the mitotic 
chromosome fraction, and more than one-third of these putative SUMO-2/3 substrates 
have known functions associated with mitotic processes.   
The identification of sumoylated proteins is challenging, as most proteins are 
modified at relatively low levels, with only 1-5% of a given protein being modified at 
steady state (36). This is particularly challenging in mitosis, where sumoylation is 
globally reduced and many regulators of mitosis are low abundance proteins (5). To 
enhance levels of sumoylation and substrate identification, recent proteomic analyses 
have identified modified proteins under conditions that cause hyper-sumoylation, 
including heat shock or proteasome inhibition (1,32,37,38). In addition, exogenous 
overexpression of tagged forms of SUMO is commonly used to enhance the abundance 
of sumoylated proteins, as well as to facilitate protein purification. In combination, these 
strategies have led to the identification of hundreds of sumoylated proteins. However, 
evaluating sumoylation under these experimental conditions introduces multiple caveats, 
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including effects of SUMO tags and overexpression on substrate specificity. Proteins 
modified specifically in mitosis may also be underrepresented using these approaches.   
To avoid these caveats and enrich for proteins sumoylated in mitosis, we 
developed an immunopurification protocol that isolates endogenous chromosome-
associated SUMO-2/3 modified proteins. First, cells were synchronized to obtain a 
population enriched in mitosis. Chromosomes were subsequently isolated to further 
enrich for chromosome-associated SUMO-2/3 substrates. Although a significant fraction 
of high molecular weight sumoylated proteins was solubilized during chromosome 
isolation (Figure 2-4B), whether these represent unique, soluble SUMO-2/3 substrates, or 
unintentionally released chromosome-associated substrates is not known. It is also 
notable that our fractionation strategy separated free, unconjugated SUMO-2/3 from 
purified chromosomes, thus reducing competition for immunopurification of low 
abundance sumoylated proteins (Figure 2-4B). Immunopurifications from solubilized 
chromosome fractions were conducted using a monoclonal antibody that recognizes 
SUMO-2/3 (5), and antibody-bound proteins were eluted with an epitope-specific peptide 
to enhance purification. As highlighted in Figure 2-6, Melchior and colleagues recently 
identified SUMO-1 and SUMO-2/3 modified proteins from asynchronous whole cell 
lysates using a related immunopurification and elution scheme (33). 
In addition to immunopurifying and identifying SUMO-2/3 modified proteins 
associated with mitotic chromosomes, we also conducted a comparable isolation and 
identification of proteins from G0 nuclei. Using these approaches, we found that more 
than half of the proteins identified in the mitotic chromosome fraction were also 
identified in G0 nuclei. This result indicates that many proteins modified by SUMO-2/3 in 
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mitosis are also likely to be modified in other phases of the cell cycle. Our validation 
studies were consistent with this finding. Nonetheless, sumoylation may still play 
important functions in controlling mitosis-specific activities of the identified 
chromosome-associated proteins. For example, topoisomerase II! was identified and 
verified to be sumoylated in both G0 and mitotic chromosome preparations (Figure 2-6). 
Despite also being modified in G0, sumoylation of topoisomerase II! specifically at the 
metaphase to anaphase transition in mitosis is required for DNA decatenation and 
chromosome segregation (12-16). Furthermore, Ndc80 and Borealin sumoylation is 
specifically enriched in mitosis but low levels of sumoylation are also detected in other 
cell cycle phases, further suggesting that sumoylation can have cell-cycle specific 
functions even though substrates are sumoylated in multiple phases (19,39). Thus, all of 
the putative SUMO-2/3 substrates identified in our mitotic chromosome preparations 
warrant further investigation to understand how sumoylation may affect their mitotic 
functions.   
In addition to the subset of proteins identified in both G0 nuclei and associated 
with mitotic chromosomes, we also identified subsets of proteins specific to one of the 
two cell fractions. It would be intriguing to speculate that these proteins are uniquely 
modified in either G0 or mitosis, but technical caveats made this interpretation difficult. 
Foremost, differences in synchronization and fractionation procedures complicated 
attempts to perform immunopurifications from truly equivalent numbers of G0 and 
mitotic cells. This significantly affected the ability to quantitatively identify proteins 
using label-free quantification based on spectral counts. To address more definitively if 
identified proteins are more abundantly or uniquely modified by SUMO-2/3 in mitosis or 
! (#!
G0, immunopurifications from whole cell lysates using substrate-specific antibodies, 
followed by SUMO-2/3 immunoblots, will need to be performed as has been 
demonstrated for  Ndc80 and Borealin (19,39). 
We identified 244 putative sumoylated proteins in G0 and mitosis with 149 of the 
identified proteins being associated with mitotic chromosomes. Of interest, these findings 
did not reveal only a few proteins in mitosis that are massively sumoylated, but rather 
identified many SUMO substrates with diverse functions (Figure 2-8). Furthermore, we 
identified >50 proteins that have previously characterized mitotic functions ranging from 
chromosome alignment to regulation of anaphase initiation, highlighting the diversity of 
SUMO function within mitosis (Figure 2-9). For example, we identified three proteins 
(cell division cycle and apoptosis regulator 1 (CCAR1), ubiquitin (UBB), and anaphase 
promoting complex subunit 4 (ANAPC4)) involved in the structure and function of the 
anaphase promoting complex (APC) (40-42). Because sumoylation temporally regulates 
APC activation, it is intriguing to speculate that sumoylation of these three proteins is 
critical for APC regulation (43). Thus, this study will act as a foundation for determining 
the SUMO substrates responsible for the diverse mitotic functions of sumoylation.  
Previous molecular and genetic studies have identified SUMO-2/3 modified 
proteins, including topoisomerase II!, Pds5, and others that are enriched at centromeres 
and kinetochores, where sumoylation regulates sister chromatid decatenation, cohesion, 
and kinetochore assembly and function (11). We identified fewer than ten SUMO-2/3 
modified proteins previously characterized to have centromere or kinetochore 
localization (Figure 2-8B). There are two possible explanations for our detection of only 
a few centromere and kinetochore proteins. First, centromere and kinetochore proteins 
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are present in very low copy numbers, so the sumoylated form of these proteins (expected 
to represent only a fraction of the total protein) may have been below our level of 
detection (44). Another possible explanation is that our synchronization method produced 
a predominantly prometaphase population of mitotic cells (Figure 2-3B). The exact 
temporal regulation of sumoylation of many kinetochore proteins is unclear, but evidence 
indicates that modification of topoisomerase II! and Ndc10 is transient and limited to 
specific phases of mitosis (5,13,19). Proteins modified in phases of mitosis under-
represented in our study may therefore have been missed.   
In contrast to sumoylation at kinetochores and centromeres, little is known about 
how sumoylation affects the functions of proteins associated within the chromosome 
protein scaffold. Treating cells with the topoisomerase inhibitor, ICRF, increases levels 
of topoisomerase I and II! sumoylation and the intensity of SUMO-2/3 within the protein 
scaffold, suggesting that the topoisomerases are a major target of scaffold sumoylation 
(31). Notably, we identified 10 proteins previously shown to be present in the protein 
chromosome scaffold by Earnshaw and colleagues including Kif4A and the block of 
proliferation 1 protein (Bop1), which have characterized mitotic functions (Figure 2-8B) 
(34). Thus, it is interesting to speculate that the requirement for Kif4A in chromosome 
segregation or for Bop1 in chromosome alignment and spindle morphology depends on 
their sumoylation in mitosis (45,46). Furthermore, we identified topoisomerase I, which 
localizes to mammalian mitotic chromosomes and regulates mitotic recombination and 
condensation of rDNA in yeast (47-49). Notably, topoisomerase 1 is also sumoylated in 
asynchronous cells after camptothecin treatment (50) so future analysis of topoisomerase 
1 sumoylation in multiple cell cycle phases may provide insight for how sumoylation can 
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affect protein function in multiple cellular contexts including the mitotic chromosome 
scaffold. 
In conclusion, we identified proteins modified in mitosis and specifically known 
to localize to the same mitotic structures as SUMO-2/3, namely the centromeres and 
kinetochores and the chromosome protein scaffold. Genetic and molecular studies have 
shown that sumoylation regulates sister chromatid separation, chromosome segregation, 
and general chromosome structure (11). However, the molecular mechanisms that 
demonstrate how sumoylation affects these critical mitotic functions are still largely 
unknown. Thus, the identification of 149 sumoylated proteins associated with mitotic 
chromosomes by this study will provide a foundation for investigating these molecular 
mechanisms in the future. Further defining the precise roles of sumoylation in mitotic 
progression will require targeted studies aimed at evaluating the spatial and temporal 
modification of individual substrates, as well as effects on localization, protein-protein 
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Figure 2-1. SUMO-2/3 localizes to the mitotic chromosome protein scaffold and 
centromeres. HeLa cells were treated with nocodazole for 4 hours and spun onto glass 
slides to produce chromosome spreads. Chromosomes were labeled using DAPI, the 
SUMO-2/3 antibody, and either (A) CREST, (B) phospho-histone 3 or (C) the Smc4 






Figure 2-2. Whole chromosome spreads showing SUMO-2/3 localizes to the mitotic 
chromosome protein scaffold and centromeres. HeLa cells were treated with 
nocodazole for 4 hours and spun onto glass slides to produce chromosome spreads. 
Chromosomes were permeabilized with triton-X 100, fixed with paraformaldehyde and 
post-permeabilized with triton-x 100. Chromosomes were labeled using DAPI, the 
SUMO-2/3 antibody, and CREST (A), phospho-histone 3 (B) or the Smc4 (C) antibodies 






Figure 2-3. Cell synchronization in G0 and mitosis. (A) Cells were synchronized in G0 
by 24 hour serum starvation and in mitosis by an overnight nocodazole treatment and two 
hour release prior to harvest. DNA was stained by propidium iodide to identify 
condensed mitotic DNA and calculate mitotic indices. Error bars represent the standard 
deviation between the two independent replicates. (B) The phase distribution of the 
mitotic cells obtained in the mitosis preparations were counted. Each mitotic replicate is 









Figure 2-4. Chromosome fractionation isolates high molecular SUMO modified 
proteins from free SUMO-2/3. Equivalent percentages of indicated cell fractions 
(0.005%) were separated by SDS-PAGE (1X) and analyzed by either (A) Coomassie 
Blue staining or (B) immunoblotting. For coomassie blue staining, 4X of the pelleted 
fraction was also loaded to strengthen the signal. Immunoblotting was conducted with 
antibodies to heat shock protein 90 (Hsp90), histone 3 (H3) and SUMO-2/3. WCL = 
whole cell lysate; S = Soluble fraction; P = Pelleted fraction which represents nuclei for 






Figure 2-5. Immunopurification of SUMO-2/3 modified proteins from mitotic 
chromosomes and G0 nuclei. (A) Schematic diagram illustrating the experimental 
strategy. Immunopurified proteins were eluted and equivalent percentages of each elution 
were separated by SDS-PAGE. Proteins were analyzed by either (B) immunoblotting 






Table 2-1. Proteins identified in G0 and mitosis by nLC-ESI-MS/MS. The gene 
names and protein IDs for the proteins identified in G0 and mitosis are listed. Only 
proteins that had at least 2 unique peptides and a SAINT score of 0.8 MAX SAINT and 
0.6 Avg SAINT are included. The total number of peptides identified for each protein in 
each cell cycle phase is given. 
  
! '$!
Gene Name Protein ID 
Total Peptides 
 Identified Mitosis 
Total Peptides 
 Identified G0 
TOP2A 19913406 934 697 
GTF2I 14670350 746 1353 
TOP1 11225260 625 349 
TOP2B 19913408 526 435 
TRIM28 5032179 438 811 
RANGAP1 4506411 437 401 
PRKDC 13654237 347 
 MGA 256017163 269 542 
RSF1 38788333 250 389 
SAFB2 7661936 244 599 
UBB 11024714 240 351 
RBM25 55741709 193 337 
NFRKB 219802034 190 346 
MORC3 28872812 187 238 
SAFB 21264343 178 471 
NOP58 7706254 177 234 
MKI67 103472005 146 
 ATRX 20336209 138 165 
PRPF40A 151301228 128 278 
CHD4 51599156 122 360 
PRPF8 91208426 110 
 BEND3 122937295 93 312 
SART1 10863889 89 239 
SUMO1 4507801 86 115 
ZNF451 72255571 81 80 
RANBP2 150418007 72 113 
SRBD1 221136781 69 
 ZMYM4 44890068 69 98 
ZFP106 11968023 67 95 
ARID4B 22035677 60 163 
CHD3 158420731 59 105 
MORC2 7662340 58 93 
CHD5 24308089 58 119 
ZNF800 39753953 56 35 
UBA2 4885649 55 91 
ANAPC4 41327749 54 208 
USP39 56550051 52 143 
ATP6 251831112 51 
 ZNF687 24308227 48 104 
YEATS2 33620755 46 84 
AHCTF1 262359929 46 
 NFIL3 52630429 45 53 
! '%!
PASD1 157785548 44 76 
BRD8 34452705 44 154 
KIF4A 116686122 44 15 
ZBTB38 148276990 42 60 
SF3B1 54112117 42 
 BCLAF1 7661958 39 89 
CEBPZ 42542392 37 
 BAZ1B 14670392 36 
 WIZ 151301215 34 83 
CTCF 5729790 33 64 
ZBTB4 192807284 32 37 
DNMT1 195927037 32 40 
ZBED1 283806699 30 
 ARID4A 115334673 29 125 
ZBTB20 257900533 28 30 
L3MBTL2 20149698 26 70 
PHIP 34996489 26 30 
CUX1 148277064 25 116 
UTP20 120587023 25 
 ACIN1 259906018 23 82 
WDR36 21281677 22 31 
NUP205 57634534 21 
 PWP2 48762926 20 
 SURF4 19557691 20 
 ZNF644 41152093 19 35 
C14orf93 195233774 18 30 
IARS 94721239 18 13 
MBD1 156105673 17 24 
CHD2 118421089 17 20 
ANLN 31657094 17 
 SP100 122939208 16 19 
DLD 91199540 16 
 PHF14 55769548 15 14 
TCOF1 207113160 15 13 
BOP1 21327667 15 
 CTR9 7661950 15 25 
HDAC1 13128860 15 
 WDR3 5803221 15 22 
LBR 37595750 15 
 SAP130 19923597 14 41 
GTF2IRD1 312836811 14 20 
PNN 33356174 14 43 
PDHA1 291084742 14 
 HNRNPF 148470397 13 
 
! '&!
FANCI 164607124 13 20 
ZC3H14 231570121 13 36 
SLC25A10 20149598 13 
 EXOSC10 4505917 13 22 
PBRM1 41281917 13 34 
DNTTIP2 54633315 12 
 DDX18 38327634 12 
 KDM2B 54112380 12 18 
AP2B1 4557469 12 
 PES1 7657455 12 
 CGNL1 31982906 12 18 
PRPF4B 89276756 12 
 PZP 162809334 12 10 
NOLC1 148596949 11 
 SLC7A5 71979932 11 
 SLC27A2 227499619 11 
 SSR3 6005884 11 
 BRWD1 16445436 11 
 WDR43 157743245 11 
 DKC1 215599015 11 
 BPTF 38788260 11 20 
TECR 24475816 11 
 ZNF295 148491088 10 
 SMC3 4885399 10 
 NIPBL 47578105 10 27 
KPNB1 19923142 10 
 NOL10 171460958 10 8 
RBM28 187960109 10 
 C8A 4557389 10 
 CCAR1 46852388 10 
 XPC 224809295 10 
 TMEM33 224589127 10 7 
ACAD9 21361497 10 
 MCM5 23510448 10 
 RLF 157671949 10 16 
TMEM165 32189371 9 
 TFAP2A 109389358 9 33 
ZMYM2 300192959 9 11 
ZBTB2 24308241 9 26 
SMC1A 30581135 9 
 SLC2A14 23592238 9 
 SCAMP3 16445419 8 
 ATP2B1 48255945 8 
 CTCFL 29570785 8 
 
! '"!
ETF1 4759034 8 7 
THOC2 125656165 8 
 MCM3 6631095 8 
 ZMYM3 283837894 8 14 
ZHX1 63079680 8 18 
DHX30 20336290 8 
 XPO5 22748937 8 
 MSANTD4 58761537 8 28 
PCNA 33239451 7 
 UTP15 50980309 7 9 
SRRM1 42542379 7 11 
OXCT1 4557817 7 
 EIF2S3 4503507 7 
 INTS3 39995084 7 18 
FGG 70906437 7 
 NHP2 77812674 7 13 
NOL11 21361468 6 7 
EIF3CL 153791492 6 
 PPAN-P2RY11 310923196 5 



































































































































































































































































































Figure 2-6. Comparison of the sumoylated proteins identified in this study to other 
SUMO-mass spectrometry studies.  Venn diagrams comparing the results of this study 
to two large scale SUMO proteomic studies conducted by Ron Hay and colleagues (1,32) 
and a recent study by Melchior and colleagues that utilized a similar approach for 






Figure 2-7. Comparison of the mitotic sumoylated proteins to other mitotic mass 
spectrometry studies. (A) Venn diagram comparing the results of this study to a 
proteomic study of the mitotic chromosome scaffold and a study of whole mitotic 
chromosomes (34,35). (B) A schematic showing the proteins identified in this study that 







Figure 2-8. Interaction networks and functional pathways of the proteins identified 
in this study. The functions of the proteins identified in this study were determined using 
GO analysis and a manual literature search, which has been depicted schematically using 
Cytoscape software. Each circle represents a protein identified by nLC-ESI-MS/MS and 
the color coding describes which cell cycle phase it was identified from (Green = both G0 
and mitosis; red = specifically in mitosis; blue = specifically in G0). The lines connecting 






Table 2-2. Literature analysis describing the known mitotic functions and/or 
sumoylation of the proteins identified in this study as SUMO-modified in mitosis. 
The gene names for the 146 sumoylated proteins associated with mitotic chromosomes 




Gene Name Mitosis G0 SUMO connection Mitosis connection 





GTF2I 746 1353 None None 





increase in mitotic 
recombination (53) 





TRIM28 438 811 




RANGAP1 437 401 
SUMO substrate 
(22) 
At kinetochores and 
affects spindle 
structure (56,57) 
PRKDC 347  
None 




MGA 269 542 None None 
RSF1 250 389 None 
Knockdown results in 
loss of CENP-A (59) 
SAFB2 244 599 Sumoylated (60) None 
UBB 240 351 Modifies SUMO (61) 
K11 chains signal 
from APC (40) 
RBM25 193 337 None None 
NFRKB 190 346 None None 
MORC3 187 238 
Sumoylation 




SAFB 178 471 Sumoylated (60) None 
NOP58 177 234 
Sumoylation 




MKI67 146  None 
Proliferation marker 
(64) 
ATRX 138 165 None 
At centromeres; 
required for cohesion 
and congression  
(65-67) 














PRPF8 110  None 




BEND3 93 312 None None 
SART1 89 239 Sumoylated at 4 sites (71) 
Polymorphisms 
connected to cancer 
(72) 
SUMO1 86 115 SUMO paralog Localizes to the mitotic spindle (5) 
ZNF451 81 80 








SRBD1 69  None None 
ZMYM4 69 98 None None 
ZFP106 67 95 None None 
ARID4B 60 163 Sumoylated (76) None 
CHD3 59 105 
SUMO1 interacting 








MORC2 58 93 None None 
CHD5 58 119 None None 
ZNF800 56 35 None None 
UBA2 55 91 SUMO E1 (78) Knockdown blocks cell proliferation (79) 
ANAPC4 54 208 None Structural subunit of APC (41) 
USP39 52 143 None  
Required for spindle 
assembly checkpoint 
integrity and mRNA 
levels of Aurora B 
(80) 
ATP6 51  None None 
ZNF687 48 104 None None 
YEATS2 46 84 None None 
! ))(!
AHCTF1 46  None 
Required for NPC 
assembly at the  
end of mitosis (81) 
and required 
 for cytokinesis  
(82) 
NFIL3 45 53 None None 
PASD1 44 76 None None 
BRD8 44 154 None None 




ZBTB38 42 60 None None 
SF3B1 42  None None 
BCLAF1 39 89 None None 
CEBPZ 37  
Alpha, beta, delta 
all sumoylated so 







BAZ1B 36  None None 
WIZ 34 83 
Part of repressive 
complex that has 2 
SUMO ligases (85) 
None 
CTCF 33 64 Sumoylated (86,87) 
At centrosomes and 
then relocalizes to 
midbody (88) 
ZBTB4 32 37 None None 




At centromeres (65) 
and knockdown 
arrests cells in G2 that 
undergo slippage and 
mitotic catastrophe 
(90) 
ZBED1 30  None 
On chromosomes at 
aligned insulators  
in mitosis – 
 mitotic bookmarking 
(91) 













Localizes to mitotic 





PHIP 26 30 None None 
CUX1 25 116 None 
Hyperphosphorylated 
in mitosis with 
reduced DNA binding 
(94) and is required in 
S phase for mitotic 
targets (95) 
UTP20 25  None None 
ACIN1 23 82 None None 
WDR36 22 31 None None 
NUP205 21  None 
Knockdown 
negatively regulates 
mitotic onset (96) 
PWP2 20  None None 
SURF4 20  None None 
ZNF644 19 35 None None 
C14orf93 18 30 None None 
IARS 18 13 None None 




At centromeres (65) 
CHD2 17 20 None None 
ANLN 17  None Cytokinesis (99) 
SP100 16 19 
Sumoylation 




DLD 16  None None 
PHF14 15 14 None None 
TCOF1 15 13 None 





BOP1 15  None 
Knockdown results in 
chromosome 
alignment and spindle 
defects (46) 
CTR9 15 25 None None 
! ))*!
HDAC1 15  
Has SIM (102) and 
is sumoylated (103) 
Specifically removed 
from chromosomes in 
mitosis to bind F-
actin (104) 
WDR3 15 22 None None 





(105) and knockdown 




SAP130 14 41 None None 





PNN 14 43 None None 
PDHA1 14  None None 
HNRNPF 13  
Sumoylated in 
proteomics and 
shown by IP (108) 
None 
FANCI 13 20 Has a SIM (109) 
Localizes to fragile 
site loci in mitosis 
and are on ultra-fine 
DNA bridges 
(110,111) 
ZC3H14 13 36 None None 
SLC25A10 13  None None 







PBRM1 13 34 None Localizes to kinetochores(65, 113) 
DNTTIP2 12  None None 
DDX18 12  None None 
KDM2B 12 18 Ubiquitin E3 ligase (114) None 
AP2B1 12  
Interacts with Ubc9 
(115) 
Interacts with BubR1 
in spindle assembly 
checkpoint (116) 
! ))+!
PES1 12  None 
Localizes to periphery 
around metaphase 
chromosomes (117) 
CGNL1 12 18 None None 





PZP 12 10 None None 
NOLC1 11  
SUMO substrate by 
proteomics (63) None 
SLC7A5 11  None None 
SLC27A2 11  None None 
SSR3 11  None None 
BRWD1 11  None None 
WDR43 11  None None 
DKC1 11  
SUMO substrate by 
proteomics (63) None 
BPTF 11 20 None None 
TECR 11  None None 
ZNF295 10  None None 
SMC3 10  
Complex 
sumoylated (119) Cohesion (120) 
NIPBL 10 27 None Cohesion (121) 





Regulates mitotic exit 
(123) 
NOL10 10 8 None None 
RBM28 10  None None 
C8A 10  None None 
CCAR1 10  None 
Binds and regulates 
APC (42) 





TMEM33 10 7 None None 
ACAD9 10  None None 
MCM5 10  None 
Regulates centrosome 
duplication in S phase 
(125) 
RLF 10 16 None None 
TMEM165 9  None None 
TFAP2A 9 33 Interacts with Ubc9 (115) None 
! ))#!
ZMYM2 9 11 
Modified by 




ZBTB2 9 26 None None 
SMC1A 9  Sumoylated (119) Cohesion (120) 
SLC2A14 9  None None 
SCAMP3 8  None Cytokinesis (127) ATP2B1 8  None None 
CTCFL 8  None 
Suggested role 
coordinating S phase 
and mitosis (128) 
ETF1 8 7 None None 
THOC2 8  None 
Deletion results in 
mitotic recombination 
defects (129) 
MCM3 8  
SUMO interacting 








ZMYM3 8 14 None None 





DHX30 8  None None 
XPO5 8  None None 
MSANTD4 8 28 None None 






UTP15 7 9 None None 
SRRM1 7 11 None None 
OXCT1 7  None None 
EIF2S3 7  None None 
INTS3 7 18 None None 
FGG 7  None None 





NOL11 6 7 None None 
EIF3CL 6  None None 
PPAN-P2RY11 5  None None 
! ))$!
Figure 2-9. Previously characterized mitotic functions of the sumoylated proteins 
associated with mitotic chromosomes. Schematic representation of the >50 proteins that 
have previously characterized mitotic functions. Each circle represents a mitotic SUMO-
substrate identified in this study. The color-coding denotes the mitotic function associated 
with that protein and the lines connecting the identified proteins represent known protein-
protein interactions as documented by www.string-db.org with a cutoff confidence level 






Figure 2-10. Validation of identified sumoylated proteins. SUMO-2/3 modified 
proteins were immunopurified from G0 nuclei and chromosome fractions and analyzed by 
immunoblotting with antibodies to topoisomerase II!, Trim28, and KIF4A as indicated. 
Equivalent fractions of proteins purified by mouse IgG (IgG IP) and SUMO-2/3 
immunopurifications (SUMO-2/3 IP) are included. The astericks marks the molecular 
























SENP1 AND SENP2 AFFECT SPATIAL AND TEMPORAL CONTROL OF 











Sumoylation of centromere, kinetochore, and other mitotic chromosome-
associated proteins is essential for chromosome segregation.  The mechanisms regulating 
spatial and temporal sumoylation of proteins in mitosis, however, are not well 
understood.  Here, we show that the SUMO-specific isopeptidases, SENP1 and SENP2, 
are targeted to kinetochores in mitosis.  SENP2 targeting was found to occur through a 
mechanism dependent on the Nup107-160 subcomplex of the nuclear pore complex 
(NPC), and to be modulated through interactions with karyopherin !.  Overexpression of 
SENP2, but not other SUMO-specific isopeptidases, caused a defect in chromosome 
congression that was dependent on its precise kinetochore targeting.  By altering SENP1 
kinetochore associations, however, this effect on chromosome congression could be 
phenocopied.  In contrast, RNAi-mediated knockdown of SENP1 delayed sister 
chromatid separation at metaphase, whereas SENP2 knockdown produced no detectable 
phenotypes.  Collectively, our findings indicate that chromosome segregation is 
dependent on precise spatial and temporal control of sumoylation in mitosis, and that 






Regulation of essential mitotic processes is achieved in large measure through the 
action of posttranslational protein modifications, including phosphorylation, 
ubiquitylation and sumoylation.  Phosphorylation has been particularly well studied, as 
some of the best characterized regulators of kinetochore and microtubule interactions 
possess protein kinase activity, including the Aurora kinases and BUBR1 (1,2).   
Ubiquitylation also plays a number of well established roles in controlling mitotic 
progression, in particular by facilitating proteasome-mediated degradation of proteins 
including securin and the mitotic cyclins (3).  Sumoylation represents a more recently 
discovered regulator of mitosis, and multiple studies have already revealed essential roles 
in controlling chromosome condensation and cohesion, kinetochore assembly and 
function, and spindle dynamics (4-15).  The molecular targets and mechanisms of action 
of sumoylation during mitosis, however, still remain to be fully explored.   
Small ubiquitin related modifiers (SUMOs) are ~100 amino acid proteins that, 
like ubiquitin, are covalently conjugated to lysine residues in substrate proteins (16,17).  
Invertebrates express a single SUMO protein while vertebrates express three predominant 
SUMO paralogs: SUMO-1, SUMO-2 and SUMO-3.  SUMO-2 and SUMO-3 are highly 
related, sharing 96% sequence homology, and are therefore referred to collectively as 
SUMO-2/3.  SUMO-1 shares only 45% similarity to SUMO-2/3. Biochemical and 
proteomic analyses have identified distinct subsets of proteins that are modified uniquely 
by SUMO-1 or SUMO-2/3, indicating that SUMO paralogs may regulate unique 
biological processes and have distinct signaling properties (17,18).  Of particular interest, 
SUMO-1 and SUMO-2/3 are uniquely regulated and conjugated to distinct proteins 
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during mitosis (13).  The molecular mechanisms regulating the spatial and temporal 
control of paralog-selective modifications and functions, however, are also not well 
understood. 
Sumoylation occurs through a three-step enzymatic cascade, which requires the 
concerted action of an ATP-dependent E1 activating enzyme (Aos1/Uba2 heterodimer), 
an E2 conjugating enzyme (Ubc9) and one of a number of SUMO-specific E3 ligases 
(16,19).  Although regulation of substrate modification can occur at the level of 
conjugation, regulation at the level of desumoylation by SUMO-specific isopeptidases 
also plays an important role.  Yeast express two major SUMO-specific isopeptidases, 
Ulp1 (Ubiquitin-like protease) and Ulp2, while vertebrates express six enzymes referred 
to as SENP1, SENP2, SENP3, SENP5, SENP6 and SENP7 (20).  These enzymes possess 
conserved C-terminal catalytic domains and divergent N-terminal domains that determine 
subcellular localization and substrate selectivity (21-28).  In addition to being localized to 
distinct subcellular domains, the six vertebrate SENPs also exhibit differences in SUMO 
paralog specificity.  This specificity is determined by differences in both N-terminal and 
C-terminal domains (29,30).   
 Given the unique activities and localizations of the vertebrates SENPs, they 
represent potentially important spatial and temporal regulators of sumoylation in cells.  
Consistent with this, SENP2 and SENP6 have both been implicated in having important, 
but functionally distinct, roles in regulating sumoylation in mitosis.  SENP6 affects 
kinetochore assembly by limiting sumoylation of the kinetochore-associated protein, 
CENP-I, and its degradation through the SUMO-targeted ubiquitin E3 ligase, RNF4 (11).  
SENP2 is believed to regulate sumoylation of kinetochore-associated proteins necessary 
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for the association of CENP-E with kinetochores.  We previously demonstrated that the 
recruitment of CENP-E to kinetochores was dependent on its ability to interact non-
covalently with SUMO2/3, and that SENP2 overexpression resulted in a loss of CENP-E 
from kinetochores (13).  How the substrate recognition and function of SENP2 and 
SENP6 are controlled spatially and temporally in mitosis is not understood, but of great 
interest.   
Here, we present evidence that SENP1 and SENP2 are positioned to uniquely 
exert spatial and temporal control on sumoylation of proteins in mitosis.  We show that 
SENP2 is distinct from SENP1 and SENP6 in its ability to cause a mitotic, prometaphase 
arrest when overexpressed in cultured mammalian cells.  The ability of SENP2 to cause a 
cell cycle arrest was due to a unique association with kinetochores during prophase that 
was dependent on interactions with the Nup107-160 subcomplex of the NPC and 
karyopherin !.  We also found that SENP1 associates with the mitotic spindle and 
kinetochores in mitosis, but had no effect on mitotic progression when overexpressed.  In 
contrast to overexpression phenotypes, RNAi-mediated knockdown of SENP1 prevented 
timely separation of sister chromatids at the metaphase to anaphase transition.  Together, 
our findings reveal critical and non-redundant roles for SENP1 and SENP2 in mitosis, 
and demonstrate the importance that sub-cellular localization plays in defining SUMO 




MATERIALS AND METHODS 
Antibodies 
SENP2 and GFP rabbit polyclonal antibodies were produced as described 
previously (31).  SENP1 antibody, a gift from Dr. Mary Dasso (National Institute of 
Health, Bethesda, MD), was generated by injecting rabbits with GST-SENP1 (273-449) 
as previously described (32).  Antibodies were affinity purified using appropriate 
antigens and standard protocols.  
Remaining antibodies were obtained from the following sources: anti-Nup107 
antibody was kindly provided by Dr. Joseph Glavy (Charles V. Schaefer, Jr. School of 
Engineering & Science, New York, NY); CREST human auto-antibodies were a 
generous gift from Dr. Ted Salmon (University of North Carolina, NC); anti-karyopherin 
!3 was provided by Dr. Stephen Adams (Northwestern University, Chicago, IL); anti-
CENP-E (Active Motif, Carlsbad, CA); anti-GFP (Clontech, Mountain View, CA); anti-
INCENP (Active Motif, Carlsbad, CA); anti-HEC1 (BD Biosciences, San Jose, CA); 
anti-Tubulin (Sigma-Aldrich, St. Louis, MO); anti-Myc (Santa Cruz Biotechnology, 
Santa Cruz, CA); anti-HA (Santa Cruz Biotechnology, Santa Cruz, CA); anti-FLAG M2 
(Sigma-Aldrich, St. Louis, MO); mAb414 (Abcam, Cambridge, MA); anti-phospho-
histone H3 (Ser10) (EMD Millipore, Billerica, MA). 
 
Plasmid constructs 
SENP2 cDNA and GFP-tagged expression constructs were obtained as previously 
described (23,31).  GFP-SENP1 and YFP-SENP6 vectors were a gift from Dr. Mary 
Dasso (National Institute of Health, Bethesda, MD).  To generate SENP1 and SENP2 
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chimeric protein expression constructs, site-directed mutagenesis was used to create 
restriction sites at the junction between the N-terminal domain and the catalytic domain 
of both SENP1 and SENP2. The catalytic domain of one isopeptidase was PCR-amplified 
and ligated into this restriction site to replace the original catalytic domain.  Flag-Nuf2 
was subcloned into pC4-RHE vector for mammalian expression (Ariad Pharmaceuticals, 
Cambridge, MA).  SENP1 was subcloned into the pC4EN-F1 vector (Ariad 
Pharmaceuticals, Cambridge, MA).  SENP1 was subcloned into a pmCherry-C2 vector 
and the siRNA resistant clones and catalytic mutants were generated using site-directed 
mutagenesis. 
 
Cells, cell culture, transfection, RNA interference 
HeLa cells stably expressing YFP-Histone H2B were a gift from Dr. Andrew 
Holland (Johns Hopkins University School of Medicine, Baltimore, MD).  HeLa or 293T 
cells were maintained at 37°C in Dulbecco’s modified eagle medium supplemented with 
10% fetal bovine serum, 10 mM HEPES (pH 8.0) and 1% penicillin-streptomycin.  Cells 
were transfected with the indicated plasmids at a confluency of 40-50% using 
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer’s protocol.  
For RNA interference, cells were grown to 40-50% confluency and then transfected using 
RNAiMax (Invitrogen, Carlsbad, CA).  siRNA oligos were used at a final concentration 
of 20 nM.  siRNA oligos included: scramble control (5’-
CUUCCUCUCUUUCUCUCCCUUGUGA-3’); SENP2 oligo(a) (5’-
AUAUCUGGAUUCUAUG GGAUU-3’); SENP2 oligo(b) (5’-
GAAAGAGAGAAGUACCGAAtt-3’); SENP1 oligo(a) (5'- 
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UCCUUUACACCUGUCUCGAUGUCUU-3') and SENP1 oligo(b) (5'-
GCAAAUGGCCAAUGG AGAAAUUCUA-3').  Cells were harvested for 
immunoblotting, immunofluorescence microscopy, or timelapse microscopy 48 hours 
after transfection.  For co-transfection of siRNA oligos and siRNA resistant forms of 
SENP1, cells were grown to 40-50% confluency, transfected using Lipofectamine 2000 
using a final concentration of siRNA oligo of 20 nM.  
  
Heterodimerization 
For heterodimerization experiments, cells were transfected with indicated 
plasmids and cultured in the presence or absence of 250 nM AP21967 for 48 hr (Ariad 
Pharmaceuticals, Cambridge, MA) prior to analysis by immunofluorescence microscopy.  
For immunopurification, cells were lysed in buffer containing 50 mM Tris-HCl (pH 7.4), 
150 mM sodium chloride, 1% Triton-X 100, 1% sodium deoxycholate, 2 mM EDTA, 1 
µg/ml leupeptin and pepstatin A, 20 µg/ml aprotinin, 2 mM PMSF.  Lysates were placed 
on ice for 5 min and then sonicated for 30 sec and centrifuged at 16,000 x g for 15 min.  
Lysates were incubated with M2 Flag agarose beads (Sigma, St. Louis, MO) for 4 hr at 
4°C and then beads were washed 6 times in PBS and bound proteins were eluted directly 
in SDS-sample buffer.  
  
GFP-SENP immunopurifications 
For GFP-SENP immunopurifications, rabbit anti-GFP antibodies were 
immobilized on Protein-A Plus agarose beads (Thermo Scientific, Rockford, IL) for one 
hour and crosslinked with DSS for 30 minutes. Beads were washed through a series of 
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four buffers including 50 mM Tris pH = 7.5, 100 mM glycine pH = 3.0, PBS, and lysis 
buffer (25 mM Tris pH = 7.4, 150 mM NaCl, 1% NP-40, 1 mM DTT, 0.05% sodium 
deoxycholate). 293T cells were transfected with the indicated plasmids for approximately 
36 hrs, treated with or without 0.1 "g/ml nocodazole overnight and then harvested 48 hr 
after transfection.  Cells were lysed in lysis buffer supplemented with 1 mM PMSF, 5 
ug/ml pepstatin A, 5 ug/ml leupeptin and 10 mM N- ethylmaleimide, sonicated and 
centrifuged 16,000 x g for 20 minutes at 4ºC.  Protein lysates were quantified using a 
BCA protocol (Thermo Scientific, Rockford, IL) to normalize protein inputs.   Antibody-
bound beads were incubated with cell lysates for 5 hours at 4ºC, washed 6 times with 
lysis buffer, and proteins were eluted directly in SDS-sample buffer.  
 
Immunoblotting  
Immunoblot analysis was performed using enzyme-linked chemiluminescence 
ECL-Prime reagent (GE Healthcare, Silver Spring, MD).  
 
Immunofluorescence microscopy and live cell imaging 
HeLa cells were cultured on glass coverslips.  Unless otherwise stated, cells were 
fixed in 2% formaldehyde for 30 min and permeabilized in 0.2% Triton-X 100 for 7 min 
at RT.  For colocalization with kinetochore proteins, cells were fixed in 3.5% 
paraformaldehyde in PBS for 7 min and permeabilized in 0.5% Triton-X 100 in PBS for 
20 min at RT.  Localization of GFP- SENP1 was examined by pre-extracting in 20 µg/ml 
digitonin in buffer containing (200 mM HEPES (pH 6.5), 110 mM potassium acetate, 20 
mM magnesium acetate, 1 µg/ml leupeptin and pepstatin A, 20 µg/ml aprotinin, and 1 
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mM PMSF) for 15 min at RT and then fixing in 2% formaldehyde in PBS for 30 min.  
Immunostaining was carried out as previously described using secondary antibodies 
conjugated to Alexa Fluor 488 or Alexa Fluor 594 (Life Technologies, Grand Island, 
NY), unless otherwise noted (13).  Images were acquired using the Zeiss Observer Z1 
fluorescence microscope with a Zeiss Plan-Apochromat 63X objective (numerical 
aperature = 1.40) and an Apotome VH optical sectioning grid.  Images were obtained 
using a Zeiss Axiocam MRm camera and processed using AxioVision Software Release 
4.8.2 (Zeiss, Gena, Germany).  
For live cell imaging, cells were cultured in Lab-Tek Chambered #1.0 
Borosilicate Coverglass slides (Nunc, Rochester, NY), transfected, and then imaged 48 
hrs post-transfection.  For imaging, cells were maintained in culture medium at 37ºC with 
5% CO2 on a Zeiss Observer Z1 fluorescence microscope fitted with an incubation 
chamber.  Images were acquired using a Zeiss EC Plan-Neofluar 40X objective 





SENP2 overexpression uniquely induces prometaphase arrest 
We previously demonstrated that overexpression of SENP2 in cultured 
mammalian cells results in a global reduction in sumoylation and a prometaphase arrest 
phenotype caused by defects in the targeting of CENP-E to kinetochores (13).  Because 
mammalian cells express multiple different SUMO-specific isopeptidases with distinct 
subcellular localizations and enzymatic activities, we sought to investigate whether 
overexpression studies could be used to identify functions for other SENPs in mitosis. 
We transiently transfected constructs encoding GFP-SENP1, GFP-SENP2, or 
YFP-SENP6 together with Myc-tagged SUMO-2 into HeLa cells and first examined the 
effects of overexpressing these isopeptidases on sumoylation.  SENP1 was chosen for 
comparison due to its close similarity to SENP2, and SENP6 due to previous evidence of 
mitotic functions (11).  In comparison to control cells, overexpression of all three 
isopeptidases caused comparable global decreases in the levels of high molecular weight 
SUMO-2 conjugates (Figure 3-1A).  To determine whether the suppression of 
sumoylation caused by SENP1, SENP2, or SENP6 overexpression resulted in similar 
prometaphase arrest phenotypes, we analyzed the cell cycle distribution of cells 48 hrs 
following transfection.  As expected, we observed a reproducible 2-fold increase in the 
mitotic index of SENP2 overexpressing cells, with a majority of mitotic cells arresting 
specifically in prometaphase with lagging chromosomes concentrated at the spindle poles 
(Figure 3-1B, D and E).  In contrast, cells overexpressing SENP1 or SENP6 showed no 
noticeable defects in chromosome segregation and the fraction of cells in mitosis were 
comparable to those of control cells (Figure 3-1B, D and E).  Notably, the ability of 
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SENP2 overexpression to cause a prometaphase arrest was dependent on suppression of 
SUMO-2 conjugate levels, as overexpression of a catalytically inactive mutant 
(SENP2C548A+W457A) did not affect levels of SUMO-2/3 modified proteins (Figure 3-1A) 
and had no effect on cell cycle progression (Figure 3-1B).   
 
SENP2-induced prometaphase arrest is determined by its N-terminal domain 
The ability of SENP2 overexpression to uniquely affect mitotic chromosome 
segregation could be explained by distinct enzymatic activity, as determined by its C-
terminal catalytic domain, or distinct sub-cellular localization or substrate specificity, as 
established by elements in its N-terminal domain (20,30,31).  To distinguish between 
these two possibilities, we generated expression constructs for chimeric SENP1 and 
SENP2 proteins.  The N-terminal domain of SENP1 was fused to the catalytic domain of 
SENP2 to generate SENP1N-2CAT and the N-terminal domain of SENP2 was fused to the 
catalytic domain of SENP1 to generate SENP2N-1CAT (Figure 3-1C).  Constructs coding 
for these chimeric proteins were transfected into cells together with Myc-tagged SUMO-
2 and their effects on sumoylation were monitored by immunoblot analysis.  
Overexpression of SENP1N-2CAT and SENP2N-1CAT both caused global decreases in high 
molecular weight SUMO-2 conjugates similar to those obtained with overexpression of 
wild-type SENP1 and SENP2 (Figure 3-1A).  To evaluate effects on cell cycle 
progression, we also analyzed transfected cells by fluorescence microscopy and 
quantified mitotic indices.  Overexpression of SENP2N-1CAT caused an arrest of cells in 
prometaphase with chromosomes concentrated at the spindle poles, similar to the arrest 
observed with wild-type SENP2 (Figures 1B, 1D and 1E).  Consistent with this effect, 
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overexpression of SENP2 and the SENP2N-1CAT chimera both blocked recruitment of 
CENP-E to kinetochores, as previously reported for SENP2 (13) (Figure 3-1E).  In 
contrast, and similar to wild-type SENP1, overexpression of the SENP1N-2CAT chimera 
had no noticeable effect on cell cycle progression, chromosome segregation, or CENP-E 
kinetochore targeting (Figure 3-1B, D and E).  Thus, the N-terminal domain of SENP2 
contains unique determinants critical to its ability to affect CENP-E targeting and 
prometaphase arrest.   
 
The N-terminal domains of SENP1 and SENP2 direct overlapping and unique 
subcellular localizations in interphase and mitosis 
Because the N-terminal domains of SUMO-specific isopeptidases are important 
determinants of localization, we next examined the subcellular distributions of GFP-
SENP1, GFP-SENP2, as well as the chimeric proteins in interphase and mitosis.  SENP1 
and SENP2 were detected predominantly at the nuclear envelope and NPCs during 
interphase, as previously reported or suggested (23-25,32) (Figure 3-2).  As predicted 
based on previous studies of SENP2 NPC targeting (31), the localization SENP2N-1CAT 
chimera was indistinguishable from wild type SENP2 (Figure 3-2B).  Similarly, the 
localization of the SENP1N-2CAT chimera was also indistinguishable from wild type 
SENP1 (Figure 3-2B).  Because the SENP2 catalytic domain alone contains no NPC-
targeting signals (31), this result is consistent with signals for NPC localization also 
residing within the N-terminal domain of SENP1. 
To evaluate localizations in mitosis, cells transfected with GFP-SENP1 and GFP-
SENP2 were labeled with human CREST antibodies to mark the centromeres of mitotic 
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chromosomes.  SENP1 was detected at centrosomes, along spindle microtubules, as well 
as at foci partially co-localizing with CREST, indicative of kinetochore localization 
(Figure 3-3A).  SENP2 was detected in nondescript aggregates, but also at foci partially 
co-localizing with CREST.  Unlike SENP1, SENP2 was not detected at centrosomes or 
on spindle microtubules  (Figure 3-3A).  Co-localization studies with INCENP and Hec1, 
markers for the inner-centromere and outer-kinetochore respectively, further confirmed 
and narrowed the association of SENP1 and SENP2 to elements of the outer-kinetochore 
(Figures 3B and 3C).  The SENP1N-2CAT and SENP2N-1CAT chimeras showed localization 
patterns in mitotic cells indistinguishable from wild-type SENP1 and SENP2, 
respectively (Figure 3-3A).  Collectively, these localization studies demonstrate that the 
N-terminal domains of SENP1 and SENP2 specify overlapping and distinct associations 
with NPCs in interphase and with elements of the mitotic spindle and kinetochore in 
mitosis.   
 
SENP1 and SENP2 both associate with the Nup107-160 subcomplex of the NPC but 
interact differentially karyopherin ! 
The association of SENP2 with NPCs is mediated in part through interactions 
with the Nup107-160 subcomplex and karyopherins (31).  Both interactions also have the 
potential to affect targeting to kinetochores in mitosis (33).  However, SENP2 
interactions in mitotic cells have not previously been characterized, and interactions 
mediating SENP1 association with NPCs also have not been fully investigated.  We 
therefore performed immunopurifications of GFP-tagged SENP1 and SENP2 from 
lysates prepared from synchronized cells arrested in mitosis, as well as from 
 133 
asynchronous cells.  Interactions with karyopherin !3 and Nup107 were investigated by 
immunoblot analysis.  Both karyopherin !3 and Nup107 co-purified with SENP2 from 
asynchronous and mitotic cell lysates (Figure 3-4).  Nup107 also co-purified with SENP1 
in immunopurifications from both mitotic and interphase lysates, consistent with stable 
association with the Nup107-160 subcomplex (Figure 3-4).  However, unlike SENP2, 
stable interactions between SENP1 and karyopherin !3 were not detected.  These 
findings are consistent with the overlapping and distinct distributions of SENP1 and 
SENP2 in interphase and mitosis.  
 
Two N-terminal elements of SENP2 specify kinetochore association and are 
required for prometaphase arrest  
The Nup107-160 subcomplex of the NPC localizes to kinetochores in mitosis 
(33).  To determine whether interactions with the Nup107-160 subcomplex facilitate 
SENP2 targeting to kinetochores, and whether this targeting is required for prometaphase 
arrest, HeLa cells were transfected with a construct encoding GFP-tagged SENP2 !144-
349 (Figure 3-5A).  This SENP2 deletion mutant is defective in interactions with the 
Nup107-160 subcomplex (31).  Although overexpression of SENP2 !144-349 caused a 
decrease in high molecular weight SUMO-2 conjugates similar to overexpression of 
wild-type SENP2 (Figure 3-5B), no detectable effect on cell cycle progression was 
observed based on quantitative analysis of mitotic indexes (Figure 3-5C).  Consistent 
with a functional relationship between kinetochore localization and prometaphase arrest, 
SENP2 !144-349 exhibited a diffuse cytoplasmic distribution in mitotic cells that was 
devoid of kinetochore or spindle association (Figure 3-5D). 
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A second NPC-targeting element in SENP2 consists of a nuclear localization 
signal (NLS) within the N-terminal 63 amino acids that mediates high affinity 
interactions with karyopherin ! (31).  To evaluate the role of karyopherin ! binding in 
affecting SENP2 localization in mitosis, we next transfected HeLa cells with SENP2 #1-
63, a deletion mutant lacking the N-terminal 63 amino acids (Figure 3-5A). Similar to 
wild-type SENP2, overexpression of SENP2 #1-63 resulted in global decreases in high 
molecular weight SUMO-2 conjugates as revealed by immunoblot analysis of whole cell 
lysates (Figure 3-5B).  Based on analysis of mitotic indices, however, overexpression of 
SENP2 #1-63 failed to produce a noticeable effect on cell cycle progression (Figure 3-
5C).  Surprisingly, analysis by fluorescence microscopy revealed that SENP2 #1-63 was 
detectable at kinetochores, but also at centrosomes and along spindle microtubules, in a 
fashion mirroring SENP1 localization (Figure 3-5D).  These findings demonstrate that the 
association of SENP2 with kinetochores in mitosis requires interactions with the Nup107-
160 subcomplex, and that karyopherin ! binding restricts SENP2 localization.  
Karyopherin !, however, was not detected at kinetochores in SENP2 overexpressing cells 
(Figure 3-6).  The results also demonstrate that the effect of SENP2 overexpression on 
mitotic progression correlates with restricted kinetochore localization.  
 
Tethering SENP1 to kinetochores induces a prometaphase arrest 
We hypothesized that a more stable association with kinetochores, or association 
with distinct kinetochore-associated proteins, could underlie the unique ability of SENP2 
to affect mitotic progression.  To test this hypothesis, we investigated the effects of 
artificially tethering SENP1 to kinetochores using the rapamycin-based 
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heterodimerization system (34,35).  Specifically, we fused the ligand-binding domain of 
the FK506 binding protein (FKBP) to HA-tagged SENP1 and the rapamycin-binding 
domain of the FKBP-rapamycin-associated protein (FRB) to Flag-tagged Nuf2, an outer-
kinetochore protein (Figure 3-7A).  Cells were either transiently transfected with a 
construct encoding FRB-Flag-Nuf2 alone, or together with a construct encoding HA-
SENP1-FKBP.  Transfected cells were then incubated in the presence or absence of the 
heterodimerizer, AP21967.  To demonstrate effective AP21967-mediated 
heterodimerization, FRB-Nuf2 was immunopurified from transfected cell lysates using a 
Flag-specific antibody and immunoblot analysis was performed using an HA-specific 
antibody.  As expected, co-purification of SENP1-FKBP with FRB-Nuf2 was dependent 
on both co-expression and the presence of the AP21967 heterodimerizer.  Minimal 
interaction between SENP1-FKBP and FRB-Nuf2 was detected in the absence of 
AP21967 (Figure 3-7B).  
 To examine how heterodimerization with FRB-Nuf2 affects SENP1-FKBP 
localization, we examined the distributions of both fusion proteins in co-transfected cells 
cultured in the absence or presence of AP21967.  Under the specific fixation and 
permeabilization conditions used, SENP1-FKBP was detected as a diffuse signal 
throughout mitotic cells in the absence of heterodimerizer, with no appreciable detection 
at kinetochores (Figure 3-7C).  Under similar assay conditions, FRB-Nuf2 was detected 
in distinct foci that co-localized with the outer-kinetochore protein CENP-E (Figure 3-
7C).  When cells were cultured in the presence of heterodimerizer, SENP1-FKBP was 
detected in prominent foci throughout mitotic cells that co-localized with FRB-Nuf2, 
consistent with enhanced kinetochore localization (Figure 3-7C).   
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To characterize the effects of artificially tethering SENP1 to the outer-
kinetochore, we next analyzed the cell cycle distribution of co-transfected cells cultured 
in the absence or presence of heterodimerizer (Figure 3-7D).  Expression of either FRB-
Nuf2 or SENP1-FKBP alone did not significantly affect cell cycle progression, 
irrespective of the presence or absence of AP21967.  Co-expression of both fusion 
proteins caused a 2-3 fold increase in the mitotic index when cells were cultured in the 
absence of the heterodimerizer, possibly reflecting the low level of basal interaction 
detected by immunopurification (Figure 3-7B and D).  Most notably, however, a 5-6 fold 
increase in the mitotic index was detected in cells co-expressing FRB-Nuf2 and SENP1-
FKBP and cultured in the presence of AP21967.  Importantly, this effect on cell cycle 
progression was dependent on SUMO deconjugation, as heterodimerization of a 
catalytically inactive SENP1 mutant (SENP1 C603A) with FRB-Nuf2 had significantly 
reduced effects on the mitotic index relative to effects observed in the absence of 
heterodimerizer (Figure 3-7B and 7D).  Similar to the phenotype observed with SENP2 
overexpression, tethering SENP1 to Nuf2 at the outer-kinetochore resulted in the 
accumulation of prometaphase-arrested cells, many of which exhibited lagging 
chromosomes present at the spindle poles (Figure 3-7E).  These results support a model 
whereby the inhibitory effects of SENP2 overexpression on mitotic progression are 






RNAi depletion reveals a critical function for SENP1 in mitosis 
 The findings outlined above involved characterization of exogenously expressed 
SENP1 and SENP2.  To evaluate endogenous proteins, we performed 
immunofluorescence microscopy with SENP1 and SENP2 specific antibodies.  As 
previously reported, SENP2 specific antibodies weakly stained the nucleoplasm and 
cytoplasm and were concentrated at the nuclear envelope in interphase cells (Figure 3-
8A) (31).  To evaluate co-localization with kinetochores in mitosis, cells were co-labeled 
with antibodies specific for Hec1.  Although SENP2 antibodies labeled foci associated 
with condensed mitotic chromosomes, we were unable to definitively localize 
endogenous SENP2 to kinetochores due to limitations of the antibody and SENP2 
expression levels (Figure 3-8B).  Large GFP-SENP2 foci observed in interphase and 
mitotic cells were not observed when analyzing endogenous SENP2.  Consistent with 
GFP-SENP1 localization, antibodies specific for SENP1 labeled predominantly the 
nuclear envelope in interphase cells, with a slight nucleoplasmic signal also being 
detected (Figure 3-8A).  In mitotic cells, SENP1 was detected as diffuse puncta 
throughout cells, with additional concentrations observed at mitotic spindles (Figure 3-8B 
and C).  As with SENP2, definitive localization at kinetochores was not possible. 
To further explore the functions of endogenous SENP1 and SENP2 in mitosis, we 
finally turned to RNAi to knock down protein expression in HeLa cells.  In HeLa cells, 
SENP2 is present as multiple isoforms ranging from 45 to 60 kDa that are thought to 
arise from alternative pre-mRNA splicing (31).  Each of these SENP2 isoforms was 
reduced by >90% using two independent siRNAs (Figure 3-9A).  SENP1 specific 
antibodies detected a predominant band of ~70 kDa, that was also reduced by >90% 
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using two independent siRNAs (Figure 3-9A).  The effects of SENP1 or SENP2 
depletion on cell cycle progression were analyzed by fluorescence microscopy and 
quantitative assessment of mitotic indices.  This analysis revealed no detectable effect on 
cell cycle progression in SENP2-depleted cells  (Figure 3-9B).  In SENP1 depleted cells, 
a reproducible 2 to 3 fold increase in mitotic index was observed relative to control cells 
using both independent siRNAs (Figure 3-9B).   
To characterize effects on mitotic progression in greater detail, we repeated 
SENP1 and SENP2 depletions in HeLa cells expressing YFP-tagged histone H2B.  We 
utilized live-cell imaging to measure the time between nuclear envelope breakdown 
(NEBD) and metaphase alignment, as well as metaphase alignment to initiation of 
anaphase (Figure 3-9C and D). Consistent with the mitotic index assessment, SENP2-
depleted cells did not exhibit an increase in the time spent in mitosis compared to the 
control cells (Figure 3-9C and D).  In contrast, although SENP1-depleted cells progressed 
from NEBD to metaphase normally, they exhibited a clear delay in anaphase onset 
following metaphase alignment (Figure 3-9C and D).  SENP1-depleted cells ultimately 
completed cell division despite prolonged times in metaphase, demonstrating that the 
SENP1-depletion conditions resulted in a mitotic delay but not an arrest. To validate that 
this effect was SENP1-specific, we co-transfected cells with siRNAs and constructs 
coding for siRNA-resistant forms of wild type or catalytically inactive (C603A or C603S) 
mCherry-SENP1 and repeated the live-cell image analysis.  Each of the mCherry-SENP1 
proteins was expressed at comparable levels, while endogenous SENP1 expression was 
clearly reduced (Figure 3-9E).  As predicted, wild type SENP1 expression restored 
normal metaphase to anaphase kinetics, while the catalytically inactive forms of SENP1 
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failed to do so (Figure 3-9F). These results demonstrate that SENP1, and its isopeptidase 
activity, is critical for timely metaphase to anaphase transition.  Collectively, the findings 
reveal that SENP1 and SENP2 depletions produce distinct results from SENP1 and 
SENP2 overexpression and reveal a critical, non-redundant role for SENP1 in 
chromosome segregation.    
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DISCUSSION 
Sumoylation is essential for chromosome segregation in organisms ranging from 
yeast to humans (36,37).  This requirement is related in part to spatial and temporal 
regulation of kinetochore assembly, including the association of CENP-E and the CENP-
H/I/K complex with kinetochores during prophase in mammalian cells (11,13).  In this 
study we have provided evidence that the SUMO-specific isopeptidases, SENP1 and 
SENP2, are positioned to affect spatial and temporal control of sumoylation through 
unique associations with kinetochores, spindle microtubules and centrosomes.  Consistent 
with roles in affecting spatial and temporal control of sumoylation in mitosis, 
manipulating the expression levels of SENP1 or SENP2 induced defects in chromosome 
congression in prometaphase or sister chromatid separation at metaphase.  Importantly, 
observed overexpression phenotypes correlated with the precise sub-cellular localizations 
of SENP1 and SENP2, demonstrating the crucial connection between isopeptidase 
targeting and biological function. 
Our studies to elucidate the localizations of SENP1 and SENP2 in mitosis relied 
largely on analysis of exogenously expressed GFP-tagged proteins.  A number of lines of 
evidence indicated that the mitotic localizations that we observed with GFP-SENP1 and 
GFP-SENP2 accurately reflect the localizations of the endogenous proteins.  First, both 
proteins were found to associate with the Nup107-160 subcomplex, whose localizations 
to spindle microtubules and kinetochores in mitosis are well established. In the case of 
SENP2, we confirmed that its association with kinetochores was dependent on 
interactions with the Nup107-160 subcomplex through analysis of SENP2 #144-349 
mutant.  Although we were unable to obtain definitive evidence for endogenous SENP2 
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at kinetochores using immunofluorescence microscopy, this likely reflected the 
combination of low SENP2 expression levels and the relatively small fraction of the 
Nup107-160 subcomplex that is targeted to kinetochores (33).  In contrast to SENP2, our 
immunofluorescence analysis revealed that a fraction of SENP1 is enriched at the mitotic 
spindle, consistent with the observed localization of GFP-SENP1.  Determining whether 
SENP1 localization is dependent on the Nup107-160 complex, however, will require 
additional studies. 
Previous studies have established that signals in the N-terminal domains of 
mammalian SENPs specify their subcellular localizations (23-26,31).  Consistent with 
this, we found using chimeric fusion proteins that the N-terminal domains of SENP1 and 
SENP2 determine their unique associations with NPCs, kinetochores and spindle 
microtubules.  The N-terminal domain of SENP2 contains multiple elements that mediate 
association with NPCs during interphase, including an element that binds the Nup107-
160 subcomplex of the NPC and an element that binds karyopherins (31).  Our findings 
indicated that both of these elements also contribute to the association of SENP2 with 
kinetochores in mitosis.  SENP1 was also found to associate with the Nup107-160 
subcomplex, but was distinct from SENP2 in that stable associations with karyopherin ! 
were not detected.   
The Nup107-160 subcomplex redistributes from NPCs to spindle poles, 
microtubules and the outer kinetochore plate in mitosis, consistent with a role in 
mediating SENP1 and SENP2 localizations to these structures (33,38-40).  The Nup107-
160 subcomplex plays important roles in controlling mitotic events, including 
chromosome segregation, by affecting the distribution of Aurora B and other 
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chromosome passenger complex (CPC) proteins (41).  Notably, several members of the 
CPC are sumoylated, including Aurora B and Borealin (27,42,43).  Our findings that 
SENP1 and SENP2 are both associated with the Nup107-160 subcomplex suggest the 
intriguing possibility that its effects on CPC distribution may be related in part to control 
of CPC sumoylation.  
Although SENP1 localized to the mitotic spindle and kinetochores, the 
distribution of SENP2 was distinct in its more restricted localization to kinetochores.  The 
restricted localization of SENP2 was dependent on interactions with the Nup107-160 
subcomplex, but also depended on interactions mediated by N-terminal residues that 
include a functional NLS.  This NLS mediates high affinity interactions with karyopherin 
!,  and in particular, RanGTP-insensitive interactions with karyopherin !3  (31).  
Deletion of the N-terminal NLS caused SENP2 to localize to spindle microtubules as 
well as kinetochores, a distribution comparable to the localization of the Nup107-160 
subcomplex and SENP1.  This change in localization could be explained by higher levels 
of soluble SENP2 #1-63 relative to full-length SENP2.  However, detection of spindle 
staining for both proteins was unaffected by expression levels.  Based on current 
knowledge, it is therefore hypothesized that both SENP1 and SENP2 are targeted to 
spindle microtubules and kinetochores through interactions with the Nup107-160 
subcomplex, and that interactions with karyopherin ! function to further stabilize or 
restrict SENP2 localization at kinetochores.  Further studies are required to test this 
hypothesis. 
Importantly, the mitotic arrest phenotype observed upon SENP2 overexpression 
was dependent on the more restricted, karyopherin !-dependent, localization of SENP2.  
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We interpret this finding as an indication that the restricted localization of SENP2 at 
kinetochores affects its substrate selectivity and thereby acts to distinguish SENP2 from 
SENP1.  By facilitating kinetochore association, karyopherin !  could affect SENP2 
substrate selectivity by enhancing its local concentration at kinetochores.  Alternatively, 
karyopherin ! could function to target SENP2 to a distinct subdomain of the kinetochore, 
or more directly facilitate association with specific SUMO-modified proteins.  Our 
finding that SENP1 could be detected at kinetochores when overexpressed, but exerted 
no mitotic defects unless artificially tethered to Nuf2, is consistent with the interpretation 
that the precise localizations or concentrations of SENP1 and SENP2 dictate their 
substrate selectivity and function.  Identification of the SUMO-modified proteins 
recognized by SENP1 and SENP2 in mitosis will help to better clarify how localization, 
concentration, or other parameters affect substrate specificity. 
 How karyopherin ! affects the association of SENP2 with kinetochores is 
unclear, but karyopherins in general have a number of established roles in affecting 
protein localization during mitosis (44).  Of particular interest, the relative distribution of 
hKid between spindle microtubules and chromosome arms is determined by interactions 
with karyopherin " and #. In a manner reminicient of our findings for SENP2, 
interactions with karyopherin " and # function to restrict hKid localization to spindle 
microtubules while promoting interactions with chromosome arms (45). Also of potential 
relevance, studies in budding yeast have demonstrated a mitotic role for the karyopherin 
Kap121p in the transport of Ulp1 from NPCs to the septin ring (46).  Further studies are 
required to determine the precise molecular details of how karyopherins affect protein 
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targeting in mitosis, including the targeting and dynamic association of SENP2 with 
kinetochores.  
In addition to providing evidence of mitotic roles for SENP1 and SENP2 in 
mitosis using protein overexpression studies, we also made important observations in 
cells depleted of SENP1 or SENP2.  We observed a reproducible 2-3 fold increase in the 
mitotic index upon depletion of endogenous SENP1.  Our timelapse microscopy analysis 
demonstrated that this increase is due to a delay in the separation of sister chromatids 
following normal alignment at the metaphase plate.  Furthermore, we demonstrated that 
this effect is due to the loss of SENP1 isopeptidase activity, as only a wild type siRNA-
resistant SENP1 rescued this phenotype.  Although further studies are required to define 
the precise defect, a delay in the metaphase to anaphase transition may be related to 
improper desumoylation of a protein involved in the spindle assembly checkpoint or 
dissolution of sister chromatid cohesion.  Surprisingly, gene knockout studies in chicken 
DT40 cells revealed a requirement for SENP1 in the maintenance of sister chromatid 
cohesion in the presence of microtubule destabilizing agents (47).  Although our SENP1 
RNAi studies revealed no defects in cohesion maintenance, differences in findings could 
be explained by the unique experimental conditions, including the presence and absence 
of drug treatments, transient knockdown versus knockout, and human HeLa cells versus 
chicken DT40 cells.  In contrast to SENP1, timelapse microscopy did not identify any 
obvious mitotic defects in SENP2 depleted cells, which could be explained in a number 
of ways.  First, SENP2 may be redundant with other SENPs, including SENP3, which has 
been shown to affect desumoylation of Borealin (27).  Alternatively, hyper-sumoylation 
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of mitotic proteins resulting from SENP2 depletion may have limited functional 
consequences, in contrast to hypo-sumoylation resulting from SENP2 overexpression.   
Our evaluations of the overexpression and knockdown phenotypes of SENP1 and 
SENP2 have revealed critical roles for both sumoylation and desumoylation at multiple 
points during mitosis.  Our findings have also highlighted the importance that subcellular 
localization plays in defining the activities of SENP1 and SENP2 in mitosis and their 
unique and non-redundant functions.  Ultimately, the identification of SENP1 and SENP2 
mitotic substrates will be essential to more fully understand the role that these enzymes 
play in regulating chromosome segregation and, more generally, how sumoylation 
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Figure 3-1.  SENP2 overexpression uniquely affects mitotic progression through 
mechanisms dependent on its N-terminal domain. (A) HeLa cells were co-transfected 
with constructs coding for Myc-tagged SUMO-2 and the indicated GFP-tagged SUMO 
isopeptidases, or empty vector (Mock) as control.  Cell lysates were analyzed by 
immunoblot analysis with antibodies specific for Myc, GFP or tubulin.  (B) HeLa cells 
were transfected with constructs coding for the indicated GFP-tagged SUMO 
isopeptidases or empty vector (Mock).  The fraction of transfected cells in mitosis was 
determined by fluorescence microscopy 48 hrs following transfection.  (C) Schematic 
diagram of SENP1, SENP2 and SENP1/2 chimeras. CAT=catalytic domain. (D) HeLa 
cells were transfected with constructs coding for the indicated SUMO isopeptidases or 
empty vector (Mock).  The fraction of transfected cells present at each of the indicated 
stages of mitosis was determined by fluorescence microscopy 48 hrs following 
transfection.  (E) HeLa cells were transfected with constructs coding for SENP1, SENP2, 
or the indicated chimeras.  Cells were stained with CENP-E specific antibodies and 
analyzed by immunofluorescence microscopy. DNA was stained with DAPI. Arrowheads 
indicate unaligned chromosome pairs.  Bar = 10 !m.  Where indicated, error bars 














Figure 3-2.  SENP1 and SENP2 association with NPCs is determined by N-terminal 
targeting signals.  HeLa cells were transfected with constructs coding for GFP-tagged 
SENP1, SENP2, or the indicated chimeras, fixed with formaldehyde and permeabilized 
with TNX-100.  Cells were stained with mAb 414 to detect nuclear pore complexes and 
imaged by immunofluorescence microscopy.  DNA was stained with DAPI.  Bar = 10 
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Figure 3-3.  SENP1 and SENP2 are targeted to overlapping and distinct mitotic 
structures through their N-terminal domains.  Constructs coding for GFP-tagged 
SENP1, SENP2 or SENP1/2 chimeras were transfected into HeLa cells.  Cells expressing 
SENP1 or SENP1N2cat were permeabilized, fixed and stained, while cells expressing 
SENP2 or SENP2N1cat cells were fixed, permeabilized and stained. Cells were co-labeled 
with: (A) CREST anti-centromere antibodies. Asterisks highlight centrosome staining 
and arrowheads indicate spindle microtubule staining.  (B) Antibodies specific for the 
inner-centromere marker, INCENP.  Arrowheads indicate centromeres flanked by 
kinetochore-associated SENP1 and SENP2 signals. (C) Antibodies specific for the outer-
kinetochore marker, Hec1.  DNA was labeled with DAPI.  Cells were imaged by 






Figure 3-4.   SENP1 and SENP2 interact with Nup107, but differentially associate 
with karyopherin !3.  293T cells were transfected with constructs coding for GFP, 
GFP-SENP1, or GFP-SENP2.  Protein complexes were immunopurified, using GFP-
specific antibodies, from lysates prepared from cells grown asynchronously or 
synchronized in mitosis by overnight incubation in the presence of nocodazole. Fractions 
of starting cell lysates (Input) and immunopurified protein complexes (IP) were analyzed 
by immunoblot analysis with antibodies specific for GFP, Nup107, karyopherin 
"3, tubulin, or phosphorylated histone H3.  Astericks denotes a contaminating band co-






Figure 3-5.  N-terminal targeting elements in SENP2 specify mitotic arrest 
phenotypes.  (A) Schematic diagram of SENP2 and targeting domain mutants.  
Abbreviations: NLS, nuclear localization signal; BD, binding domain; CAT, catalytic 
domain.  (B) HeLa cells were co-transfected with constructs coding for Myc-tagged 
SUMO-2 and wild type GFP-SENP2, the indicated GFP-tagged SENP2 mutants, or 
empty vector as control (Mock).  Cell lysates were analyzed by immunoblot analysis with 
antibodies specific for Myc, GFP or tubulin.  (C) HeLa cells were transfected with 
constructs coding for wild type GFP-SENP2, the indicated GFP-tagged SENP2 mutants, 
or empty vector (Mock).  The fraction of transfected cells in mitosis was determined by 
fluorescence microscopy 48 hrs following transfection.  (D) HeLa cells were transfected 
with constructs coding for wild type GFP-SENP2 or the indicated GFP-tagged SENP2 
mutants.  Cells were permeabilized, fixed and stained with Hec1 specific antibodies and 
analyzed by immunofluorescence microscopy. DNA was labeled with DAPI. Bar = 10 







Figure 3-6. Colocalization of karyopherin !3 and SENP2 is observed in interphase 
cells but is not detectable in mitotic cells.  HeLa cells were transfected with constructs 
coding for GFP-SENP2, fixed and permeabilized 48 hours post-transfection.  Cells were 
stained with karyopherin "3aryopherin st-transfection.  Cells were stained with 





Figure 3-7.   SENP1 induces mitotic arrest when artificially tethered to 
kinetochores.  (A) Schematic diagram of HA-tagged SENP1-FKBP and FLAG-tagged 
FRB-Nuf2 fusion proteins.  (B) HeLa cells were transfected with empty vector, or 
constructs coding for FRB-Nuf2, wild type   SENP1-FKBP, or catalytically inactive 
SENP1-FKBP (C603A), as indicated.  Cells were cultured in the presence (+) or absence 
(-) of AP21967 heterodimerizer.  FLAG-tagged Nuf2 was immunopurified from cell 
lysates and immunoblot analysis was performed on starting cell lysates (Input) and 
immunopurified complexes using FLAG, HA and tubulin specific antibodies (IP).  
Asterisk denotes antibody heavy chain.   (C) HeLa cells were co-transfected with 
constructs coding for HA-tagged SENP1-FKBP and FLAG-tagged FRB-Nuf2.  Cells 
were cultured in the absence or presence of AP21967 heterodimerizer and analyzed by 
immunofluorescence microscopy using HA and FLAG specific antibodies.  DNA was 
labeled with DAPI.  Bar equals 10 !m.  (D) Cells were transfected with constructs coding 
for the indicated fusion proteins and cultured in the absence or presence of AP21967 
heterodimerizer.  Mitotic indexes were determined by fluorescence microscopy.  Error 
bars denote standard deviations from three independent experiments.  (E) Illustration of 
mitotic chromosomes observed in cells co-expressing FRB-Nuf2 and SENP1-FKBP and 





Figure 3-8.  Immunofluorescence microscopy analysis of endogenous SENP1 and 
SENP2.  HeLa cells were fixed, permeabilized, stained, and analyzed by 
immunofluorescence microscopy. DNA was labeled with DAPI.  Cells were co-labeled 
with: (A) SENP1 or SENP2 specific antibodies and mAb 414 to detect nuclear pore 
complexes in interphase.  (B) SENP1 or SENP2 specific antibodies and Hec1 specific 







Figure 3-9. Analysis of endogenous SENP1 and SENP2 by siRNA knockdown.  (A 
and B) HeLa cells were transfected with a control scramble siRNA, two independent 
SENP-2 specific siRNAs, or two independent SENP1 specific siRNAs.  (A) Cell lysates 
were analyzed by immunoblot analysis with SENP1 or SENP2 specific antibodies and 
anti-tubulin antibodies as indicated.  Dots indicate multiple SENP2 isoforms.  (B) Mitotic 
indices were determined by fluorescence microscopy analysis of DAPI stained cells 48 
hours after transfection.  Error bars equal the standard deviations from three independent 
experiments.  (C and D) YFP-H2B expressing HeLa cells were transfected with control 
scramble, SENP1 or SENP2 siRNAs and imaged by live-cell fluorescence microscopy 
starting 48 hours after transfection.  (C) Time from nuclear envelope breakdown to 
metaphase alignment and (D) metaphase alignment to anaphase onset was quantified for 
#65 cells from at least three independent experiments for each condition.  Outliers, as 
defined as being 1.5 x the interquartile range above or below the dataset minimum or 
maximum, are not shown.  (E and F) YFP-H2B expressing HeLa cells were co-
transfected with control scramble or SENP1a siRNA and siRNA resistant constructs of 
mCherry-SENP1 WT or the catalytic mutants C603A and C603S.  (E) Cells lysates were 
analyzed by immunoblot analysis with SENP1 or tubulin specific antibodies.  (F) Time 
from metaphase alignment to anaphase onset was measured by live-cell fluorescence 
microscopy starting 48 hours after transfection and quantified for #35 transfected cells 
from three independent experiments for each condition.  Outliers, as defined as being 1.5 

















SUMO: A MULTI-FACETED MODIFIED OF CHROMATIN  
STRUCTURE AND FUNCTION 
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ABSTRACT 
 A major challenge in nuclear organization is the packaging of DNA into dynamic 
chromatin structures that can respond to changes in the transcriptional requirements of 
the cell.  Posttranslational protein modifications, of histones and other chromatin-
associated factors, are essential regulators of chromatin dynamics.  In this chapter, we 
summarize studies demonstrating that posttranslational modification of proteins by small 
ubiquitin-related modifiers (SUMOs) regulates chromatin structure and function at 
multiple levels and through a variety of mechanisms to influence gene expression and 






The discovery of the nucleosome, the iconic “beads on a string,” and finally the 
realization that there are higher order chromatin packing structures have made it clear 
that DNA is intricately organized.  Since this time, significant progress has been made in 
identifying the proteins responsible for higher order DNA packaging and in 
understanding how regulation of these proteins affects chromatin structure.  A major 
theme that has emerged is the important role of posttranslational protein modifications in 
modulating the functional accessibility of DNA.  Of particular interest, recent global 
proteomic and genetic studies have linked modification by the small ubiquitin-related 
modifier (SUMO) to many processes involving chromatin, including transcriptional 
activation and repression, DNA replication and repair, as well as chromosome 
segregation (1,2).  Here, we review the current knowledge of how SUMO modification 
(sumoylation) of chromatin-associated proteins regulates chromatin structure and 
function and thereby controls these essential cellular processes. 
After introducing the sumoylation pathway and general connections between 
SUMO and chromatin, we will discuss the complex role of sumoylation in both 
euchromatin and heterochromatin environments.  First, the multiple mechanisms by 
which sumoylation modulates gene expression through effects on DNA methylation, 
histones and transcriptional regulators will be reviewed.  Subsequently, the functional 
role of sumoylation in repetitive DNA structures, including rDNA, telomeres, and 
centromeres will be discussed.  We will highlight the unique functions of sumoylation 
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within each of these domains as well as its common role as a protector of genomic 
integrity.    
Several emerging themes will be reiterated throughout the review.  First, that 
sumoylation often functions as a signal to facilitate protein-protein interactions on 
chromatin.  These interactions may be simple hetero-dimeric associations, but can also 
involve assembly of very large multi-protein complexes.  Second, that sumoylation also 
specifies multiple other fates, including effects on enzyme activity and changes in protein 
sub-cellular localization.  And lastly, that although in many cases sumoylation is linked 
to heterochromatin and gene inactivation, a growing number of studies indicate that 
sumoylation also plays important roles in enhancing chromatin accessibility and gene 
activation.  Thus, the effects of sumoylation are dichotomous and often context 
dependent.    
 
SUMO Modification and Function 
Mechanistically, sumoylation occurs through an enzyme cascade very similar to 
ubiquitylation (Figure 4-1A).  The SUMO paralogs are synthesized as precursor proteins 
that are cleaved by a family of SUMO isopeptidases referred to as SENPs (3).  Mature 
SUMO is subsequently activated by a heterodimeric E1 activating enzyme (Aos1/Uba2), 
transferred to an E2 conjugating enzyme (Ubc9), and finally transferred to lysine residues 
in target proteins.  This last step may be facilitated by the action of E3 ligases, which in 
addition to enhancing rates of sumoylation, are also believed to contribute to specificity 
(4,5).  Substrate specificity in the sumoylation pathway, however, still remains poorly 
understood as only a single E2 enzyme and relatively few E3 ligases have been 
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identified.  Sumoylation is, however, highly dynamic and can be reversed by the action of 
desumoylating enzymes. In vertebrates, these isopeptidases include a family of six 
SENPs defined by a conserved cysteine protease domain, distinct-subcellular 
localizations and non-redundant functions (Mukhopadhyay and Dasso, 2007).  In 
addition, several unique desumoylating enzymes have more recently been identified, 
including the metalloprotease Wss1, the PPPDE–domain containing proteins DeSI-1 and 
DeSI-2, and the ubiquitin-specific protease-like protein 1 (USPL1)  ((3,6-8). Sumoylation 
of individual proteins is likely to be regulated by a fine-tuned balance between 
conjugation and deconjugation (5).  Consistent with this, and as outlined below, both 
SUMO conjugating and deconjugating enzymes are important effectors of chromatin 
structure.   
Sumoylation of proteins can affect protein stability, enzymatic activity, alter 
localization, or mediate novel protein-protein interactions with other proteins containing 
SUMO-interacting motifs (SIMs) (Figure 4-1B) (9,10).  In many instances, sumoylation 
may play a role in facilitating the assembly of large multi-protein complexes between 
proteins that are either covalently modified by SUMO and/or contain SIMs, as 
exemplified by PML nuclear bodies.  In these sub-nuclear structures, SUMO acts as a 
scaffold to mediate interactions between the PML protein and other associated factors 
(11,12).  Although multiple effects of sumoylation on proteins have been discovered, the 
ability of SUMO to promote the assembly of multi-protein complexes is an especially 
prominent theme.   
The diverse effects of sumoylation may be explained in part through the 
generation of functionally distinct signals.  Although invertebrates express only a single 
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SUMO, vertebrates express four paralogs (SUMO-1, SUMO-2, SUMO-3 and SUMO-4), 
each with the potential to act as unique signals by interacting with distinct downstream 
factors (9).  SUMO-2 and SUMO-3 share ~97% identity with each other and likely 
represent redundant signals and are thus referred to as SUMO-2/3. However, they share 
only ~50% identity with SUMO-1 (5).  SUMO-4 shares ~86% identity with SUMO-2/3, 
but questions exist about its ability to be conjugated to other proteins (6,13).  The ability 
of SUMOs to form polymeric chains provides an additional opportunity for signal 
diversification (Figure 4-1B) (9).  Currently the best-studied functional role for polymeric 
SUMO chains involves their recognition by SUMO-targeted ubiquitin E3 ligases 
containing tandem SIMs (14).  Other functional distinctions between paralogs and 
polymers remain to be fully understood.  Finally, the diverse effects of sumoylation can 
also be explained through intersections with other posttranslational modification 
pathways (Figure 4-1B).  For example, both phosphorylation and acetylation affect 
interactions between SUMO and downstream SUMO-binding proteins (15,16). 
 
General connections between sumoylation, chromatin and transcription 
Associations between sumoylation and chromatin structure have been well 
documented through numerous immunofluorescence microscopy studies.  All three 
SUMO paralogs, for example, are detected in the heterochromatin XY bodies of rat 
pachytene spermatocytes (17-20), and SUMO-1 is associated with long stretches of 
constitutive heterochromatin in human spermatocytes (21).  In mitotic cells, SUMO-2/3 
has been observed at the inner centromere of chromosomes and also along the length of 
chromosome arms as cells progress from metaphase through telophase (22-24).  
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Associations between SUMO and mitotic chromosomes are also detected in S. cerevisiae 
(25) and in D. melanogaster using polytene chromosome spreads (26), suggesting that 
sumoylation of chromatin-associated proteins has a conserved and fundamentally 
important function.  
Associations between SUMO and chromatin are further supported by biochemical 
studies, including chromatin immunoprecipitation experiments (ChIP).  In S. pombe, for 
example, ChIP experiments revealed that the SUMO E2 conjugating enzyme Ubc9 is 
chromatin bound and specifically enriched in regions of heterochromatin (27).  Similarly, 
fractionation of X. laevis egg extracts demonstrated interactions between PIAS E3 ligases 
and chromatin (23).  Surprisingly, a comprehensive genome-wide ChIP analysis to detect 
the precise association of SUMO or SUMO-modified proteins with chromatin has not yet 
been reported.  However, more targeted studies link SUMO or SUMO pathway enzymes 
to distinct chromatin domains, including pericentric heterochromatin, PcG bodies, the 
nucleolus, telomeres, and centromeres, as reviewed in detail below.  
Studies related to the involvement of sumoylation in controlling transcription 
regulation provide the strongest evidence for functional links between SUMO and 
chromatin.  Genetic approaches have revealed a general causal relationship between 
sumoylation and gene repression.  Inducing hyper-sumoylation by targeting SUMO 
and/or Ubc9 to specific gene promoters primarily induces gene repression (28,29).  
Consistently, inducing hypo-sumoylation by overexpressing SUMO isopeptidases or by 
depleting cells of Ubc9 or SUMO enhances ectopic gene expression (30-32).  These 
effects are mediated at multiple levels, including direct effects on transcription factor 
activities (33).  Transcription factors and co-regulators make up one of the most abundant 
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classes of SUMO-modified proteins. Although clearly able to mediate transcriptional 
repression, sumoylation is not simply a negative regulator of transcription.  The 
dichotomous role of SUMO in gene regulation is demonstrated by the observations that 
sumoylation of certain transcription factors, including Ikaros, enhance their 
transcriptional activity (Figure 4-2E) (34).  
Studies in yeast also provide a striking example of the complexities of 
sumoylation as both an activator and repressor of transcription.  ChIP analysis in S. 
cerevisiae reveals the presence of sumoylated proteins at the promoters of constitutively 
active genes and the recruitment of Ubc9 and SUMO to promoters of inducible genes in 
response to activation (35).  Surprisingly, sumoylation is not only required for optimal 
transcriptional activation of constitutive genes but also for repression and timely 
inactivation of inducible genes.  At constitutively active genes, sumoylation enhances 
transcription by promoting RNA polymerase II recruitment (Figure 4-2F).  However, at 
inducible promoters sumoylation functions downstream of transcription initiation.  
Specifically, sumoylation of the transcription factor Gcn4 promotes its removal from 
promoters and its degradation, thereby limiting transcription reinitiation (35,36).  
Another elegant example of the subtle and complex effects of sumoylation on 
transcription is illustrated by phenotypes in mice expressing a mutant form of the SF-1 
transcription factor that cannot be sumoylated.  Although studies in cultured cells indicate 
that sumoylation negatively regulates SF-1 transcriptional activity, mice expressing non-
sumoylatable SF-1 fail to phenocopy a constitutively active SF-1 (37,38).  Thus, 
sumoylation does not function as a simple on-off switch, but rather enhances the 
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functional diversity of SF-1, adding a layer of regulation for fine-tuning gene expression 
during development.  
 The utility of sumoylation as a mechanism to fine tune transcription can be 
explained in part on its broad effects on chromatin modifications and structure.  This is 
illustrated by studies of a well-characterized SUMO-1 modified transcription factor, Sp3.  
In cells expressing specific mutant isoforms of Sp3 that cannot be sumoylated, 
transcription activation and chromatin modifications at Sp3-targeted promoters are 
dramatically different from those observed at the same promoters in cells expressing wild 
type Sp3.  For instance, levels of both DNA and histone methylation are reduced at 
promoters in cells expressing mutant Sp3 and, concomitantly, levels of histone 
methyltransferases, heterochromatin protein 1 (HP1), and two ATP-dependent chromatin 
remodelers are also reduced (39-42).  These findings provide a relatively simple view of 
how sumoylation of just one transcription factor exerts multiple effects, some direct and 
others indirect, to alter chromatin structure.  However, even in the case of Sp3, the 
situation is not so simple, as evidenced through additional studies demonstrating that the 
effects of sumoylation are unique for different Sp3 isoforms and for different gene 
promoters (43,44).  An emerging view is that sumoylation sits at the intersection of 
multiple pathways, affecting the activities of not only transcription factors, but also other 
chromatin-associated proteins and chromatin modifying enzymes.  Thus, effects of 
sumoylation on gene expression and chromatin structure represent collective effects on 
multiple, context-dependent, levels (Figure 4-2).  How sumoylation affects gene 
expression at the level of chromatin structure and accessibility, and within the context of 
distinct genomic subdomains, is the focus of the following sections.   
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DNA Methylation 
DNA methylation of CpG dinucleotides restricts DNA accessibility by two 
mechanisms. Methylation either blocks the binding of sequence-specific DNA binding 
proteins and/or recruits chromatin modifying complexes that promote a restrictive 
chromatin structure (45).  Multiple lines of evidence indicate that sumoylation plays 
important roles in regulating CpG methylation and demethylation, as well as the 
assembly and functions of downstream complexes recruited to methylated DNA. 
First, sumoylation of DNA methyltransferases (Dnmts) may alter their enzymatic 
activity (Figure 4-2A). This has been demonstrated most clearly for the maintenance 
methyltransferase, Dnmt1, whose SUMO-1 modification increases its activity toward S 
phase hemi-methylated DNA substrates in vitro (46).  In addition, the de novo DNA 
methyltransferases Dnmt3a and Dnmt3b are both sumoylated in vivo, although the 
functional consequences of their modifications remain to be fully elucidated (47-49).  
Strikingly, nearly all of Dnmt3a is sumoylated in cells overexpressing SUMO-1, an effect 
that correlates with a disruption of Dnmt3a interactions with histone deacetylases 1 and 2 
(HDAC1 and -2) and a loss of Dnmt3a-mediated repression (49).  Further studies are 
needed to determine whether these effects are strictly related to Dnmt3a sumoylation. 
In addition to regulating DNA methylation, sumoylation also promotes DNA 
demethylation through mechanisms mediated by RNF4, a ubiquitin E3 ligase that 
specifically recognizes and ubiquitylates sumoylated proteins (Figure 4-2D) (14,50).  
RNF4 deficiency is embryonic lethal in mice.  RNF4-/- mouse embryonic fibroblasts, 
however, are viable but exhibit hypermethylation of genomic DNA.  Conversely, 
overexpression of wild type RNF4, but not SUMO-binding or ubiquitin ligase mutants, 
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results in global DNA demethylation (50).  Thus, SUMO and ubiquitylation are required 
for RNF4-mediated DNA demethylation, although the precise mechanisms of action 
remain unclear.  Intriguingly, one favored model for DNA demethylation is based on 
deamination of methylcytosines to create T:G mismatches that are repaired by thymidine 
DNA glycosylase (TDG) and base-excision repair (BER) (51).  TDG is known to interact 
with RNF4 (50) and sumoylation has been proposed to play an important role in 
regulating TDG by enhancing its enzymatic turnover (52,53). Thus, ubiquitylation of 
sumoylated TDG or other interacting proteins could produce a signal required for DNA 
demethylation and possibly BER in general.  
Sumoylation also functions downstream of DNA methylation, affecting the 
assembly of methyl-CpG binding domain (MBD) proteins and other factors with 
methylated DNA (Figure 4-2B) (54).  SUMO-1 and SUMO-2/3 both localize to 
heterochromatin domains enriched in MBD1, as well as heterochromatin proteins HP1 
and MCAF1 (55).  Formation of these heterochromatin domains is SUMO-dependent, as 
knockdown of either SUMO-1 or SUMO-2/3 disrupts the co-localization of HP1 and 
MCAF1 with MBD1-containing foci (55).  Intriguingly, MBD1 and HP1 are both 
sumoylated, whereas MCAF1 binds all three SUMO paralogs (55-57).  Thus, it is 
tempting to speculate that MBD1-containing heterochromatin domains are organized 
around covalent and non-covalent SUMO interactions in a fashion similar to PML 
nuclear bodies (11).  In contrast with these repressive functions, however, sumoylation of 
MBD1 also interferes with its interactions with the histone methyltransferase SETDB1 
and might thereby limit gene inactivation (56).  Therefore, sumoylation underlies 
multiple mechanisms for fine-tuning the functional properties of methylated DNA 
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through effects both positive and negative, again demonstrating the dichotomous effects 
of SUMO on gene expression. 
 
Histones and HDACs 
Posttranslational modification of histones also represents a central mechanism for 
controlling chromatin structure and gene expression, and not surprisingly, histones are 
sumoylated.  All four histones as well as the H2A.Z variant are sumoylated in S. 
cerevisiae (58,59), whereas only H4 has been shown to be modified in mammalian cells 
(29).  The functional significance of histone sumoylation is surprisingly not well 
understood.  ChIP experiments involving exogenously expressed SUMO-histone fusion 
proteins in yeast reveals enrichment at subtelomeric regions, an area of the genome where 
SUMO is generally thought to antagonize transcriptional repression (58,60,61). In 
contrast, expression of SUMO-histone fusion proteins represses transcriptional reporters 
in both mammalian cells and in yeast at least in part through recruitment of histone 
deacetylases (HDACs) and HP1 (29,58).  Such findings suggest that histone sumoylation 
functions as a signal to recruit proteins to chromatin (Figure 4-2B).  Consistent with this 
general concept, recruitment of the transcription corepressor complex, 
LSD1/CoREST1/HDAC, to chromatin is dependent on a SIM in CoREST1 (30).  
Whether CoREST1 recognizes sumoylated histones and/or other sumoylated factors, 
however, remains to be determined.  
In addition to histones, multiple studies have identified HDACs as another 
important effector of SUMO-mediated transcriptional repression.  Most simply, HDACs 
themselves are sumoylated (Figure 4-2B).  Sumoylation of HDAC1 and HDAC4 is 
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required for the full transcriptional repression activities at defined promoters (62-64).  
Whether sumoylation directly affects HDAC activity or acts as a signal for the 
recruitment of other chromatin repressors, however, is a question that remains to be fully 
addressed.  In addition to being directly modified, HDACs are also recruited to gene 
promoters in response to sumoylation of other factors, including transcription factors and 
cofactors such as Elk-1 and p300 (65-67).  These findings suggest that HDAC 
recruitment may be mediated through non-covalent interactions with SUMO, a 
suggestion that has been confirmed for at least HDAC1 which contains a functionally 
important SIM (68).  A third level of association between HDACs and sumoylation has 
been made based on the observations that HDACs 4, 5, and 7 appear to function as 
SUMO E3 ligases for certain substrates (69-71).  These findings are based largely on 
effects of HDAC overexpression, where an alternative mechanism for enhanced 
sumoylation might involve substrate binding and protection from isopeptidases.  In either 
case, HDAC interaction would provide a feed-forward mechanism for enhancing 
sumoylation-mediated histone deacetylation and repression.  
 
PcG Bodies  
Polycomb group (PcG) bodies are subnuclear structures that function as small 
hubs of transcriptional repression. To facilitate repression, PcG bodies cluster distant 
DNA promoter elements and recruit chromatin remodeling complexes called polycomb 
repressive complexes (72).  Given its involvement in repression and organizing large 
protein complexes, it is not surprising that SUMO localizes to PcG bodies (Figure 4-2C) 
(73).  In addition to SUMO, Ubc9, the SUMO isopeptidase SENP2, and the SUMO E3 
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ligase Cbx4/Pc2 all localize to PcG bodies (73-75).  Because Pc2 stimulates the 
sumoylation of many repressive proteins, including Dnmt3a, CTCF, and components of 
the polycomb repressive complex 2, it is attractive to speculate that sumoylation regulates 
the dynamic recruitment and assembly of these proteins within PcG bodies in a fashion 
similar to PML nuclear bodies (11,48,76,77).  
 Consistent with essential functions in PcG body-mediated repression, two 
independent studies have demonstrated links between sumoylation and expression of 
PcG-body regulated genes.  In C. elegans, depletion of SUMO, E1 or E2 conjugating 
enzymes results in ectopic expression of Hox genes normally controlled by PcG body 
recruitment (78).  The appropriate repression of Hox genes is dependent at least in part on 
sumoylation of the PcG protein SOP-2, which is required for the association of SOP-2 
with PcG bodies (78).  SUMO-dependent assembly of PcG bodies is also conserved in 
mammalian cells and is also critical for normal gene expression during embryonic 
development.  In particular, assembly of the polycomb repressive complex 1 (PRC1) at 
the promoters of genes important for normal heart development is misregulated in mice 
deficient in the SENP2 isopeptidase (75).  This misregulation is due in part to 
hypersumoylation of the Cbx4/Pc2 SUMO E3 ligase and enhanced assembly of PRC1 
complexes on the promoters of PcG target genes.  These findings illustrate the important 
balance between SUMO conjugating enzymes and isopeptidases, which is a common 
theme in ubiquitylation (79).  Further studies are required to understand how the activities 
of Cbx/Pc2 and SENP2 are normally regulated to affect proper PcG body function.   
Finally, in another example of the dichotomous effects of sumoylation, assembly 
of the PcG protein Sex Comb on Midleg (Scm) into repressor complexes in D. 
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melanogaster appears to be negatively regulated by its SUMO modification (80).  
Whether sumoylation has universally opposing effects on PcG body formation in D. 
melanogaster compared to other organisms remains to be determined.  An alternative and 
more appealing scenario is that sumoylation both positively and negatively affects PcG 
body assembly, with the ultimate effects on individual protein recruitment and gene 
expression being influenced by multiple, context-dependent factors and interactions. 
 
Chromatin insulators 
Sumoylation also influences gene expression by affecting the activities of 
chromatin insulator complexes.  This function was first revealed by studies in D. 
melanogaster, demonstrating that loss of the PIAS E3 ligase homolog results in ablation 
of heterochromatin-euchromatin barriers and normal polytene chromosome banding 
patterns (81).  Consistent with a role in regulating insulator functions, SUMO was 
subsequently localized to insulator bodies in D. melanogaster and two of the major 
protein components, Mod(mdg4)2.2/67.2 and CP190, were found to be sumoylated 
(82,83).  However, the function of SUMO in organizing and regulating the function of 
insulators is still unclear.  Enhancing sumoylation by Ubc9 overexpression leads to 
dispersal of insulator bodies, suggesting that sumoylation may negatively affect local 
and/or long-range interactions between insulator complexes (82).  In contrast, SUMO 
depletion or expression of a Mod(Mdg4)2.2/67.2 mutant that cannot be sumoylated 
inhibits insulator body formation, arguing for a positive role in insulator assembly (83).  
Such opposing findings indicate that insulator assembly and/or maintenance may rely on 
a finely tuned balance of sumoylation and desumoylation, as required for the association 
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or HP1! with pericentric DNA (84).  Further analysis is needed to understand the 
function of SUMO in insulator activity in Drosophila and particularly in other species.  
CTCF, a well characterized vertebrate insulator protein, is sumoylated in human cells, but 
how sumoylation affects its insulating activities remains unknown (76).  
 
The nucleolus 
 The nucleolus is a specialized sub-nuclear domain for ribosomal RNA (rRNA) 
gene expression and pre-ribosomal particle assembly (85).  Studies in both vertebrates 
and yeast indicate that sumoylation plays important roles in the nucleolus, including 
regulation of rRNA processing and pre-ribosomal particle assembly (86-89).  Consistent 
with this, SUMO-1 and SUMO-2/3 are detected within the nucleolus in vertebrate cells 
(22,90), as are the isopeptidases SENP3 and SENP5 (91).  Sumoylation also appears to 
have important effects on nucleolar rDNA structure and function.  Thus, 
hyposumoylation due to defects in the SUMO E3 ligase Mms21, a component of the 
Smc5/6 complex, lead to abnormal nucleolar morphology in S. cerevisiae (61).  In 
addition, aberrant activation of silenced rDNA occurs in S. cerevisiae strains deficient in 
the Slx5/Slx8 SUMO-targeted ubiquitin E3 ligase (92). How sumoylation affects rDNA 
chromatin structure and silencing remains to be fully characterized.  However, recent 
proteomic identification of the SUMO substrates within the nucleolus should enhance 
these efforts (93,94). 
Because of the repetitive nature of rDNA genes, specialized SUMO-dependent 
DNA repair mechanisms exist to maintain stability of nucleolar rDNA loci (Figure 4-3E).  
DNA double-strand breaks within rDNA loci are repaired at extranucleolar sites in a 
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manner dependent on the Smc5/6 complex and sumoylation of Rad52.  Specifically, yeast 
strains expressing Smc5/6 mutants or a Rad52 mutant that cannot be sumoylated form 
DNA repair foci within the nucleolus itself and these strains exhibit hyper-recombination 
within the rDNA locus (95,96). Whether Mms21-mediated sumoylation regulates DNA 
repair in other repetitive sequences by a similar mechanism remains to be determined, but 
the role of SUMO in general repetitive DNA maintenance is reviewed in detail below.  
 
Telomeres 
Telomeres are composed of DNA repeats coated by resident telomere-binding 
protein complexes, called shelterin complexes, that protect them from degradation and 
inappropriate recognition by DNA repair enzymes (97).  Because telomere shortening 
jeopardizes genome integrity, maintenance of telomere length is a tightly controlled 
process.  Telomere maintenance is controlled through multiple mechanisms, including 
recruitment of telomerase (the enzyme that catalyzes the addition of telomere DNA 
repeats), modulation of the heterochromatin environment of the subtelomeric regions, and 
modulation of the alternate lengthening of telomeres (ALT) pathway (97).  In strains of S. 
cerevisiae and S. pombe defective in SUMO, Ubc9, or SUMO E3 ligases, telomeres are 
abnormally elongated, demonstrating a role for sumoylation in affecting one or more of 
these mechanisms (60,61,98-101).  
The telomere elongation observed in yeast mutants defective in sumoylation is 
telomerase-dependent, suggesting that sumoylation normally limits the accessibility of 
telomeres to telomerase (Figure 4-3A) (101).  To date, there is no demonstration that 
telomerase itself is regulated through sumoylation. Studies have shown that sumoylation 
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affects the activity of Cdc13, a single-stranded telomere binding protein and regulator of 
telomerase recruitment, by promoting Cdc13 association with the telomerase inhibitor, 
Stn1.  Consequently, yeast strains expressing a Cdc13 mutant that cannot be sumoylated 
have lengthened telomeres, while shortened telomeres are observed in strains expressing 
a Cdc13-SUMO fusion (99).  Furthermore, multiple components of the shelterin 
complex, which are known to limit telomerase recruitment to telomeres (102), are 
sumoylated (99,103-106).  Sumoylation of one or more of these factors is likely to 
contribute to the full inhibitory effect of SUMO on telomere lengthening. However, the 
underlying molecular mechanisms remain unknown.  
 Sumoylation may also regulate telomere length by modulating the 
heterochromatin environment of the subtelomere (Figure 4-3B).  Mutations in yeast that 
disrupt telomeric heterochromatin structure and silencing also cause shortened telomeres, 
indicating that heterochromatin proteins positively regulate telomere length (97).  
Because SUMO negatively regulates telomere length, this model would predict that 
sumoylation antagonizes silencing in the subtelomere.  Remarkably, the data confirms 
this model despite the more general association of SUMO with enhanced repression.  
Reducing levels of sumoylation in yeast leads to increased telomeric silencing (60,61), 
while increasing sumoylation relieves telomeric silencing (92,107).  The molecular 
mechanisms underlying these effects are not fully understood, but are likely to be 
complex.  For instance, sumoylation is required for the clustering and anchoring of 
telomeres to the nuclear periphery, a process that stabilizes telomeric heterochromatin 
and limits telomerase activity (61,81,103).   
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Finally, sumoylation is involved in telomere maintenance through effects on the 
ALT pathway (4-3C).  In mammalian cells that utilize ALT, knockdown of the SUMO 
E3 ligase Mms21 results in reduced telomere length and increased senescence.  Although 
this may appear to contradict phenotypes observed in yeast, this effect is unique to ALT 
and is not observed if telomerase is introduced into cells (106).  The requirement of 
sumoylation in ALT is explained in part because telomere elongation is dependent on 
assembly of subnuclear structures formed around telomeres called ALT-associated PML 
nuclear bodies (APBs).  Similar to PML nuclear bodies, assembly of APBs is SUMO 
dependent.  Artificially tethering SUMO or Mms21 to telomeric regions is sufficient to 
promote APB formation, while Mms21 knockdown limits APB formation (106,108).  
Thus, requirements for sumoylation in the ALT pathway are due at least in part to an 
essential role in APB formation. 
 
Centromeres   
Centromeres are specialized chromatin structures that form the foundation for 
kinetochores and are therefore essential for proper chromosome segregation during cell 
division (109). The gene encoding SUMO was first identified in yeast as a high copy 
suppressor of a mutant allele of the centromere-associated protein Mif2 (the vertebrate 
CENP-C homolog) (110), providing an early indication of a connection between 
sumoylation and centromeres.  Since then, immunofluorescence microscopy has 
demonstrated that SUMO-2/3 localizes to centromeres on chromosomes formed in 
Xenopus egg extracts and on mammalian mitotic and meiotic chromosomes (17,20,22-
24,111).  Furthermore, various SUMO E3 ligases, including PIASy, PIAS3, and 
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Nup358/RanBP2, are also present at centromeres of mitotic chromosomes (81,112-114).  
Consistent with essential roles in regulating centromere and kinetochore function in 
mitosis, chromosome segregation defects occur when the SUMO pathway is either up or 
down regulated (24,25,81,113,115-117). Segregation, cohesion, and other roles for 
sumoylation during mitosis have been characterized and are reviewed in more detail 
elsewhere (118).  Here, we focus more specifically on effects of sumoylation on 
centromeric heterochromatin. 
In contrast to mitosis, few studies have addressed potential roles for sumoylation 
at centromeres or kinetochores during interphase. Of particular interest, it is not known 
whether SUMO remains associated with centromeres throughout the cell cycle or 
whether its association is specific to mitosis.  A role for sumoylation in the maintenance 
of centromeric heterochromatin during interphase is, however, suggested by the findings 
that inhibiting sumoylation in both yeast and mammalian cells results in activation of 
genes within normally repressed centromeric regions (Figure 4-3D) (27,101,119).  For 
example, S. pombe mutants lacking the Pli1 SUMO E3 ligase exhibit reduced silencing 
and enhanced conversion of genes inserted into core centromeric regions (60).  How Pli1-
dependent sumoylation normally restricts transcription and recombination within this 
centromeric region is not fully understood.  Inhibition could be mediated through effects 
on transcription and recombination factors, or through more direct effects on the 
formation and/or maintenance of centromeric heterochromatin.  
One mechanism by which centromeric chromatin structure is regulated by 
sumoylation is through recruitment of the heterochromatin factor HP1! (Figure 4-3D).  
Sumoylation of HP1! regulates its interactions with major !-satellite RNA transcripts 
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which in turn directs pericentric DNA targeting (57).  Although sumoylation occurs 
within the hinge domain of HP1! thought to be involved in RNA binding, the exact 
molecular mechanisms underlying SUMO-dependent interactions with !-satellite RNAs 
remain to be determined.  Intriguingly, further studies have revealed that depletion of 
SENP7, a SUMO protease that localizes to HP1-enriched pericentric domains, disrupts 
HP1! localization (84).  This finding suggests that localization of HP1a is dependent on 
transient sumoylation of HP1! followed by desumoylation and may explain the common 
“SUMO enigma” (120), namely that steady state levels of sumoylated HP1! in the cell 
represent only a relatively minor fraction of total HP1!.  A role for sumoylation in HP1 
targeting and gene silencing has also been observed in S. pombe, where HP1 mutants that 
cannot be sumoylated are less efficiently recruited to heterochromatin domains and 
compromised in their ability to repress gene expression (27).  Thus, sumoylation of HP1 
represents an important and conserved regulatory point for controlling heterochromatin 
structure and gene expression at centromeres and other chromatin domains. 
 
Maintenance of repetitive DNA  
Repetitive DNA sequences, including those found at telomeres, centromeres and 
within the rDNA gene loci, represent especially fragile domains in the genome due to 
issues related to replication and recombination (121).  The maintenance of these and 
other repetitive DNA domains is highly dependent on the activity of the cohesion-like 
complex, Smc5/6, and the associated SUMO E3 ligase, Mms21 (122).  Similar to other 
SMC complexes, Smc5/6 activities are mediated at least in part through cohesion-related 
effects on higher-order chromatin structure, but also through the targeting of Mms21 to 
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appropriate DNA targets. Smc5/6 and Mms21 are essential for the maintenance of 
genome integrity, with mutants exhibiting gross chromosomal rearrangements and 
chromosome segregation defects.  These defects are due in part to the incomplete 
resolution of replication-associated homologous recombination intermediates, 
particularly within the rDNA locus and at telomeres (Figure 4-3F) (96,122-125).  
While the exact molecular targets and functions of sumoylation in the 
maintenance of heterochromatic repetitive DNA are not fully understood, a growing body 
of evidence indicates that replication through these domains requires DNA repair factors, 
including BRCA1 and Rad51 (126,127).  Sumoylation is intimately linked to the control 
of these and a large number of other DNA repair factors (128-130), suggesting that 
Mms21-dependent sumoylation is required for proper resolution of DNA repair 
intermediates produced during replication.  Consistent with this, recombination-
dependent DNA repair intermediates accumulate during replication in Smc5/6, Ubc9 and 
Mms21-deficient cells (122,131). 
Sumoylation also plays an essential role in regulating the resolution of DNA 
intermediates at centromeres during sister chromatid separation in mitosis by affecting 
the localization and activities of topoisomerase II (Figure 4-3F) (23,132,133).  In 
addition, immunofluorescence microscopy studies in mammalian cells indicate that 
centromeres transiently co-localize with PML nuclear bodies in G2, a phenomena that is 
enhanced by proteasome inhibition (134).  Although the functional significance of this 
association remains unexplored, telomere association with APBs is required for their 
maintenance in telomerase-deficient cells.  It is therefore tempting to speculate by 
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analogy to APBs that interactions between centromeres and PML nuclear bodies in late 
G2 promotes SUMO-dependent reactions required for maintenance of centromeric DNA.  
 
Future perspectives and conclusions 
 Sumoylation functions as a multifaceted regulator of chromatin structure, gene 
expression and genome integrity.  Its utility resides in part in the ability of SUMO to 
elicit diverse downstream consequences following conjugation to different proteins.  
These consequences include affects on protein activity, localization, stability and 
interactions with a wide range of SIM-containing proteins.  Understanding the rules that 
define the effects of sumoylation on specific chromatin-associated proteins, which are 
determined by the nature of the proteins themselves as well as any downstream 
interacting proteins, remains an important challenge for the field.  In particular, 
understanding how sumoylation of different proteins mediates interactions with specific 
downstream SIM-containing proteins is critical.  Specificity is likely to involve bivalent 
recognition of SUMO-modified proteins through downstream factors that contain both 
SIMs and motifs for recognizing the modified protein itself, as recently determined for 
Srs2 recognition of SUMO-modified PCNA (135).   Specificity is also very likely to be 
determined and regulated by the intersection with other posttranslational modification 
pathways, including ubiquitylation, phosphorylation and acetylation.  Understanding the 
crosstalk between sumoylation and other posttranslational modifications in greater detail 
is also an important challenge for the field.    
Defining the role of sumoylation in controlling chromatin structure and function 
more specifically and at a molecular level will also require a more detailed 
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characterization of relevant SUMO-modified proteins.  While the identification of 
SUMO-modified proteins with roles in chromatin structure and function has expanded 
greatly in the past several years, the functional effects of sumoylation on the majority of 
these proteins remain unknown.  Characterizing the effects of sumoylation on individual 
proteins is often challenging, due in part to the relatively small fraction of most proteins 
modified at steady state.  Other challenges involve identifying approaches for specifically 
affecting sumoylation of individual proteins or pathways.  While many important studies 
linking sumoylation to chromatin structure and gene expression have relied on global 
activation or suppression of sumoylation, more targeted approaches are needed.  The 
identification of new and functionally unique E3 ligases, as exemplified by Mms21, 
represents one avenue for developing more specific approaches.  The identification of 
separation-of-function alleles of SUMO or SUMO pathway enzymes in yeast or other 
genetically tractable organisms could also prove valuable.  
    Finally, a more detailed understanding of the genome-wide interactions 
between SUMO (and SUMO pathway enzymes) and chromatin is needed.  ChIP 
experiments on a small scale provided the surprising finding the SUMO is associated 
with the promoters of active but not repressed genes (35).  Whole chromosome ChIP 
experiments, revealing genome-wide associations of SUMO during different stages of the 
cell cycle cell or under different cell growth conditions, could be particularly insightful 
and provide even more surprises.  
In summary, we have reviewed the role of SUMO as a regulator of chromatin 
structure and function.  In one important capacity, sumoylation regulates the assembly of 
multi-protein complexes on chromatin, including repressive complexes organized around 
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sites of DNA methylation and PcG bodies, as well as transcriptional regulatory 
complexes at gene promoters.  A recurring theme from the reviewed studies is the 
dichotomous role of sumoylation.  By facilitating the assembly of distinct complexes, 
sumoylation affects the chromatin environment in ways that can either activate or repress 
gene expression.  In addition to facilitating protein complex assembly, sumoylation also 
affects proteins in multiple other ways by mediating changes in localization, stability or 
enzymatic activity.  Thus, another recurring theme is the diverse and context-dependent 
effects of sumoylation on chromatin-associated proteins.  Finally, we have reviewed the 
prominent role played by sumoylation in maintaining the integrity of repetitive 
heterochromatin domains, including telomeres, centromeres and rDNA loci.  
Collectively, the reviewed studies reveal the incredible versatility of sumoylation, which 
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Figure 4-1.  The SUMO pathway and molecular consequences of sumoylation.  
(A)  SUMO is synthesized as a precursor, processed to a mature form by SUMO-specific 
isopeptidases and covalently conjugated to protein substrates via an E1, E2 and E3 
enzyme cascade.  Sumoylated protein substrates are demodified by SUMO-specific 
isopeptidases. (B) The molecular consequences of sumoylation (S) include protein 
targeting, alteration of protein or enzyme function, effects on protein stability, and effects 
on protein-protein interactions. Sumoylation can promote or antagonize protein stability 
by either blocking ubiquitylation of lysine residues or by promoting ubiquitylation (Ub) 
upon recognition by SUMO-targeted ubiquitin ligases (STUbL). Effects on protein-
protein interactions may be modulated at multiple levels, including polymeric chain 
formation and intersection with other posttranslational modifications such as 





Figure 4-2.  Sumoylation functions as an activator and a repressor of gene 
expression. (A) Sumoylation represses gene expression by promoting DNA methylation 
(yellow dots) through DNMT1 activation.  (B) Sumoylation represses gene expression by 
facilitating assembly of repressive complexes on methylated DNA and at promoters.  
Sumoylation also inhibits the activities of transcription factors (TFs) and affects HDAC 
recruitment and function. (C) Sumoylation promotes the assembly of repressive PcG 
bodies.  (D) Sumoylation promotes DNA demethylation and gene activation through 
mechanisms involving the SUMO-targeted ubiquitin E3 ligase activity of RNF4.  (E) 
Sumoylation facilitates the assembly of complexes on chromatin that promote 
transcription.  (F) Sumoylation positively influences RNA polymerase II (RNA Pol II) 




Figure 4-3.  Sumoylation maintains genome integrity at repetitive DNA domains. 
(A) Sumoylation limits telomere elongation by regulating interactions between Cdc13 
and Stn1.  (B) Sumoylation of unknown proteins affects sub-telomeric chromatin 
structure.  (C) Sumoylation promotes the assembly of ALT PML nuclear bodies (APBs) 
essential for telomere maintenance in telomerase-deficient cells.  (D) Sumoylation of 
Rad52 promotes the movement of DNA double-strand breaks from intranucleolar 
domains to the nucleolar periphery for optimal repair. (E) Sumoylation of HP1! 
regulates its association with !-satellite RNA and recruitment to centromeres.  (F) 
Sumoylation functions to resolve DNA replication and repair intermediates within 





















 SENP1, a SUMO protease, is important for temporal and spatial control of 
sumoylation in mitosis. Notably, SENP1 localizes to nuclear pore complexes (NPCs) in 
interphase and centrosomes, mitotic spindles, and kinetochores in mitosis, where it is 
required for a timely metaphase to anaphase transition. In this study, we further 
characterized the targeting signals in SENP1 in interphase and mitosis. In addition, we 
utilized siRNA knockdown studies to characterize the molecular mechanism of SENP1 
regulation of the metaphase to anaphase transition. We observed no defects in APC 
activation, sister chromatid cohesion, mitotic spindle structure, or general kinetochore 
protein recruitment after SENP1 knockdown. However, SENP1-depleted cells have an 
abnormal retention of Mad2, a spindle assembly checkpoint (SAC) protein, at 
kinetochores after bipolar attachment. Furthermore, the metaphase to anaphase transition 
delay observed after SENP1-depletion is rescued by a SAC inhibitor. Thus, in this study 




The SUMO protease SENP1 is often associated with cancer phenotypes, but the 
molecular mechanisms involved are still largely uncharacterized. SENP1 is 
overexpressed in prostate cancers and promotes cellular proliferation by affecting 
androgen receptor function (1-4). Furthermore, SENP1 overexpression has been observed 
in colon cancer and laryngeal squamous cell carcinomas (5,6). Notably, SENP1 is a 
driver of tumorigenesis in colon cancer cells because knockdown of SENP1 reduces 
tumor size (5). Thus, understanding the biochemistry and molecular mechanisms of 
SENP1 function is critical to learning how SENP1 drives tumorigenesis. In this appendix, 
I will address the functional role of SENP1 in mitosis, which may be one molecular 
mechanism by which SENP1 promotes cancer.  
Two different groups have produced SENP1-/- mice that are embryonic lethal, 
demonstrating that SENP1 has essential, non-redundant functions with the other 
isopeptidases (7,8). SENP1-/- MEFs have a clear accumulation of SUMO-1 modified 
proteins and a more moderate increase in SUMO-2 modified proteins (7,8). Notably, the 
SENP1-/- embryonic lethality was partially rescued by crossing SENP1+/- mice into a 
SUMO-1+/- background, suggesting that the accumulated SUMO-1 modified proteins are 
the cause of some of the observed developmental defects (9). However, accumulations in 
SUMO-1 modified proteins are not the only defect in SENP1-/- animals, as these mice 
were stillborn or died shortly after birth.  
Additional functions have been connected to SENP1 in various organisms and 
cell types. SENP1 knockout studies have shown that SENP1 functions in sister chromatid 
cohesion, placental development, the response to hypoxia, and mitochondrial biogenesis 
! ""%!
(7,8,10,11). In addition, SENP1 siRNA knockdown studies have demonstrated that 
SENP1 is a cell cycle regulator, consistent with its role as a driver of tumorigenesis. 
SENP1-depletion results in cellular senescence or a G1 arrest in human foreskin 
fibroblasts and human colon cancer DLD-1 cells, respectively (5,12). Thus, SENP1 has a 
myriad of characterized functions, which likely reflects its cell-type specific isopeptidase 
activity and localization.  
SENP1 binds SUMO-1, SUMO-2 and SUMO-3 and has the most robust 
endopeptidase activity of all the SENPs (13,14). Thus, SENP1 is expected to play an 
important role in the cleavage of precursor SUMOs to expose a GG motif at the C-
terminus. SENP1 exhibits the strongest endopeptidase activity towards SUMO-1 and the 
weakest activity for SUMO-3 (13,15). Strikingly, chimeric proteins that swap the amino 
acids C-terminal to the GG on SUMO alter SENP1 specificity, demonstrating that 
divergence of the amino acids C-terminal to the GG are essential for SENP1 paralog-
specific endopeptidase activity (13,15).  
In addition to endopeptidase activity, SENP1 also has robust isopeptidase activity 
important for the cleavage of SUMO from protein substrates. Interactions between 
SENP1 and SUMO occur within the relatively conserved C-terminus of mature SUMO 
and the active site cleft of SENP1, allowing SENP1 to bind and deconjugate all three 
SUMO paralogs (16). However, SENP1 has a preference for deconjugating the different 
SUMO paralogs from substrates in vitro, with the highest activity against SUMO-2 
modified proteins and the lowest activity against SUMO-1 (13). In almost all cell types, 
SENP1 is the most robust isopeptidase for SUMO-1 modified proteins and also has very 
strong activity for SUMO-2 modified proteins (17).  
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Finally, there have been a few other interesting observations about SENP1 
catalytic activity. First, overexpression of the catalytic mutants of SENP1 C603A or 
C603S results in an accumulation of SUMO-1 modified proteins (18,19). These findings 
suggest that the catalytically dead SENP1 proteins are binding substrates and preventing 
their deconjugation by other isopeptidases. This hypothesis is supported by the 
observation that SENP1 C603S can be co-purified with large numbers of SUMO-1 
modified proteins (18).  
 Precisely what regulates the isopeptidase and endopeptidase activities of SENP1 
are still unknown. Three different studies have demonstrated that SENP1 is modified by 
SUMO-1 and SUMO-2/3 (9,18,20). SENP1 sumoylation is most clearly observed with 
catalytically dead versions of SENP1, suggesting auto-desumoylation occurs (20,21). 
However, the site of SENP1 sumoylation and its functional significance has yet to be 
characterized. Interestingly, SENP1 activity may also be regulated by protein stability. 
For example, Nup153 depletion causes a reduction in SENP1 protein levels (20). Because 
SENP1 and Nup153 interact, this result suggests that SENP1-Nup153 protein-protein 
interactions are required for SENP1 stability (20). Further studies are required to fully 
understand how SENP1 is regulated through other posttranslational or protein stability 
mechanisms. 
In addition to its catalytic domain, SENP1 contains an N-terminal domain that is 
critical for its substrate specificity and localization to nuclear pore complexes (NPCs) in 
interphase (Chapter 3). However, the targeting signals and protein-protein interaction 
domains within the SENP1 N-terminus are still largely uncharacterized. Amino acids 
171-177 encode a nuclear localization signal (NLS) that is necessary but not sufficient for 
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nuclear import, while amino acids 634-644 encode a nuclear export signal (NES) (18,19). 
Thus, SENP1 likely shuttles between the cytoplasm and nucleus, which is supported by 
findings showing SENP1 localization varies from nucleoplasmic to cytoplasmic in 
different cell types (19,21,22). In addition, SENP1 interacts with the nucleoporins 
Nup153, the Nup107-160 complex, and Nup358  (Chapter 3 and (20)), suggesting that 
SENP1 targeting to NPCs is likely mediated by a combination of nucleoplasmic shuttling 
and interactions with nucleoporins. However, a more careful analysis of the SENP1 N-
terminus is required to determine which interaction domains are critical for targeting. 
 We previously demonstrated that SENP1 localizes to NPCs and that SENP1 
knockdown results in a delay in the metaphase to anaphase transition (Chapter 3). In this 
study, we sought to further characterize the interactions of SENP1 with the NPC because 
multiple nucleoporins, including the Nup107-160 complex, Nup358, Tpr, Nup153, and 
Nup98, have critical mitotic functions at kinetochores and the mitotic spindle (23).  We 
demonstrated that SENP1 localizes to the nucleoplasmic face of the NPC and has two 
independent NPC-targeting elements. In addition, we evaluated the function of SENP1 in 
four potential molecular processes that could cause a metaphase to anaphase transition 
delay: sister chromatid cohesion, anaphase promoting complex activation, mitotic spindle 
and kinetochore assembly, and the stability of the spindle assembly checkpoint (SAC). 
We demonstrated that the SENP1 knockdown phenotype is dependent on the SAC and 
causes abnormal retention of Mad2, a SAC protein, at kinetochores after proper 
chromosome alignment. Thus, our findings demonstrate that SENP1 is a novel regulator 
of SAC inactivation and function. 
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MATERIALS AND METHODS 
 
Antibodies 
GFP rabbit polyclonal antibodies were produced as described previously (24).  
The SENP1 antibody, a gift from Dr. Mary Dasso (National Institute of Health, Bethesda, 
MD), was generated by injecting rabbits with GST-SENP1 (273-449) as previously 
described (20).  Antibodies were affinity purified using appropriate antigens and standard 
protocols.  
Remaining antibodies were obtained from the following sources: Tpr (5E10), 
Nup358 (14E6), Nup358 C-288, Hec1 (BD Transduction – 611040); CENP-E (Active 
motif - 39620); CENP-F (BD 610768); INCENP (Active motif – 39259); CREST human 
auto-antibodies were a generous gift from Dr. Ted Salmon (University of North Carolina, 
NC); Mad2 was a generous gift from Dr. Ted Salmon (University of North Carolina, 
NC); Cyclin B1 (Santa Cruz sc-245), SUMO-2/3 (8A2), Tubulin (DM1A) Sigma T9026; 
TRIM28 (20A1) Enzo ADI-KAM-TF200-D; mAb 414 – BAbCO. 
 
Plasmid constructs 
SENP1 GFP-tagged and mCherry-tagged expression constructs were obtained as 
previously described (Chapter 3). The GFP-SENP1 !NES (1-633) construct was 
generated using site directed mutagenesis to create a stop codon at amino acid 634. The 
GFP-SENP1 fragments (1-40, 41-153, 154-272, 273-449, 320-400 and 401-644) were a 




Cells, cell culture, transfection, RNA interference 
HeLa cells stably expressing YFP-Histone H2B were a gift from Dr. Andrew 
Holland (Johns Hopkins University School of Medicine, Baltimore, MD).  HeLa and 
HEK 293T cells were maintained at 37°C in Dulbecco’s modified eagle medium 
supplemented with 10% fetal bovine serum, 10 mM HEPES (pH 8.0) and 1% penicillin-
streptomycin.  Cells were transfected with the indicated plasmids at a confluency of 40-
50% using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the 
manufacturer’s protocol.  For RNA interference, cells were grown to 40-50% confluency 
and then transfected using RNAiMax (Invitrogen, Carlsbad, CA).  siRNA oligos were 
used at a final concentration of 20 nM.  siRNA oligos included: scramble control (5’-
CUUCCUCUCUUUCUCUCCCUUGUGA-3’); SENP1 oligo(a) (5'- 
UCCUUUACACCUGUCUCGAUGUCUU-3') and SENP1 oligo(b) (5'-
GCAAAUGGCCAAUGG AGAAAUUCUA-3'). For nocodazole synchronizations, cells 
were treated with 0.1 µg/ml nocodazole overnight prior to harvest. For some experiments, 
nocodazole was washed out with fresh media for two hours prior to harvest.  Cells were 
harvested for immunoblotting, immunofluorescence microscopy, or FACs 48 hours after 
transfection. For reversine experiments, cells were treated with 1 µM reversine for 1.5 
hours prior to harvest.  
 
Immunoblotting  
Immunoblot analysis was performed using enzyme-linked chemiluminescence 
ECL-Prime reagent (GE Healthcare, Silver Spring, MD).  
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FACS Analysis  
 Cells were trypsinized 48 hours after knockdown and processed for FACs 
analysis as described previously (25). Briefly, cells were spun for 5 minutes at 200 x g 
and resuspended in 500 µl PBS with a glass pipette. Cells were vortexed 3 times in 5 
second pulses and added dropwise to 4.5 ml 70% ethanol on ice and rocked at 4°C for at 
least 2 hours for fixation. Cells were spun for 5 minutes at 200 x g, resuspended in PBS, 
and centrifuged again. Cells were resuspended in freshly prepared staining solution (0.1% 
(v/v) Triton X-100, 0.2 mg/ml RNAse A, 20 µg/ml Propidium Iodide (Invitrogen)) for 30 
minutes at 37°C prior to FACs analysis. Samples were processed on a FACS Calibur 
flow cytometer (BD Biosciences) using a 488 nm laser according to manufacturer 
protocols. Data was collected for 10,000 cells and analyzed using the Cell Quest 
software.   
 
Geimsa Staining of Chromosomes 
HeLa cells were transfected and synchronized. 12 hours after transfection, cells 
were treated with 2.5 mM thymidine for 24 hours, followed by 12 hour wash out and then 
harvested by mitotic shake off and trypsinization approximately 48 hours after the initial 
transfection. Cells were spun at 200 x g for 10 minutes at 4°C and all media except 500 
µl was aspirated. The pellet was flicked to gently resuspend the cells and 7 ml of 37°C 
0.8% sodium citrate was added to cells dropwise while tapping the tube. Cells were 
incubated at room temperature for 10 minutes and centrifuged at 200 x g for 10 minutes 
at 4°C. The supernatant was aspirated except 500 µl and the pellet was flicked to 
resuspend cells. 7 ml of freshly prepared Carnoy’s fixative was added (75% methanol, 
! "#+!
25% acetic acid) dropwise. Cells were incubated at room temperature for 10 minutes and 
centrifuged at 200 x g for 10 minutes at 4°C. Resupension and incubation in Carnoy’s 
fixative was repeated 2 more times. Cells were resuspended in a final volume of 500 µl 
Carnoy’s fixative and dropped onto slides. Slides were placed on a wet paper towel in a 
37°C water bath and cells were dropped from the standing height of a person on a stool. 
Slides were dried in a fume hood for approximately 10 minutes and stained in 1:20 
diluted Geimsa stain (Sigma – GS500) for 30 minutes. Slides were rinsed twice in water, 
air-dried, and a mounting medium was added prior to sealing the slide with a cover slip.  
 
Immunofluorescence microscopy  
HeLa or HEK 293T cells were cultured on glass coverslips. Unless otherwise 
stated, cells were fixed in 2% formaldehyde for 30 min and permeabilized in 0.2% 
Triton-X 100 for 7 min at RT. For digitonin permeabilization in interphase, cells were 
fixed in 2% formaldehyde for 30 min and permeabilized in 10 µg/ml digitonin in PBS for 
10 minutes. Localization of mitotic GFP-SENP1 was examined by pre-extracting cells in 
20 µg/ml digitonin in buffer containing (200 mM HEPES (pH 6.5), 110 mM potassium 
acetate, 20 mM magnesium acetate, 1 µg/ml leupeptin and pepstatin A, 20 µg/ml 
aprotinin, and 1 mM PMSF) for 15 min at RT and then fixing in 2% formaldehyde in 
PBS for 30 min. For localization of kinetochore proteins, cells were fixed in 3.5% 
paraformaldehyde in PBS for 7 min and permeabilized in 0.5% Triton-X 100 in PBS for 
20 min at RT. Immunostaining was carried out as previously described using secondary 
antibodies conjugated to Alexa Fluor 488, Alexa Fluor 594, or Alexa Fluor 647 (Life 
Technologies, Grand Island, NY), unless otherwise noted (26).  Images were acquired 
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using the Zeiss Observer Z1 fluorescence microscope with a Zeiss Plan-Apochromat 63X 
objective (numerical aperature = 1.40) and an Apotome VH optical sectioning grid.  
Images were obtained using a Zeiss Axiocam MRm camera and processed using 





SENP1 localizes to the nuclear side of the NPC and contains two independent NPC 
targeting elements  
 Although we have localized SENP1 to NPCs in interphase and to mitotic spindles, 
centrosomes and kinetochores in mitosis, the precise associations of SENP1 remain 
uncharacterized.  First, we determined if SENP1 is associated with the cytoplasmic or 
nuclear face of the NPC. Cells were fixed and permeabilized with Triton-X 100, which 
exposes epitopes in both the nucleus and cytoplasm, or with digitonin, which only 
exposes cytoplasmic epitopes. HeLa cells were stained for endogenous SENP1 and Tpr, a 
protein on the nucleoplasmic face on the NPC, or Nup358, a component of the 
cytoplasmic filaments of the NPC (Figure 5-1A). Endogenous SENP1 was only 
detectable after Triton-X 100 permeabilization, indicating that SENP1 localizes 
specifically to the nucleoplasmic face of the NPC (Figure 5-1A).  
Because many of our experiments will rely on GFP-SENP1 constructs, we 
investigated the localization of overexpressed wild-type GFP-SENP1 at NPCs. For these 
studies, we transfected HeLa cells with GFP-SENP1 and identified SENP1-expressing 
cells by the fluorescent signal of GFP. Furthermore, we utilized indirect 
immunofluorescence using a GFP-specific antibody with either a Triton-X 100 or 
digitonin permeabilization to determine the precise localization of GFP-SENP1. 
Overexpressed GFP-SENP1 localized to the nuclear face of the NPC, consistent with the 
observations for endogenous SENP1 (Figure 5-1B).  
The targeting signals affecting SENP1 localization are still largely 
uncharacterized. Therefore, we utilized a series of SENP1 fragments fused to GFP to 
! "#$!
identify regions important for SENP1 NPC targeting (Figure 5-2A). HeLa cells were 
transfected with constructs coding for the GFP-SENP1 fusions and stained with mAb 414 
to detect NPCs. Two SENP1 fragments, including amino acids 154-272 and 273-449 
localized to NPCs, indicating that each contains an independent targeting element (Figure 
5-2B). The signal within residues 273-449 of SENP1 was further narrowed to amino 
acids 321-400 (Figure 5-2B), which has a comparable signal to the larger fragment, 
suggesting there is a single targeting signal within the amino acid 273-449 sequence. In 
conclusion, we demonstrated that SENP1 localizes to the nucleoplasmic face of the NPC 
and that this localization is mediated by two independent elements in the N-terminus. 
  
Mitotic targeting of SENP1 is mediated by three independent elements 
During mitosis, SENP1 redistributes from NPCs to centrosomes, the mitotic 
spindle and kinetochores (Chapter 3). Thus, we next sought to investigate the signals 
affecting SENP1 localization to these mitotic structures. We have hypothesized that GFP-
SENP1 targeting to mitotic structures is dependent on interactions with nucleoporins 
(Chapter 3). We therefore investigated whether regions of SENP1 critical for NPC-
targeting were also necessary and sufficient for mitotic targeting (Figure 5-3).  
HeLa cells were transfected with GFP-SENP1 or GFP-SENP1 fragments and 
stained with antibodies specific for "-tubulin to highlight the mitotic spindle and CREST 
to identify the centromere. We identified three SENP1 fragments, containing amino acids 
41-153, 273-449, and 401-644, that were sufficient for centrosome, spindle and 
kinetochore localization. Surprisingly, only the SENP1 fragment containing amino acids 
273-449 was also sufficient for NPC targeting (Figure 5-2 and 5-3). Thus, we 
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demonstrated that GFP-SENP1 localization to kinetochore contains three independent 
targeting elements for its mitotic localization.   
 
SENP1 knockdown does not affect APC activation or cohesion stability 
 Next, we sought to further characterize the potential causes of the metaphase to 
anaphase transition delay observed with SENP1 knockdown (Chapter 3). One potential 
mechanism may involve improper activation of the anaphase promoting complex (APC) 
in SENP1-depleted cells, resulting in hyper-stable cohesion. However, a recent analysis 
of SENP1-/- DT40 chicken cells showed that the absence of SENP1 destabilized cohesion. 
Thus, we characterized the effects of SENP1-depletion on APC activation and cohesion 
stability.  
To evaluate APC activity, we analyzed cyclin B1 protein levels, a known APC 
target, at various stages of mitosis. As predicted, cyclin B1 staining was very high in the 
early mitotic stages, declined at the metaphase to anaphase transition, and was completely 
absent from anaphase cells (Figure 5-4A) (27). Control and SENP1-depleted cells 
exhibited comparable cyclin B1 staining, indicating that APC activation is normal in the 
absence of SENP1 (Figure 5-4A).   
 Next, we investigated the effects of SENP1-depletion on sister chromatid 
cohesion maintenance. We evaluated the ability of SENP1-depleted cells to maintain 
cohesion when cultured in the presence of nocodazole. Control and SENP1-depleted cells 
were both synchronized to similar levels following overnight nocodazole treatments, 
indicating the absence of SENP1 does not promote mitotic slippage (Figure 5-4B). In 
addition, we characterized cohesion stability after SENP1-depletion in the absence of 
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microtubule destabilizing agents by conducting a chromosome spread analysis. Under 
normal mitotic cycling, chromosomes can be observed with sister chromatid cohesion 
intact, partially separated or completely separated (Figure 5-4C). Over 200 cells were 
quantified for control and SENP1-depleted cells, but no significant differences in 
cohesion distribution were observed (Figure 5-4D). In summary, our studies exhibited no 
defects in APC activation or cohesion stability after SENP-1 depletion. 
 
SENP1 knockdown does not cause morphological changes in the mitotic spindle or 
kinetochore structure  
 SENP1 localizes to the mitotic spindle, suggesting a possible function for 
desumoylation in spindle structure or function. Thus, we analyzed the mitotic spindle 
morphology in SENP1-depleted cells.  
First, we investigated the general spindle morphology by "-tubulin staining. 
However, SENP1-depleted cells had mitotic spindle structures comparable to control 
cells (Figure 5-5A).  Next, we sought to investigate if mitotic spindles in SENP1-depleted 
were unusually sensitive to treatment with a microtubule destabilizing agent. We treated 
control and SENP1-depleted cells with nocodazole overnight followed by a 2 hour 
release to allow mitotic spindle reformation. Control and SENP1-depleted cells exhibited 
mitotic spindles in various stages of reformation, indicating SENP1-depeletion did not 
cause enhanced nocodazole-sensitivity (Figure 5-5B). Finally, we investigated whether 
SENP1 is required for the proper spindle positioning within mitotic cells. Previous 
studies have shown #1-integrin-depletion results in the metaphase plate formation very 
close to the cell cortex (28). Thus, we utilized TRIM28-staining to visualize the 
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cytoplasm and determine the position of the metaphase plate relative to the cell cortex 
(Figure 5-5C). No changes in metaphase plate position were observed SENP1-depleted 
cells compared to controls. In conclusion, our analysis did not detect any obvious defects 
in mitotic spindle morphology. 
 Even though mitotic spindle morphology was normal in SENP1-depleted cells, 
defective kinetochore-microtubule attachments could also cause a metaphase to anaphase 
transition delay. Thus, we analyzed the localization of eight different centromere and 
kinetochore proteins in prometaphase, metaphase and anaphase to characterize 
kinetochore assembly and structure. The recruitment and dynamics of CENP-E, CENP-F, 
CREST (CENP-A, B and C), Hec1, INCENP, and Nup358 were unaffected by SENP1-
depletion (Figure 5-6). Thus, we detected no obvious defects in the general centromere 
and kinetochore structure. 
 
The metaphase to anaphase transition delay observed in SENP1-depleted cells is 
caused by improper inactivation of the SAC   
 Previous studies have shown that improper inactivation of the SAC results in a 
metaphase to anaphase transition delay comparable to our observations after SENP1-
depletion (29-31). Therefore, we utilized a recently identified inhibitor of the SAC, 
reversine, to determine if the mitotic delay observed with SENP1-depletion depends on 
SAC activity (32). First, we demonstrated that reversine treatment inhibits SAC activity 
by causing mitotic slippage in the presence of nocodazole (Figure 5-7A). HeLa cells were 
treated with two independent oligos specific for SENP1 for 48 hours and treated with 
reversine to inactivate the SAC for 1.5 hours prior to harvest. Strikingly, the 2-3 fold 
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increase in mitotic index observed in SENP1-depleted cells was rescued by reversine 
treatment, indicating that the SAC activity is required for the SENP1 knockdown mitotic 
delay phenotype (Figure 5-7B).  
Next, we evaluated the recruitment and release of Mad2, a core SAC component, 
in SENP1-depleted cells. In the early phases of mitosis, Mad2 is recruited to kinetochores 
unattached to the mitotic spindle, which was observed in control and SENP1-depleted 
cells (Figure 5-7C). Following proper chromosome alignment, Mad2 is released from 
kinetochores, which is clearly observed in the control cells (Figure 5-7C). Notably, Mad2 
foci are still detectable at kinetochores of chromosomes that have aligned on the 
metaphase plate in SENP1-depleted cells, indicating that Mad2 release is delayed. 
However, there is not a complete block in Mad2 release because Mad2 is no longer 
detectable on kinetochores in anaphase of SENP1-depleted cells (Figure 5-7C). Thus, we 
have demonstrated that the metaphase to anaphase transition delay observed after SENP1 
depletion requires the SAC, and that Mad2 is improperly retained at kinetochores. 
 
SENP1 knockdown results in a delay in S phase progression  
 We have characterized the function of SENP1 in mitotic progression, but previous 
studies have demonstrated that SENP1 knockdown caused cells to arrest in G1 or senesce 
(5,12). Thus, we investigated if there were any other cell cycle delays in our SENP1-
depleted HeLa cells. We utilized FACs analysis to evaluate the DNA content of cells 
after SENP1 knockdown. There was a statistically significant increase in the number of 
cells in S phase, indicating that there is a prolonged S phase after SENP1 depletion 
(Figure 5-8). A reciprocal reduction in the number of cells in G1 was also observed. 
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Surprisingly, a statistically significant increase was not detected with both SENP1-
specific oligos in the G2/M population. However, the mitotic progression phenotype after 
SENP1 depletion we characterized by live cell imaging was only a 1 to 2 hour delay and 
thus, was likely below the threshold of detection by this assay. Further analysis is 
required to determine the functional significance of the prolonged S phase observed in 
the absence of SENP1.  
 
SENP1 has unique localizations in different cell types because of its dynamic nuclear 
shuttling  
 In this study, we focused on the function of SENP1 in HeLa cells, but SENP1 has 
been reported to localize to nuclear speckles, the nucleoplasm, the cytoplasm, or the NPC 
depending on the cell type analyzed (18,19,22) (Chapter 3). Thus, we sought to 
investigate this cell type dependent localization of SENP1 further. Kim and colleagues 
previously demonstrated that amino acids 634-644 constitute a NES that is necessary and 
sufficient for SENP1 nuclear export. Furthermore, the NES was responsible for GFP-
SENP1 localization to the cytoplasm in CV-1 cells, as GFP-SENP1 !NES, a construct 
encoding amino acids 1-633 of SENP1, exhibited a nucleoplasmic localization (19). 
Thus, we determined the cellular localization of GFP-SENP1 in HeLa and HEK 
293T cells. In both cell types, SENP1 was enriched at the nuclear rim, indicative of NPC 
staining (Figure 5-9A). However, GFP-SENP1 also exhibited a strong cytoplasmic 
localization in HEK 293T cells under all expression levels, while HeLa cells expressing 
low to moderate levels of GFP-SENP1 exhibited a more restricted NPC localization 
(Figure 5-9A).  
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Next, we sought to determine if SENP1 nuclear shuttling was important for the 
differential localization observed in HeLa and HEK 293T cells. Thus, we transfected both 
cell types with GFP-SENP1 WT or GFP-SENP1 !NES and conducted a fluorescence 
microscopy analysis. Strikingly, the cytoplasmic localization in HEK293T cells was 
significantly diminished, with the majority of GFP-SENP1 !NES localizing to the 
nuclear rim (Figure 5-3B). SENP1 localization in HeLa cells, on the other hand, was 
unaffected (Figure 5-3B). Thus, the cytoplasmic localization of GFP-SENP1 in HEK 




 SENP1 localizes to NPCs in interphase and relocalizes to kinetochores, 
centrosomes, and the mitotic spindle during mitosis. Furthermore, SENP1-depletion 
results in a metaphase to anaphase transition delay that is rescued by WT but not the 
catalytically dead versions of SENP1 (Chapter 3). In this study, we further characterized 
the localization of SENP1 in interphase and mitosis and determined that the mechanism 
for SENP1-dependent regulation of the metaphase to anaphase transition involves the 
SAC. 
 Our studies demonstrated that SENP1 localizes to the nuclear face of NPCs 
(Figure 5-1). SENP1 is known to bind Nup153, Nup358 and the Nup107-160 subcomplex, 
but only Nup153 and Nup107-160 are found on the nucleoplasmic side of the NPC 
(20,33,34) (Chapter 3). Thus, we would speculate that Nup153 and Nup107-160 are 
important for SENP1 NPC localization. Intriguingly, two core SAC proteins Mad1 and 
Mad2 also localize to the nuclear face of NPCs in interphase and in this study, we 
demonstrated that SENP1 is an important regulator of the SAC (Figure 5-7) and (35). 
These findings suggest that SENP1 may regulate the localization or function of Nups or 
Mad proteins on the nucleoplasmic face of NPCs in interphase.  
In addition, we demonstrated that SENP1 has two independent NPC targeting 
signals: amino acids 154-272 and 321-400. Intriguingly, amino acids 186-199 
(VQEEEREIYRQLLQ) of the SENP1 N-terminus are highly conserved with the region 
of SENP2 known to bind the Nup107-160 subcomplex (24). Thus, we hypothesize that 
the region of SENP1 between amino acids 154-272 promotes NPC-targeting through 
interactions with the Nup107-160 subcomplex. The region of SENP1 between amino 
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acids 321-400 may mediate interactions with Nup153 or the Mad proteins. In the future, 
we can utilize the two NPC targeting elements of SENP1 in co-immunoprecipitation 
experiments to determine the protein-protein interactions that mediate SENP1 association 
with NPCs.  
 We mapped three targeting elements of SENP1 sufficient for mitotic localization 
to spindles, centrosomes, and kinetochores: amino acids 41-152, 273-449, and 401-644. 
Surprisingly, the putative Nup107-160 subcomplex binding region, including amino acids 
154-272, was not sufficient for mitotic targeting of SENP1 even though the Nup107-160 
subcomplex localizes to the same mitotic structures as SENP1 (36). However, it will be 
critical to conduct co-immunoprecipitation experiments using the SENP1 fragments from 
mitotic cell extracts to determine which Nups or potentially SAC proteins are binding 
SENP1 and potentially promoting recruitment to kinetochores, spindles and centrosomes.  
We previously demonstrated that a chimeric protein that contained the SENP2 N-
terminus and the SENP1 catalytic domain (amino acids 419-644) called SENP2N1CAT 
does not localize to centrosomes or mitotic spindles (Chapter 3). Thus, it was surprising 
that amino acids 401-644 were sufficient for SENP1 kinetochore, centrosome and spindle 
targeting in mitosis (Chapter 3). There are multiple interpretations for this result. First, 
this finding could suggest that the amino acids 401-418, which were not in the chimeric 
protein SENP2N1CAT, contain a critical targeting element for centrosomes and spindles.  
This is supported by the observation that the smaller SENP1 fragment containing amino 
acids 320-400 was insufficient for centrosome and spindle targeting. However, we cannot 
rule out that the SENP2 N-terminus could have a dominant targeting element that masked 
the spindle and centrosome targeting elements in the SENP1 catalytic domain. In 
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summary, these findings warrant further investigation of the SENP1 mitotic spindle and 
centrosome targeting element potentially present between amino acids 400-418 of the N-
terminus or within the catalytic domain of SENP1.  
 Next, we sought to characterize the molecular mechanism involved in the 
metaphase to anaphase delay observed in SENP1 knockdown cells. No defects were 
observed with APC activation, sister chromatid cohesion, mitotic spindle morphology, or 
general kinetochore structure in the absence of SENP1. Notably, we demonstrated that 
the delayed mitotic progression observed after SENP1-depletion depends on the SAC. 
Furthermore, the absence of SENP1 causes retention of Mad2 at kinetochores after 
bipolar attachment, which indicates that the SAC inactivation is defective. Intriguingly, 
the SAC proteins Mad1 and Mad2 are known to bind the nucleoplasmic side of the NPC, 
which mirrors SENP1 interphase localization (35). Thus, we hypothesize that SENP1 
interacts with SAC proteins throughout the cell cycle and regulates their function at the 
metaphase to anaphase transition.  
There are three molecular mechanisms described in the literature for a metaphase 
to anaphase transition delay caused by abnormal retention of SAC proteins at 
kinetochores. Mps1 is a kinase critical for SAC protein recruitment to kinetochores. 
Intriguingly, when Mps1 is artificially tethered to kinetochores, a SENP1-like phenotype 
is observed (31). Of note, Mps1 was identified as a SENP1-interacting protein by 
preliminary BioID and mass spectrometry analysis, further suggesting that SENP1 may 
regulate Mps1 activity (Unpublished, Dr. Brian Raught, Univeristy of Toronto). In 
addition, a SENP1-like phenotype occurs after knockdown of dynein. Dynein facilitates 
the removal of Mad2 from properly bioriented kinetochores and dynein knockdown 
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results phenotype that mimics SENP1-depletion (30). Finally, knockdown of Spindly, a 
relatively uncharacterized SAC protein, blocks proper dynein recruitment and thus 
phenocopies a dynein knockdown (29). In the future, we will investigate if SENP1 
interacts with Mps1, dynein or spindly, which could provide insights into precisely how 
SENP1 regulates SAC function.   
In summary, our investigations have identified SENP1 as a novel regulator of the 
SAC. The common localization of SENP1 and Mad1 and Mad2 to the nucleoplasmic face 
of the NPC in interphase and the abnormal retention of Mad2 at bi-oriented kinetochores 
after SENP1-depletion suggests that SENP1 interacts with SAC proteins throughout the 
cell cycle. Further investigation of the SUMO modification of SAC proteins throughout 
the cell cycle and after SENP1-depletion will be vital in further characterizing the 
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Figure 5-1. SENP1 localizes to the nucleoplasmic face of the NPC. (A) HeLa cells 
were fixed and permeabilized with either Triton-X 100 (TNX-100) or digitonin. Cells 
were stained using antibodies specific for SENP1, Tpr or Nup358 and analyzed by 
immunofluorescence microscopy. (B) HeLa cells were transfected with GFP-SENP1, 
fixed and permeabilized with either TNX-100 or digitonin 48 hours after transfection. 
Cells were stained using antibodies specific for GFP and analyzed by 




Figure 5-2. SENP1 targeting to the NPC is mediated by two independent targeting 
elements. (A) Cartoon schematic showing the known domain structure and targeting 
elements of SENP1. The SENP1 fragments utilized in this study are also depicted. The 
N-terminal domain is shown in blue and the catalytic domain (CAT) is shown in green. 
The following elements are also highlighted: the nuclear localization signal (NLS) is 
yellow, the catalytic cysteine is cyan (C603) and the nuclear export signal (NES) is red. 
(B) HeLa cells were transfected with WT GFP-SENP1 or GFP-SENP1 fragments. Cells 
were harvested 48 hours after transfection, fixed, permeabilized with TNX-100 and 
stained with mAb 414, which recognizes Nup62, Nup153, Nup214 and Nup358. DNA 






Figure 5-3. SENP1 mitotic targeting is mediated by three independent targeting 
elements. HeLa cells were transfected with GFP-SENP1 full length and the indicated 
GFP-SENP1 fragments for 48 hours, permeabilized and fixed. Cells were stained with 
antibodies specific for !-tubulin and CREST and analyzed by immunofluorescence 




Figure 5-4. APC activation and sister chromatid cohesion are normal in the absence 
of SENP1. HeLa cells were transfected with a scramble control or a SENP1-specific 
oligo for 48 hours. (A) Cells were fixed, permeabilized and stained with a cyclin B1 
specific antibody. (B) Cells were treated overnight with nocodazole prior to harvest and 
the fraction of transfected cells in mitosis was determined by fluorescence microscopy. 
Nocodazole synchronization only results in an approximately 30% synchronization after 
siRNA knockdown (C) Cells were fixed in solution, dropped onto slides to spread 
chromosomes and stained with Geimsa. Chromosomes from cells in multiple states of 
sister chromatid cohesion are shown. (D) Quantification of the sister chromatid cohesion 
state in scramble control or SENP1 oligo treated cells. Where indicated, error bars 
represent standard deviations from two independent experiments.  DNA was stained with 




Figure 5-5. SENP1 knockdown does not affect mitotic spindle morphology and 
structure. HeLa cells were transfected with control scramble or one of two SENP1-
specific oligos (siSENP1a and siSENP1b) and harvested 48 hours after transfection. (A) 
Cells were fixed, permeabilized and stained with antibodies specific for !-tubulin and 
CREST to detect the mitotic spindle and centromeres, respectively. (B) Cells were treated 
with nocodazole overnight and washed out for 2 hours prior to harvesting 48 hours after 
transfection. Cells were fixed, permeabilized and stained with an !-tubulin specific 
antibody. Spindles in various stages of reformation were observed. (C) Cells were fixed, 
permeabilized and stained with an antibody specific for TRIM28 as a cytoplasmic marker. 




Figure 5-6. SENP1 knockdown does not affect the recruitment and dynamics of 
centromere and kinetochore proteins. HeLa cells were transfected with a control 
scramble or a SENP1-specific oligo (siSENP1a) and harvested 48 hours after transfection. 
Cells were fixed, permeabilized and stained with (A) CENP-E (B) CENP-F (C) CREST 
(D) Hec1 (E) INCENP (F) Nup358. Pictures were taken at identical exposures for each 





Figure 5-7. The metaphase to anaphase transition delay after SENP1 depletion is 
SAC dependent and results in abnormal Mad2 retention at kinetochores. (A) HeLa 
cells were treated overnight with nocodazole. 1.5 hours prior to harvest, cells were treated 
with reversine to inactivate the SAC. Mitotic indices were determined by fluorescence 
microcopy. (B) HeLa cells were transfected with control scramble or a SENP1-specific 
oligo (siSENP1a) and harvested 48 hours after transfection. 1.5 hours prior to harvest, 
cells were treated with reversine. Mitotic indices were determined by fluorescence 
microcopy. (C) HeLa cells were transfected with control scramble or a SENP1-specific 
oligo (siSENP1a) and harvested 48 hours after transfection. Cells were fixed, 
permeabilized, and stained with Mad2-specific antibodies. Arrowheads mark Mad2 






Figure 5-8. SENP1 depletion causes a prolonged S phase. HeLa cells were transfected 
with a scramble control or one of two SENP1-specific oligos (siSENP1a and siSENP1b) 
for 48 hours. Cells were trypsinized, fixed in solution and stained with propidium iodide. 
DNA content was measured with a 488 nm laser on a FACS Calibur flow cytometer. 
Error bars indicate the standard deviation of three independent experiments. Astericks 








Figure 5-9. SENP1 cytoplasmic localization in HEK 293T cells is dependent on 
SENP1 nuclear export. HeLa and HEK293T cells were transfected with (A) GFP-
SENP1 or (B) GFP-SENP1 "NES (amino acids 1-633) and harvested 48 hours post 
transfection. Cells were fixed, permeabilized and visualized by fluorescence microscopy. 




























 Sumoylation was identified as a mitotic regulator more than a decade ago, but the 
identity of the SUMO-modified proteins and how this sumoylation is regulated in mitosis 
is still poorly understood (1). In this thesis, we identified the mitotic sumoylated proteins 
through an unbiased mass spectrometry study. This work will provide a foundation for 
future characterization of how sumoylation affects the mitotic functions of the identified 
proteins. In addition, we evaluated the mitotic roles of SENP1 and SENP2 to enhance our 
understanding of SUMO regulation in mitosis. We utilized SENP2 overexpression 
studies to demonstrate that sumoylation is required for dynamic association of 
subcomplexes at the kinetochore and chromosome alignment. Furthermore, we 
demonstrated that SENP1 isopeptidase activity is required for a timely metaphase to 
anaphase transition because it is a novel regulator of the spindle assembly checkpoint 
(SAC). Finally, we conducted a literature review analyzing the functions of sumoylation 
in regulating chromatin, which may provide insight into the functions of sumoylation at 
unique chromatin environments like centromeres in mitosis.  
 
CHAPTER 2: Identification of mitotic sumoylated proteins 
 In this chapter, we conducted a large scale identification of sumoylated proteins 
associated with mitotic chromosomes. We utilized a combination of nocodazole 
synchronization, cell fractionation and immunopurification techniques to isolate the 
SUMO-modified proteins on chromosomes. As a result, we identified 149 proteins that 
are sumoylated in mitosis. Among these proteins, we identified proteins involved in 
mitotic progression, chromosome segregation, sister chromatid cohesion, anaphase 
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promoting complex regulation, mitotic spindle function, and cytokinesis, illustrating the 
diverse functions of sumoylation in mitosis. Thus, this study provides a foundation for 
further investigating the molecular mechanisms by which SUMO regulates these diverse 
mitotic processes.  
In addition, we immunopurified and identified SUMO-2/3 modified proteins from 
G0 nuclei to determine how many of the mitotic SUMO-modified proteins were also 
sumoylated at another distinct cell cycle phase. Using this analysis, we identified 89 
proteins that were modified in both G0 and mitosis, which was similar to the degree of 
overlap between our identified mitotic substrates and proteins identified in other SUMO 
mass spectrometry analyses. Notably, topoisomerase II! is among the best characterized 
mitotic SUMO-modified proteins and its modification is essential for the timely 
decatenation of the centromeric DNA and sister chromatid separation (2-5). However, 
our study showed that topoisomerase II! is sumoylated in G0 and mitosis, indicating that 
its regulation through sumoylation is not restricted to mitosis. Thus, it is important to 
recognize that sumoylation may have functionally important effects on proteins in mitosis, 
even if those proteins are also modified in other stages of the cell cycle.  Determining the 
functional significance of sumoylation in mitosis must therefore be conducted for each 
protein of interest, irrespective of whether modification is restricted to mitosis. 
 Now that a list of chromosome-associated proteins modified by SUMO-2/3 in 
mitosis has been generated, further analysis needs to be conducted for the substrates of 
interest. For example, KIF4A was identified as a mitotic sumoylated protein and is 
known to regulate chromosome condensation and segregation (6). Thus, we need to 
identify the sumoylation site on KIF4A and make mutant forms that cannot be 
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sumoylated. Then, we will be able to characterize the functional significance of KIF4A 
sumoylation in mitosis. Furthermore, it will be interesting to determine if KIF4A 
sumoylation is uniquely regulated in mitosis. Our preliminary immunoblot analysis 
demonstrated that more KIF4A was sumoylated in G0, but our experimental design had 
many caveats that make a direct comparison of sumoylation levels impossible. Thus, 
conducting immunopurifications with KIF4A antibodies and then immunoblotting for 
SUMO, will be critical to evaluating quantitative changes in modification between stages 
of the cell cycle. 
 
CHAPTER 3: SENP1 and SENP2 regulate mitotic sumoylation 
 
 In this chapter, we demonstrated that SENP1 and SENP2 are temporal and spatial 
regulators of mitotic sumoylation. They both localize to NPCs in interphase and 
kinetochores in mitosis, but SENP1 has additional mitotic targeting to spindles and 
centrosomes. However, only SENP2 overexpression caused a chromosome congression 
defect due to defective recruitment of CENP-E to kinetochores. We determined that this 
unique mitotic function of SENP2 depends on its interactions with the Nup107-160 
subcomplex and karyopherin !3. Furthermore, we showed that SENP1 interacts with the 
Nup107-160 subcomplex but not karyopherin !3, suggesting that the SENP2 interaction 
with karyopherin !3 is the distinction between the SENP1 and SENP2 overexpression 
effects on mitotic progression. Finally, we conducted siRNA knockdown experiments for 
both isopeptidases but only SENP1 knockdown resulted in a mitotic phenotype. SENP1 
depletion caused a delay in the metaphase to anaphase transition, which was rescued by 
expressing siRNA-resistant WT SENP1 but not the catalytically dead forms. Thus, we 
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demonstrated that SENP1 and SENP2 have unique and non-redundant functions in 
regulating mitosis.  
 To further understand how SENP1 and SENP2 differentially regulate mitosis, it 
will be critical to identify what substrates each isopeptidase desumoylates. Because 
SENP-substrate interactions are transient, these interactions are difficult to identify by 
classical immunopurification techniques. Thus, we have begun to utilize a recently 
described technique for producing biotin ligase fusion proteins that is very sensitive for 
detecting protein-protein interactions (7). For these experiments, we will express SENP1 
or SENP2 proteins fused to the BirA ligase domain and culture cells with excess biotin. 
Then, the SENP interacting proteins will be isolated by streptavidin purification and 
identified by mass spectrometry. Utilizing this proteomic approach, we will identify 
SENP1 and SENP2 interacting proteins and specifically look for proteins that are bound 
uniquely by one of the two isopeptidases. Furthermore, if kinetochore proteins are not 
identified by these methods, we could combine cell synchronization techniques and 
precisely time the addition of biotin to enrich for proteins that interact with SENP1 and 
SENP2 during specific cell cycle stages.  
 
CHAPTER 4: SUMO regulates chromatin 
 In this chapter, we conducted a literature review to illustrate the multi-faceted role 
of SUMO in regulating chromatin structure. We reviewed evidence that SUMO regulates 
transcription in a dichotomous fashion, promoting and antagonizing transcription 
depending on the SUMO substrate. Furthermore, we described the many functions of 
sumoylation in unique chromatin structures like centromeres, telomeres, and rDNA. 
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Overall, our study demonstrated that SUMO is critical for many components in 
chromatin regulation.  
 The functions of SUMO in interphase chromatin can have profound impacts on 
mitotic progression. For example, chromosome hypocondensation is observed in MEFs 
hypomorphic for Ubc9 and in flies lacking a the SUMO E3 ligase Su(var)2-10, indicating 
sumoylation is required for proper chromosome condensation (8,9). However, 
chromosome condensation defects can also be caused by problems in chromatin structure 
(10). Thus, it is unclear if sumoylation is directly regulating chromosome condensation or 
if the mitotic condensation phenotypes in the absence of sumoylation are merely an 
consequence of defective chromatin structure. Thus, when investigating mitotic 
phenotypes related to chromosome condensation or centromere structure, it will be 
critical to take into account the effects of SUMO on chromatin structure.!!
 In addition, recent work has demonstrated that many chromatin modifying 
enzymes specifically relocalize to centromeres and kinetochores in mitosis, suggesting 
potential mitotic functions for chromatin modifiers (11). Furthermore, our mass 
spectrometry study identified many chromatin remodelers that are sumoylated in both 
mitosis and G0. Thus, it is exciting to speculate that sumoylation of chromatin modifying 
enzymes may regulate their activities in potentially interphase or mitosis. Thus, this 
review provides a foundation for evaluating and understanding the effects of SUMO 





APPENDIX: SENP1 regulates SAC activity 
 In this appendix, we further characterized interactions of SENP1 with the NPC 
and its functions in mitosis. First, we demonstrated that SENP1 localizes to the 
nucleoplasmic side of the NPC and that it has two independent NPC-targeting domains. 
Surprisingly, we demonstrated that SENP1 mitotic localization is mediated by multiple 
domains that are at least partially unique from SENP1 NPC-targeting. Next, we further 
characterized the metaphase to anaphase delay observed with SENP1 knockdown. Sister 
chromatid cohesion, mitotic spindle morphology, kinetochore structure, and activation of 
the anaphase promoting complex were all normal in the absence of SENP1. Notably, we 
demonstrated that the metaphase to anaphase delay caused by SENP1 depletion was 
dependent on the SAC and resulted in abnormal retention of Mad2 at kinetochores, 
indicating that SENP1 is a novel regulator of SAC function.  
 To further investigate the mechanism of SENP1 mitotic regulation, we will 
characterize the interactions between SENP1 and the SAC proteins. Notably, 
manipulations of dynein, spindly and mps1 have been reported to exhibit similar 
phenotypes to the SENP1 knockdown, so we will determine if SENP1 regulates their 
mitotic functions (12-14). Furthermore, we will analyze the sumoylation status of SAC 
proteins in the presence and absence of SENP1. Notably, BubR1 has already been shown 
to be sumoylated after long exposures to nocodazole (15). In addition, a more critical 
analysis of the dynamics of SAC recruitment and release in SENP1-depleted cells will 
strengthen our conclusion that SENP1 is required for the inactivation of the SAC at 
anaphase initiation. Finally, Mad1 and Mad2 are SAC proteins that localize to the nuclear 
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basket just like SENP1 in interphase, so will determine if SENP1 interactions with Mad1, 
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